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Sam*"" 
The health situation in Sub-Saharan Africa is complex and multifactorial. Along with its poorly 
developed economy and lack of basic health services, vector-borne diseases and nutritional 
disorders are major contributors to the high morbidity and mortality seen today. Malaria and 
anaemia due to iron deficiency and/or to infectious diseases are rampant in the area affecting its 
population in general women and children in particular. Although the problem of iron deficiency 
and anaernia was dealt with varying strategies in different places iron supplementation is widely 
used in many developing countries and has become a routine procedure in maternal and child 
health programmes. In recent years, however, there has been a growing concern regarding this 
approach due to the emergence of conflicting evidence on the health outcome of iron 
supplementation. In addition to the beneficial effect of iron supplementation, a possible adverse 
effect on health, particularly on the risk to malaria, has been suggested. The continued controversy 
has raised doubts as to whether to implement iron supplementation programmes in malaria 
endemic areas. 
A randomised, placebo-controlled field trial was conducted in a malaria endemic area in the north- 
western part of Ethiopia in May 1993-October 1995 to determine the haernatological response to 
oral iron supplementation and measure the risk of malarial illness associated with iron. The study 
involved 776 women and 841 children with low haemoglobin (HB) level who were randomly 
allocated to receive oral iron or a look alike placebo for a period of 12 weeks. 
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The results of this study showed that anaernia is common in the study population with prevalences 
of 72.3% and 84.6% among women and children respectively. The content of the staple diet in the 
area was generally iron insufficient. The dietary iron insufficiency was further realised to be both 
due to inadequate intake and poor absorption of the iron ingested. The supplementation for 12 
weeks was completed by 729 (93.9%) women and 740 (88%) children in the study. After 
supplementation more women (82.6%) and children (93.5%) in the iron group showed an 
improvement in their FIB compared with those women (54.6%) and children (43.7%) in the 
placebo respectively. The mean HB rise was also significantly higher in women and children in 
the iron than in the placebo group, 1.43 vs 0.28 g/dL, (t= 12.6; p<0.0001) for women and 1.38 vs 
0.22 g/dL Q=21.3; p<0.0001) for children respectively. After supplementation women and 
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x children with severe anaemia were fewer in the iron (5.1% and 0.3%; 17.2; p<0.001) than in 
the placebo group (13.5% and 8.0%; y, 2 =27.9; p<0.001) . After supplementation more women 
(9.6%) and children (18.2%) in the iron group reached the HB cut-off point showing no anaernia 
(X2 X2 than women (1.4%) and children (9.6%) who received placebo " =23.9; p<0.001 and =34.3; 
p<0.001 for women and children respectively). 
Post-supplementation prevalences of clinical malaria among women in the iron and placebo groups 
were 24.2% and 18.3% respectively (RR=1.3, C1,1.0-1.8). The parasite rate was also higher in the 
iron supplemented women than those in the placebo, 29.4% and 20.2% respectively (RR=1.47, Cl, 
1.4-1.9). During supplementation, women in the iron group experienced more frequent episodes of 
fever and spent more days with fever than women in the placebo group, (RR=1.16, CI, 1.03-1.30). 
Similarly, clinical malaria was diagnosed in 19.7% and 13.2% of children in the iron and placebo 
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treatment groups respectively, (RR=1.49, CI, 1.07-2.08). Splenomegaly in children was detected 
in 27.3% of those in the iron 19.1% of those in the placebo, (RR=1.43, Cl, 1.1-1.9). The parasite 
rates for iron and placebo supplemented children were 34.5% and 27.1% respectively, (RR=1.28, 
Cly 1.0-1.6). Febrile episodes were experienced by 68.9% and 58.9% of children in the iron and 
placebo groups respectively, (RR=1.17; CI, 1.05-1.30. 
The results indicated not only that the dietary iron intake of the population was inadequate but also 
was poorly bioavailable due to lack of foods which enhance absorption and due to a high intake of 
food substances which interfere absorption all of which may have contributed to the anaernia. 
Study women and children who received iron supplementation have shown a substantial 
haernatological response (HB rise) and significantly improved their anaemia. The study has also 
demonstrated that there is a considerable risk of uncomplicated malaria associated with oral iron 
supplementation as malariometric indices used in this study were all significantly higher among 
women and children in the iron than in the placebo group. 
Intervention programmes involving iron supplementation in malaria endemic areas in the future 
need to weigh the health benefits and the malarial risk attributable to iron. In the present study 
area, where nearly all women and children suffer from anaernia and its consequences on health, the 
haematological response to iron supplementation outweighs the associated drawbacks. In such 
areas oral iron supplementation should therefore continue to be used to prevent and control iron 
deficiency and anaemia. Public health activities pertaining to the control and prevention of malaria 
and/or anaernia should, however, protect the population most at risk from malaria when 
implementing iron supplementation during the malaria transmission seasons. 
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1.1. background. ý introduction 
6ýý Oote 
A. BACKGROUND 
1.1. INTRODUCTION 
The poor quality of life in terms of high morbidity and mortality seen today in the 
developing world, particularly in Sub-Saharan Africa, is increasingly unacceptable. 
Causes are multifactorial and complex. Along with prevailing under-development 
and poverty, vector-borne diseases, nutritional disorders and lack of basic health 
services are major contributors to this situation. 
Vector-borne and other endemic tropical diseases are rampant, malaria being the 
most important. It is estimated that about 2200 million people in the world are 
exposed to malaria infection and that about 300-500 million clinical cases occur each 
year. In Africa alone, over 275 million people are infected with a total of over 100 
million clinical cases annually. In malaria endemic areas, about 10% of deaths of 
infants and children below 14 years of age is attributed to malaria. Women and 
children are the groups most at risk of developing and dying from malaria. 
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1.1. background: introduction 
Besides malaria, women and children are at risk of many other health problems, of 
which deficiency of nutrients, including iron, is one of the most important. Anaemia 
in women and children can result from various causes, but nutritional deficiency and 
infectious diseases are the most important. Apart from dealing with underlying 
causes, combating iron deficiency and anaernia requires supplementation with 
elemental iron and food fortification; the former approach is a relatively feasible 
strategy in developing countries. 
It has been asserted that iron deficiency and anaernia impairs the optimal functioning 
of the immune system thus predisposing the individual to an increased risk of 
infections including malaria but this view has been questioned in recent years by new 
evidence to the contrary. Reports of an increased risk of malaria and other infections 
in association with iron supplementation continue to appear. As a result, the iron- 
malaria controversy continues to divide the scientific community and presumably, 
affects the implementation of public health interventions against iron deficiency and 
anaernia. The issue of whether iron supplementation is beneficial or harmful in areas 
of high malaria endemicity needs to be re-examined. It is particularly important in 
countries where malaria is endemic, anaernia (nutritional and/or infectious) prevalent 
and where strategies to control and prevent anaernia rely mainly on oral iron 
supplementation. 
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1.1. background: introduction 
The present investigation was conducted in a rural community in north-western 
Ethiopia to investigate the malarial risk among women and children given 
supplementation with oral iron. 
The design of the study was a randomised, placebo controlled, double-blind field 
trial. Women and children with anaemia were allocated randomly into oral iron or 
placebo supplementation groups and followed for a total of 12 weeks in order to 
monitor their malaria experience. In the study area, transmission of malaria is 
seasonal and follows the short and long rains, during March/April and June- 
September respectively. The supplementation trial was conducted during the rainy 
season of July-October 1994. 
This study was conducted to provide information on the possible antagonism between 
iron and malaria and to contribute to the continued effort to narrow the division in 
opinion on this subject. 
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1.2. background information on Ethiopia 
BACKGROUND INFORMATION ON ETHIOPIA 
Ethiopia is one of the oldest nations in Africa, with a history and culture identified 
with ancient civilisation and with contrasting chapters of prosperity and poverty, war 
and peace, drought and famine. Ethiopia is situated in the north-eastern part of 
Africa (known as the Horn) extending between latitudes of 3-18' north and 
longitudes of 33-48' east. The country shares international borders with the Sudan in 
the west, Kenya, Somalia and Djibouti in the south and east, and since very recently, 
with Eriterea in the north (Figure 1). The massive high plateau in the central and 
northern parts of the country is surrounded by the hot semi-arid lowlands in the west, 
east, and south and is bisected by the Rift Valley. It is estimated that about 50% of 
the land above 2000 m in Africa is in Ethiopia (Kloos, 1993). The varied topography 
and landscape of the country provides a mixture of tropical and temperate climatic 
zones which is of immense importance to the pattern of disease in different areas. 
Numerous rivers originate from the highlands and flow outwards in all directions 
through deeply incised valleys and gorges. The river basins, lakes and other water 
bodies in the country are of enormous agro-economic and public health importance. 
Ethiopia has an area of 1.25 million km 2 and is the third most populated country in 
Africa with a population of 51 million (projected from the 1984 census. CSA, 1990). 
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1.2. background information on Ethiopia 
Although a few ethnic groups (the Amhara, Oromo, Gurage and Tigre) form the great 
majority of the population, the country is home to nearly a hundred other minority 
groups. The population is largely rural and agriculture is the basis of the economy. 
In spite of the vast geographical area of the country, population settlement is very 
uneven with densely populated areas in the central highlands and sparsely populated 
regions in the lowlands. 
20 
1.2. background kTkxTmtion ion Effiiopia 
Figure 1. Map of Ethiopia 
MAP OF ETHIOPIA SAUDI ARALIA 
.......... ................ RED SEA 
................ .... . ............... 
'300 ....... 
... ....... ERITREA 
Avnoru 0 
YEMEN 
........................... ............ ............. 
........... GRAY ... 
M-Aelle .................... 
140f REA 
AF 
....................................... .............. ................................................... SUDAN Gondar 
AMHARA 
D%14; e 
6ENIS AN'so, 
-'-"::::::: 
':::::: GULF OF ADEN7: 
................. 
------- ------------------- ... ........ . ..................... ..................... 
........... 
------- ----- --------- ------ --- 
Dim Dc-o 
ADDIS A&ABA 
G4A AGI 
G A. Ai. E E LLA 
hA. Di rAj 
IkA. 4iBAT7,4 - 4c 
C) C, T. ,c "Li ER OROMO 
K-Af fA 'WOLA Y7A A%wo-so 
SCDAAýA 
UGANDA KE NYA 
SOMAULAND 
.,., 
I 
SONALI 
09ocken / SOMAIJA 
1.3. iron deficiency and anaemia 
IRON DEFICIENCY AND ANAEMIA 
Today, iron deficiency and iron deficiency anaernia are recognised as the most 
prevalent nutritional problems in the world. It is estimated that 700-1000 million 
persons are affected with anaernia (DeMaeyer et al., 1989). The distribution of 
anaernia varies greatly between different population groups and in different 
geographical regions. The literature on iron deficiency anaernia reveals clearly that 
developing countries in Asia, Africa, and Latin America are disproportionately 
affected (Royston, 1982; DeMaeyer and Aiels-Tegman, 1985; DeMaeyer, 1989). The 
distribution in developing regions is also markedly variable, sub-Saharan Africa and 
South East Asia being most affected. 
Nutritional anaemia results from inadequate intake or poor absorption of iron, folate 
or vitamin B12, but it is deficiency of iron that is by far the most important 
contributor (WHO, 1959; Hofvander, 1968; Cook and Finch, 1979; DeMaeyer, 1989). 
Dietary iron which is absorbable from the intestine is in two main chemical forms,, 
haem and non-haem iron. Haem iron is present in animal products such as meat, fish, 
and poultry, while the sources of non-haem iron are mainly cereals, legumes, 
vegetables and other foods of plant origin. Absorbability (bioavailability) of the two 
chemical forms of iron is different and absorption is by different pathways (Hallberg, 
1981). Haem iron is more bioavailable than non-haem iron and it is generally agreed 
that 20-30% of haem iron is absorbed. 
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1.3. iron deficiency and anaemia 
In contrast, as little as 1-8% of non-haem iron in plant diets, even those rich in iron 
content is absorbable (Monsen et al., 1978; Hallberg, 1981). In most rural parts of 
developing countries, green leafy vegetables, legumes and cereals form the main part 
of the diet. Such diets contain insufficient iron and consequently absorption of 
dietary iron is very low. A cereal and legume-based diet also contains substances 
capable of chelating dietary iron and diminishes its bioavailability. These substances 
such as phytic (phytates) and phosphoric acids which interfere with the 
bioavailability of minerals are sometimes referred to as antinutrient substances 
(WHO, 1959; Hofvander, 1968; Hallberg, 1981). In many cases, African children 
and women whose cereal diets contain these inhibiting substances are victims of iron 
deficiency anaernia not only due to their high physiological demand but also due to 
inadequate intake and poor absorption of the dietary iron available. Under such 
circumstances in developing countries, iron deficiency can start early in life because 
of the adoption of plant-based diets immediately after weaning, although iron in 
breast milk is highly bioavailable and provides considerable protection during 
infancy. 
Anaemia secondary to infectious diseases is also prevalent in most areas in the tropics 
and lowland areas. Malaria contributes to anaernia in endemic areas. Another 
common parasitic disease which causes blood loss and anaernia is hookworm 
infection which generally shares a geographic distribution with malaria. 
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There is an inverse relationship between hookworm infections and altitude, with a 
higher prevalence of hookworm infection in lowlands with an altitude of <2000 m. 
below sea level (Jemaneh and Tedla, 1984; Tedla and Jemaneh, 1985). There is an 
overlap in the geographical distribution of malaria and hookworm which together 
may lead to severe anaernia. 
Many studies have shown that iron deficiency and anaemia are more prevalent among 
women of reproductive age and children, due to the extra physiological demand for 
elemental iron in these subjects. A world wide review (DeMayer and Adiels- 
Tegman, 1985) showed that, on average, the proportion of non-pregnant women with 
anaernia in the world is 40% against a figure of 15% among men. This global review 
documents that the prevalence of anaernia among women and men is 37% and 27% in 
Africa, 23% and 11% in Latin America, and 47% and 17% in Southern Asia. Even in 
the developed world, the distribution pattern between women and adult males 
remains similar (14% and 2% anaernic respectively). During their reproductive 
period women experience a regular cycle of menstrual blood loss, an average of 40 
ml per period, (Jacobs and Butler, 1965; Hallberg et al., 1966). This suggests that a 
normal menstruating woman needs on average an extra 0.6-0.8 mg per day of iron 
which is about a 75% increase over the usual daily requirement of 1 mg. An even 
higher intake is needed in about 10% of women who have an abnormally high loss Of 
blood at menstruation. 
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Contraceptive use can influence menstrual blood loss. Hormonal preparations (pills) 
are known to decrease blood loss by 50% (Guilleband et al., 1976) and their use can 
reduce the risk of iron deficiency anaernia. On the other hand, intra-uterine devices 
increase average blood loss by 35%-150% (Guilleband et al., 1976). However, 
contraceptive usage in areas where iron deficiency is likely is very low. For example, 
contraceptive usage by women in Ethiopia is less than 2-5% (MOH unpublished 
document, 1989). 
During pregnancy, a woman's demand for iron increases greatly due to foetal and 
placental development. Overall the demand for iron during and a little after 
pregnancy increases by an extra 35-70% with a dramatical increase during the last 
trimester when iron requirements are more than six times greater than the 
requirement of a non-pregnant women of the same age (Royston, 1982; INACG, 
1981). The global prevalence of anaernia among women during pregnancy was found 
to be 51.0%, ranging from 3-100% and prevalences in South Asia and Africa were 
65% and 63% respectively (DeMayer and Adiels-Tegman, 1985). Following blood 
loss during birth, lactating women continue to require additional iron to replace this 
loss and to compensate for losses to the infant through breast milk. The prevalence of 
anaernia among lactating women, although lower than that found in menstruating 
women, is still higher than that found in adult men or in non-lactating and non- 
pregnantwomen. 
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1.3-1. Iron deficiency and anaemia in Ethiopia 
In Ethiopia, information on anaernia is generally lacking. The available data are from 
either scanty focal prevalence studies or from data collected in health facilities. An 
extensive description on dietary intake of highland Ethiopians (Hofvander, 1968) 
indicated that in Ethiopia, dietary iron intake per person was among the highest in the 
world, largely due to consumption of the iron rich cereal Eragrostis Abyssinica, 
locally known as teff, which is a staple food in most parts of the country. Hofvander 
estimated the average iron intake to be 433 (98-1400) mg per day, which is very 
much higher than the recommended daily allowance of 15-30 mg per day (WHO, 
1959). As mentioned earlier, absorption of iron depends on factors which influence 
its bioavailability. Bioavailability (absorbability) of non-haem iron from plant 
sources is estimated to be about 2-8% of the total ingested (Monsen et al., 1978), so 
only 9-35 mg of the estimated 433 mg dietary iron ingested every day by the teff 
consuming population of Ethiopia is likely to be absorbed. This estimate of iron 
absorption suggests that the average Ethiopian's dietary iron intake is adequate, or 
even in excess of the recommended daily allowance and sufficient to prevent and 
control iron deficiency and nutritional anaernia. Thus, it would be anticipated that 
iron deficiency and anaernia would be unlikely to be a problem of public health 
concern in areas where leff is a dietary staple. 
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The very low prevalence of anaernia found in the highland study undertaken by 
Hofvander (1968) was attributed to the consumption of iron rich grain and other 
investigators have supported this view (Zewdie et al., 1993). On the other hand, 
investigations on the biochemical content of teff (Besrat et al., 1980) indicated that 
the high iron content claimed for this particular grain derives much from soil 
contamination during traditional threshing rather than from the seed itself and 
highlights the overemphasis given to this grain in relation to iron sufficiency in teff 
consuming areas. Studies on the prevalence of anaernia in the north-western part of 
the country, where teff is a staple diet (Zein and Mekonen, 1987; Zein, 1991), have 
shown a higher prevalence of iron deficiency anaemia in the lowland compared with 
highland regions, and have found a prevalence of 40.0% in areas where teff is a staple 
diet, suggesting that consumption of this grain alone is not adequate to prevent the 
population from developing anaernia. 
In the lowland parts of Ethiopia such as the present study area, other cereals such as 
millet and sorghum are grown widely and form the major source of dietary iron; 
production and consumption of teff is on only a small scale and teff is grown mostly 
as a cash crop. The problem of iron deficiency and anaernia is more widely 
distributed in the lowlands, compared with the highlands, due to additional causes 
such as malaria and hookworm infections which are more prevalent in the lowlands. 
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In some parts of the Ethiopian lowlands, the magnitude of anaernia and its overall 
prevalence, adjusted for altitude, was estimated by different investigators to be 
between 55.2% and 59.0% (Hofvander, 1968; Zein and Mekonen, 1987). 
Further data on anaernia in Ethiopia are provided by reports from health institutions. 
In a recent report from the Ministry of Health (MOH, 1991), anaernia was shown to 
be the 14 Ih most important cause of out patient visits to health institutions at all levels 
and it was the 111h most important cause of hospital deaths. It is apparent that 
hospital statistics reflect only the tip of the iceberg of anaernia, particularly of severe 
anaernia, as there are only limited health facilities where anaernic patients can obtain 
treatment. In addition, most patients with mild to moderate anaemia, who feel 
generally healthy and fit enough to engage in their routine daily work do not 
necessarily seek medical help and are unlikely to be detected by health institutions. 
1.3.2. Consequences of iron deficiency and anaemia for health 
The effect of anaernia on health is dependent on its magnitude but is also related to 
the underlying cause. Iron deficiency anaernia and its ill effects on health have been 
documented by many researchers. Infants and children with iron deficiency and low 
levels of haernoglobin suffer from impaired growth and have retarded development. 
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Young children with anaemia have poor motor co-ordination, delayed language 
development and impaired scholastic achievement (Soemantri et al., 1985; Pollitt el 
al., 1986; Pollitt et al., 1989). 
Undesired consequences of anaemia in women, particularly during their reproductive 
age, are well identified. Major health problems which affect women include an 
increased risk of maternal mortality and morbidity, foetal morbidity and mortality 
and an increased risk of low-birth weight (Oppenheimer and Hendrickse, 1983; 
Brabin et al., 1990). Maternal morbidity is believed to increase when the 
haernoglobin level falls below 7.0 g/dL and when it falls below 4.9 g/dL cardiac 
failure which is often fatal may develop (Oppenheimer and Henddrickse, 1983). 
Foetal mortality is also increased among women when maternal haemoglobin falls 
below <7 g/dL and in cases of untreated severe anaernia during pregnancy up to 30% 
of infants may die of hypoxia (Fleming, 1989). The risk of low birth weight was 
found to be significantly increased in primigravidae whose haernoglobin level was 
below 8.0 g/dL (Brabin et al., 1990). 
In anaemia, there is an impairment of the delivery of oxygen to tissues for which the 
human body compensates through increased ventilation and cardiac output. 
However, the compensatory mechanism can only be effective up to a certain degree 
and cannot overcome the deficit completely. 
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Adult populations of either sex with a low haernoglobin have a decreased capacity for 
physical work and experience fatigue more easily than people with normal 
haernoglobin levels. A positive correlation between maximum physical work and 
haernoglobin level has been shown, and work capacity increased by 83% after 
patients with severe anaernia were transfused (Edgerton et al., 1979; Edgerton et al, 
1981). In the developing world, the way of life (manual labour in the field and 
walking long distances) relies very much on physical fitness. Impaired work 
performance of adults has a major effect on the health of the individual and on the 
well-being of the family and the community at large. 
1.3.3 Treatment, control, and prevention of iron deficiency and anaernia 
The treatment of choice for confirmed or suspected cases of iron deficiency anaernia, 
is based on iron repletion, mainly in the form of medicinal iron. While individual 
patients are handled in this way, the problem of anaernia in the community is much 
more difficult to address due to the wide spectrum of iron deficiency and anaernia 
and also due to lack of health facilities for proper diagnosis and treatment. Under 
these circumstances alternative approaches which are feasible and cost effective are 
needed. These are usually based on either fortification of certain food items with iron 
or supplementation of populations most at risk with medicinal iron. 
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Many attempts to implement food fortification or to administer supplementation with 
elemental iron have been made. Iron supplementation has often been tried along with 
other primary health care programmes to control iron deficiency and anaernia in 
developing countries. Nowadays supplementation of pregnant women and infants 
with low birth weight with iron is often carried out through maternal and child health 
programmes and is promoted by international agencies, such as the World Health 
Organisation (WHO) and the United Nations Children's Fund (UNICEF). 
Prevention of iron deficiency anaernia in poor countries has not been easy and may 
be impossible to achieve under existing circumstances. In the developed world, the 
major causes of anaernia, including malaria, schistosomiasis and hookworm, have 
either been eradicated or controlled and as a result, the problem of anaernia, 
nutritional and/or infectious, has fallen sharply. In addition, because the life style and 
eating habits in the developed world allow fortification of food with iron, the overall 
improvement of the dietary intake of both haem and non-haem iron, has been 
successfully implemented and this has contributed to the low level of iron deficiency 
seen in these areas. 
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The success in the developed world will be difficult to attain in the developing world. 
Firstly, it is nearly impossible to eradicate the nutritional deficiency and infectious 
diseases which are major causes of anaernia. Secondly, conditions are less 
favourable to food fortification programmes in developing countries and these may 
be impractical. Finally, due to various socio-economic and cultural reasons, it is very 
difficult to improve and/or modify the dietary habits of rural communities towards an 
improved and balanced dietary iron consumption. As the problems associated with 
iron deficiency and anaernia do not generally lend themselves to easy solutions, it 
seems that poorer countries are left with the limited option of relying on 
supplementation of iron to prevent iron deficiency and to control anaernia. 
MALARIA IN ETHIOPIA 
As the health information system in Ethiopia is inadequate, accurate and 
comprehensive morbidity and mortality data, including that relating to malaria, is 
lacking. Over 60% of the population inhabit areas below an altitude of 2000 metres 
above sea level (CSA, 1990), the altitude previously believed to be the level above 
which malaria was no longer a health threat. However, the distribution of the overall 
population of Ethiopia indicates that two-thirds inhabit areas where malarial 
transmission exists. It is presumed that fear of malaria has prevented population 
movement into the more fertile, but malarious, areas and has resulted in the dense 
settlement found in many of the malaria-free highlands of the country. 
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In recent years, however, the demographic and settlement pattern has changed due to 
the over-cultivation and soil erosion in the densely populated highlands, and by 
forced re-settlement programmes instituted by the government. 
Malaria is accepted as a major public health problem in Ethiopia. It remains the 
single most important communicable disease with a considerable impact on the 
nation's health, economy and development. It is only in this century that useful 
information on the epidemiology of malaria in Ethiopia became available, in part as a 
result of the work of Italian and British investigators, but the overall pattern of 
malaria in the country is now more or less known. Pilot control projects were under 
way when, in 1958, a large scale epidemic hit most of the country resulting in three 
million cases and 150,000 deaths (Fontaine, 1961). Since then, cyclic waves of 
epidemics and outbreaks have been noted every few years (Negussie, 1988). 
Following the devastating epidemic in 1958, malaria control in Ethiopia has gone 
through various stages of organisational development. An eradication programme 
established in 1959 gave way to a well organised, national control programme 
operating more or less vertically within the Ministry of Health. This has recently 
been restructured and decentralised into regions, reducing the national control 
programme to a core expert team in the Ministry. 
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Assessments of malaria morbidity and evaluation of control activities in selected 
parts of the country indicated that malaria is a major public health problem in 
Ethiopia. Even though country wide information is unavailable, the magnitude of the 
malaria problem is reflected in an annual parasite index of 41.7 per thousand and a 
disease incidence of 21 per thousand population in 1989 (Negussie, 1988; Tulu, 
1989). Hospital and health centre data for 1989 (MOH, 1991) showed that malaria 
was the eighth leading cause of outpatient visits in health facilities at all levels and 
that it was the sixth most important cause of hospital isation. Nearly 5% of all 
hospital deaths were attributed to malaria. 
During the past few decades, frequent outbreaks of malaria have been experienced in 
lowland, urban centres and rural areas at an altitude above 2000 m above sea level, 
the previous geographic barrier. Changes of climate in terms of rainfall, humidity, 
and temperature and the varied topography of the country have favoured the present 
disease pattern (Tulu, 1996). The social and political instability of the past two 
decades, particularly the unpopular mass resettlement programmes in which hundreds 
of thousands of highlanders were forcibly mobilised to malarious lowlands resulted in 
epidemics and high morbidity and mortality from malaria. Cyclic famine and 
drought in the country have also led to population displacements and these large scale 
migrations have also contributed substantially to the change in the epidemiology of 
malaria. 
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Development activities with the construction of irrigation schemes and state farm 
programmes, which demanded migration of labour from the malaria free highlands to 
endemic areas, are also believed to have influenced host resistance and vector 
behaviour in favour of malaria. 
Earlier studies on vectors of malaria in Ethiopia started by Italian and British 
malariologists have been continued by the National Control Programme. So far, 
forty-two Anopheline species have been identified (Negussie, 1988), of which only 
four, An. gambiae, s. L, An. funestus, An. pharoensis, and An. nili are of public health 
importance. Because of its wide distribution in the country, An. gambiae sl is the 
most important vector. Among the species in the An. gambiae complex, An. 
arabienesis is the most important vector due to its breeding capacity in temporary 
small water collections around human dwellings and its resting and feeding 
characteristics (Tulu, 1989). 
The four species of plasmodiurn causing human malaria are known to exist in 
Ethiopia. However, the distribution and importance of each species varies within the 
different geographical regions of the country. 
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Overall, Plasmodium falciparum and P. vivax are the two most important species in 
Ethiopia comprising about 60% and 40% of all infections respectively (Tulu, 1989). 
Although P. ovale is rarely reported, P. malariae is frequently reported in the south- 
western tip of the country and both are reported in < 1% of all malaria cases. P. 
falciparum is widely distributed in much of the country being responsible for the 
malarial epidemics which result in many cases of severe and complicated malaria. P. 
vivax is the second most important species in terms of overall malarial morbidity, but 
it rarely causes epidemics or death from malaria. 
The malarial situation in Ethiopia has been aggravated by the emergence of P. 
falciparum resistant to chloroquine. Until recently, the problem of drug resistant 
malaria was observed only in the peripheral lowland areas bordering Kenya, Somalia 
and the Sudan, (Teklehaimanot, 1986). However, recent reports of chloroquine 
treatment failures in different parts of the country suggest that the problem is 
progressively moving inland (Alene and Bennet, 1996; Tulu, 1996). 
Host factors contributing to malaria in Ethiopia have not been well studied. As 
malaria is by and large seasonal and unstable, all population groups living in endemic 
areas are potentially at risk irrespective of their age, sex or ethnicity. However, it is 
well known that women and young children are the groups most affected from 
malarial morbidity and mortality compared with other population groups in areas 
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with moderate or high levels of transmission. In a study in the Gambia, cell mediated 
immunity against malaria among pregnant women, particularly among primigravidae, 
was shown to be suppressed (Riley et al., 1989). Pregnant women in Kenya have 
shown an increased prevalence of clinical malaria, with a higher parasite rate and 
parasite density, which was more marked among primigravid women than 
multigravida women (Vleugels et al., 1989). Complications of malaria such as 
anaernia, low birth weight, and an increased risk of abortion and stillbirth have all 
been documented among pregnant women (Brabin et al., 1990). 
Other host factors which influence susceptibility to malaria include genetic 
polymorphisms. Studies have pointed out that the pattern of malarial illness varies 
within various population groups exposed to the same malarial endemicity and 
similar environmental factors. Greenwood (1989) pointed out that both genetic and 
environmental factors are likely to contribute to variations in the prevalence of 
malaria between neighbouring villages and within different parts of the same village. 
Similarly, in a study in Papua New Guinea, Brabin (1988) identified a high spleen 
rate in a subpopulation of women who lived under the same conditions of malaria 
endemicity and suggested that genetic factors could have played a major role in 
explaining the differences observed. Ethiopia is home to many ethnic populations, 
and genetic variations of interest to health and disease are expected to exist. 
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However, genetic factors related to the epidemiology of malaria and other diseases in 
the country have been little studied. A study done in the south-western parts of the 
country described the presence of considerable resistance to P. vivax infection among 
people of Nilotic origin when compared to Hamito-Semites. As measured by slide 
positivity, prevalences of P vivax infections in populations of Nilotic origin and 
among Hamito-semitcs was 0.7% and 4.6% respectively (Armstrong, 1978). Further 
investigations in the same area and people revealed that people of Nilotic origin lack 
the Duffy-antigen with positivity for this antigen of 8.0% compared with 70.0% 
among the Hamito-Semitic group. The prevalence of P. vivax among the Nilotics 
was 2.4% compared with 27.3% among the Hamito-Semites respectively (Mathews 
& Armstrong, 1981). Other genetic factors relevant to malaria susceptibility are 
deficiency of glucose- 6-phosphate dehydrogenase (G-6-P-D) and presence of sickle 
cell trait (Hb S). In an earlier survey, Perine and TesfaMichael (1974) showed that 
both conditions were absent in Ethiopia except in a small tribe in the south western 
part of the country where they found two cases of G-6-P-D deficiency but no carrier 
of the sickle cell gene. In view of the vastness of the country and the diversity of the 
population it is impossible to make any firm conclusions about the likely role of 
genetic factors in predisposing to malaria in Ethiopia. 
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MALARIA AND ANAEMIA 
Anaernia is a common presenting feature of malaria which is sometimes life 
threatening, depending on the severity and duration of the infection and the intensity 
of parasitaernia (Weatherall, 1988, WHO, 1990a). Even though the mechanism by 
which malaria causes anaernia is not well defined, several studies have shown that 
malaria is an important cause of anaernia. Chronic anaernia may result from 
dyserythropoetic canges in the bone marrow due to repeated attacks of uncomplicated 
malaria while in patients with a previously normal haemoglobin, severe falciparum 
malaria can cause the rapid development of anaernia as a result of massive 
haernolysis (McGregor et al., 1956; Abdalla et al., 1980). It has been suggested that 
the pathogenesis of malarial anaernia is the result of destruction of parasitised red 
cells and enhanced erythrophagocytosis of normal red cells (Gilles et al., 1969; 
McGregor et al., 1966; Greenwood, 1987a; Abdalla et al, 1980; Royston, 1982). 
As the level of malaria parasitaemia is usually higher in young children and women 
during pregnancy, malarial anaernia is also more common and severe in these 
population groups, (Abdalla et al., 1980). 
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Anaernia during pregnancy is multifactorial and varies in cause with geographical 
locations, but malaria is often the dominant cause in malaria endemic areas (Brabin, 
1983; Fleming, 1989; WHO, 1990b). In areas where both malaria and anaernia are 
prevalent, treatment and chemoprophyl axis against malaria has usually been observed 
to improve the haemoglobin level and to reduce the incidence of anaernia. Children 
in Nigeria and pregnant women in Papua New Guinea who were protected with 
antimalarial chemoprophyl axis showed a higher mean haernoglobin level and higher 
packed cell volume compared with the control subjects (Bradley-Moore et al., 1985; 
Brabin et al., 1990). 
In malaria endemic areas, schistosomiasis and hookworm, which both cause 
prolonged blood loss and anaemia tend to be prevalent and are considered among the 
major public health problems in such areas (Roche and Layrisse, 1966; Variyam and 
Banwell, 1982; Latham et al., 1983). Frequently these disease conditions coexist 
with malaria in the same person, each playing a role in causing their anaernia. It has 
been shown that in children with a high schistosome egg counts, heavy hookworm 
infection and malaria positivity are all associated with a low haernoglobin 
(Stephenson el al., 1985) although it may be difficult to establish the importance of 
each in the causation of the anaernia, posing practical problems for treatment and 
control programmes. 
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THE EFFECT OF IRON SUPPLEMENTATION 
ON INFECTIONS AND MALARIA 
Treatment and control of iron deficiency and anaernia has depended largely on food 
fortification, on treatment of individual cases or on supplementation of groups at risk 
with medicinal iron. Although both fortification and supplementation are advocated 
as solutions to the control and prevention of iron deficiency and anaernia, the 
effectiveness and efficacy of each varies greatly, depending on the circumstances of 
the place where it is implemented. 
Over the years, particularly during the last two decades, the role of iron and its effect 
on health in general, and its role in infections in particular, has been the subject of 
substantial scientific scrutiny involving experts in epidemiology, nutrition and public 
health. Although a considerable effort has been made to investigate the role of iron 
in health and disease, results from in vivo and in vitro studies have so far been 
inconsistent. The beneficial haernatological effect of iron, given either by 
supplementation or fortification, has long been accepted and backed by the medical 
and public health professions. However, clinical and epidemiological evidence for a 
beneficial effect of iron on morbidity is rather scanty. Some studies have shown that 
iron has a protective effect against infections while others suggest that iron 
supplementation results in an increased risk of infections. 
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An early prospective study, (Andelman et al., 1966) compared morbidity patterns 
among infants given iron fortified or unfortified cow's milk. The authors suggested 
that the incidence of respiratory infections was lower among the group on iron 
fortified milk compared with the group without iron. In another study, adult male 
plantation workers in Indonesia were supplemented with oral iron for 60 days; men in 
the iron group had decreased morbidity scores and the prevalences of influenza, 
bronchitis and diarrhoea were significantly higher among those in the placebo group 
(Basta et al., 1979). Although both studies provided useful evidence on the beneficial 
effect of iron on morbidity, the reliability of the morbidity data is open to question 
due to lack of diagnostic criteria and other issues in the study design. 
Other studies have shown neither a protective nor a deleterious effect of iron 
supplementation on morbidity. In a study in India, 300 children aged <6 years 
received either oral iron or placebo for 1 year. Morbidity follow up showed that there 
was no difference in the average number of diarrhoeal attacks and respiratory 
infections among children in the two supplementation groups (Damodaran, et al., 
1979). A study from the Gambia investigated the relationship between nutritional 
status, as determined by anthropometric and measurements of iron status, and 
susceptibility to malaria among children (Snow et. al., 1991). 
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The incidence of clinical and asymptornatic malaria were not significantly different 
between children with different levels of protein calorie malnutrition and/or iron 
deficiency. It was noted, however, that children who developed a clinical attack of 
malaria accompanied by a high level of parasitaernia tended to have a higher mean 
weight-for-age and a higher mean serum ferritin level. The authors concluded that 
neither protein calorie malnutrition nor iron deficiency have a protective effect 
against clinical or asymptornatic malarial infections. 
A similar study was conducted in the Gambia to examine the combined effects of 
iron, thiamine, riboflavin, and vitamin C supplementation on the incidence of malaria 
among 5-14 year old children (Bates et al., 1987). No difference in the incidence of 
malarial episodes was found between the supplemented and the control groups. 
However, among children who developed parasitaernia, those who received 
supplementation had higher parasite counts compared with the placebo group 
implying the possibility of adverse effects of micronutrient interventions. 
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A carefully designed randomised, placebo-controlled study in Papua New Guinea 
was carried out to investigate the effect of iron therapy on malarial infections 
(Harvey et al., 1989). The study was undertaken in 318 school children, aged 8-12 
years, matched by haernoglobin levels and age who were randomised to receive either 
200 mg of iron or a look alike placebo. Children were followed for 16 weeks with 
thick and thin smears, serological assessment for antimalarial antibody and morbidity 
recall on children absent from school. No evidence was found to support an 
increased incidence of malaria among the children who received iron and the authors 
suggested that oral iron for iron deficiency can be given safely to school children in 
malaria endemic areas. The absence of adverse effects of iron supplementation on 
malaria observed in Papua New Guinea was substantiated further by a relatively 
recent iron supplementation trial in Togo, West Africa, which was conducted on 241 
children aged 6-36 months (Chippaux et al., 1991) to determine the risk of malaria 
associated with iron supplementation. Results of this study revealed that the 
frequency of parasitaernia was identical in both the iron and placebo groups and the 
prevalence of P. falciparum was identical in all three surveys, i. e. before, during and 
after supplementation of iron. It was also noted that the mean parasite density 
decreased during and after the rainy season which was in contrary to expectations and 
the authors concluded that iron supplementation did not modify the susceptibility to 
malaria in children aged 6-36 months. 
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Because iron is an essential nutrient for all living cells, including pathogens, it has 
been postulated that increasing circulating iron, following treatment or 
supplementation, will give invading organisms the opportunity to compete for iron 
and to grow in a way which would have not been possible in a state of iron 
deficiency. Thus, iron deficiency in the host could play a protective role against 
infection (Pearson and Robinson, 1976; Stockman, 1981). 
An early study investigated adult patients with iron deficiency anaernia admitted into 
a Tanzanian hospital (Massawe et al., 1974) and showed that patients with anaernia 
experienced more malarial infections following iron treatment. On the other hand, 
bacterial infections were relatively infrequent among the group receiving iron. 
Though ambiguity in case definitions of malaria, anaernia and other infections were 
all evident and the sequence of disease occurrence during admission to the hospital 
was unclear, the results of this study were among the earliest to raise the issue on the 
possible adversity of elemental iron on malarial and other infection. 
Another trial carried out among 137 Somali nomads in south-eastern lowlands in 
Ethiopia who received 900 mg of ferrous sulphate or placebo for 30 days showed an 
increased rate of disease episodes and reactivation of pre-existing malaria, brucellosis 
and tuberculosis among those anaernic subjects supplemented with iron compared 
with those given placebo (Murray et al., 1978). 
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The authors of this study on Somali nomads did not clarify whether their observation 
of increased malaria among iron supplemented nomads was a direct effect of iron or 
as has been suggested, was due to improvement in T cell function following the 
repletion of iron leading to an enhanced immune response to a pre-existing infection 
(Tomkins and Watson, 1989). This study also had methodological problems and 
lacked measures against confounders. The size of the study population was 
determined by the availability of ferrous sulphate rather than by conventional 
statistical and other objective considerations. However this study was among the 
earliest to alert the scientific community on the possible health hazards associated 
with iron supplementation. 
A more recent controlled randomised study was conducted in Papua New Guinea 
(Oppenheimer et al., 1986a) to test the hypothesis that iron deficiency increases the 
susceptibility to infections and that administration of prophylactic iron to actual or 
potential iron deficient subjects diminishes this risk. Infants aged two months were 
given 3 ml of intramuscular iron dextran and followed up for a period of one year. 
The prevalence of malaria, as measured by parasite and spleen rates, was higher in 
the first year of life among infants who received prophylactic iron dextran, a finding 
contrary to the hypothesis on which the study was based. The results revealed that 
iron dextran had a deleterious effect on all infections, particularly on respiratory 
infections. More admissions and a longer duration of hospital stay were noted among 
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infants in the iron dextran group compared with those in the placebo group. The 
observation that higher haernoglobin levels at birth were correlated with the risk of 
admission and that the deleterious effect of iron dextran was greatest among infants 
with high birth haernoglobin strengthens the conclusions of this study. Although this 
study was better designed and more carefully conducted than many of the earlier 
studies, there were some issues which may have influenced its outcome. The 
administration of parenteral iron to infants with undetermined baseline iron status 
poses a problem in interpreting outcomes and the appropriateness of the subjects 
recruited for the study. Clinical and laboratory data collection to determine outcome 
measures were conducted at intervals of 8,24, and 52 weeks after the single injection 
of iron dextran so the time between the exposure to iron treatment and the outcome 
measurements was perhaps too long to relate morbidity experiences to the treatment 
alone. The study population comprised infants with a low degree of exposure to 
malaria, so it is difficult to generalise the results of this study to other populations 
with varying status of exposure to malaria. 
A more controlled trial was conducted among Gambian children aged 6 months to 6 
years to determine their susceptibility to malaria following oral iron supplementation 
(Smith et aL, 1989). Two hundred and thirteen children were randomly assigned to 
oral iron (107) or placebo (106) treatment and followed for twelve weeks. Results of 
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this study demonstrated that the incidence of fever associated with parasitaernia was 
higher among the anaemic group receiving iron compared with children treated with 
placebo. This effect was significant in those with 10 or more high power fields 
positive for malaria parasites on microscopy. Cross sectional results, failed to show 
statistically significant differences between groups although parasite and spleen rates 
were higher among the iron supplemented than among the placebo group. The design 
of this study in the Gambia was sound and carefully conducted and its results were in 
agreement with the previous study in Papua New Guinea (Oppenheimer et al., 1986a) 
which suggested the need to reassess the role of iron in malaria endemic areas. 
Studies of iron supplementation given together with antimalarial treatments have also 
shown conflicting results. A recent study of iron supplementation given with 
chloroquine or pyrimethamine-sulfadoxine for Gambian children with uncomplicated 
malaria showed that iron was not associated with a delay in the response to anti- 
malarial treatment and found no evidence of any harmful parasitological 
consequences (van-Hensbroek et al., 1995). On the other hand a contrasting result 
was shown in another study in Malawi where children treated with pyrimetharnine- 
sulfadoxine together with iron failed to clear their parasitaernias compared with those 
given the antimalarial alone (Nwanyanwu et al., 1996). 
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Review of previous studies on this subject generally indicates that the evidence 
regarding the protective or the adverse effects of iron supplementation is 
inconclusive. Explanations on the proposed mechanism of interaction between iron 
in the host and the pathogenic agent remain inadequate to fully support either side of 
the argument. Past studies showed major differences in design characteristics and 
outcome measures. Many of them were methodologically dissimilar and they showed 
lack of uniformity in the type and size of the study population, drug formulations and 
dose, duration and route of administrations and above all in selection of outcome 
measures which are all potential factors likely to influence the results. A summary of 
previous works on iron and infection are presented in Table 1. 
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1.1. objectives of the study 
B. PURPOSE AND AIMS OF THE PRESENT STUDY 
1.1. BROAD OBJECTIVES 
Because clinical and epidemiological evidence linking malaria and iron 
supplementation is still inconclusive, the need to further work on the subject is 
apparent. The need is most urgent in developing countries, particularity in Africa, 
where anaemia is highly prevalent, iron supplementation widely used and malaria an 
important public health problem. The present study was conceived and planned 
within this frame work of public health and was carried out among populations 
where iron deficiency and anaernia are prevalent and in an area where malaria is 
endemic. 
Following a quick census and environmental assessment, a cross sectional survey was 
conducted to determine the level and distribution of iron deficiency anaemia and of 
malaria. Iron deficient and mild to moderately anaernic persons were randomly 
allocated to iron supplementation or placebo groups and followed for the 
development of malaria. This study was intended to provide information to policy 
makers and programme managers to help them in formulating new strategies for the 
treatment and/or control of anaernia and malaria. 
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SPECIFIC OBJECTIVES OF THE STUDY 
1. To determine the prevalence of anaemia among Ethiopian women 15- 
49 years and children 6-84 months of age by measuring haernoglobin 
concentration, packed cell volume and serum ferritin concentration. 
2. To assess the determinants of iron deficiency anaemia in the 
community by identifying actual and potential sources of dietary iron 
and by studying the iron consumption behaviour of community 
members. 
3. To assess the haernatologic response to oral iron supplementation and 
measure the effect on women and children with different levels of 
anaemia. 
4. To measure the risk of malarial illness among anaernic women of 15- 
49 years and children 6-84 months during and following a 12 week- 
period of oral iron supplementation. 
5. To investigate morbidity experiences by measuring the frequency of 
probable episodes of diarrhoea, acute respiratory and helminthic 
infections among children and common maternal illnesses during the 
iron supplementation period. 
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eAoAm 7ao 
STUDY METHODS 
Study area 
2.1.1. Geography & Climate: 
The study was carried out in two rural communities, one rural town and a small 
village situated in the north-western part of Ethiopia, about 900 kms north of the 
capital Addis Ababa, and 180 kms west of the historical town of Gondar. It was 
initially planned to conduct the study in the south-western part of Ethiopia. However, 
due to a change in the government and other political reasons it was necessary to 
change the study site in consultation with the Malaria Control Programme office. 
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Once it had been decided that the study should be moved to the north-western part of 
the country, one town and one village twelve kilometres apart, were chosen using 
similar criteria to those that had been used to identify the original site. The town, 
Shehdi, is relatively new one, which in the last decade, has become the administrative 
capital of the surrounding area. Many people had been attracted to this town as it has 
become an important trading centre between people in the border areas of Ethiopia 
and the Sudan. In contrast to the highland terrain to its east, which has an altitude of 
over 4500 metres, the study area is warm and only 900 meters above sea level. The 
area is covered with forests and bushes, although increasing agricultural activity is 
intensifying deforestation. The climate is generally influenced by the highlands in the 
east and the Sudanese desert in the west. The area is dry and hot for most of the year. 
There are two rainy seasons which have major importance for agriculture, nutrition 
and public health. The 'short' rains during March-April and the 'long' rains in June- 
September, locally known as belg and kiremt respectively, dictate agricultural 
productivity and the availability of food. When compared with the central highlands 
rainfall in this particular region is scanty but, if timely, it is normally sufficient for 
agricultural purposes. Although annual rainfall fluctuates from year to year, in 
1994/95 it was 82.8 mm. Similarly, the annual temperature varies greatly from 
season to season, ranging from the lower twenties in July/August to the high forties in 
April/May. During the same period of 1994/95, the annual mean maximum and 
minimum temperatures were 35.1 0C and 14.7'C respectively. 
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Socio-economic characteristics: 
The study site is situated within an area of substantial economic and agricultural 
potential as the soil is fertile and the climate favourable for agricultural crops. 
However, as for the region in general, traditional and labour intensive farming 
methods including the use of oxen and bare hands dominate and fertilisers and 
improved seed are unknown. Recently, efforts have been made to introduce large 
scale and mechanised farming by the state and private corporate groups. Large and 
small rivers cut through the area and flow westwards to join the Blue Nile. Despite 
the generous water resources, agricultural activities is predominantly rain dependent 
and irrigation is not practised. The local economy is largely dependent on the 
production of the principal cash crops such as cotton and sesame but also on millet, 
sorghum and maize which are produced for local consumption and for sale. There are 
many cattle in the area. Small scale production of dairy products and honey adds a 
little to the income of farmers. 
There are two primary schools in the study area, one in the town and another in the 
village. Most children in the town go to school but fewer children in the village do so. 
There are two radio communication installations, one in the hospital and one in 
another government institution but these are not open to the public. A postal service 
is available, but there is no telephone. 
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The study area is accessible by surface or air. There is an all weather gravel road 
leading to the area but access is difficult during the rainy seasons during which the 
road and bridges are flooded and covered with mud. There are flights to and from 
Gondar three times a week. At the start of the study no electricity was available for 
public use in the town, but a generator was installed during the study period. The 
local hospital has its own generator which runs only six to eight hours a day 
depending on the availability of fuel. Water is obtained, from a protected, deep well 
and distributed through a few stand pipes. As water supply from this source is neither 
adequate nor available at all times, residents use water from the nearby river to 
supplement their need. 
Health and disease in the study area: 
The overall health situation of the study area has not been defined. As it has long 
been an area of armed conflict between opposition forces and the previous 
government, development of health services has been severely impeded. The area 
and its people have suffered negligence from central governments and have 
experienced waves of displacement and migration due to war and its consequences. 
The one rural hospital has about 60 beds and is staffed with five doctors, fifteen 
nurses and technicians of various disciplines. The hospital provides basic diagnostic 
services except for x-rays as the machine has been out of order for more than two 
years. 
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As was true for the country as a whole, major problems facing the health service in 
the study area at the time of the survey were an acute shortage of manpower and 
supplies which was reflected in the organisational and managerial disarray observed 
during the study. There is one health centre and about four satellite health stations 
scattered within a diameter of 30-50 kilometres to the town. The hospital and its 
satellite health posts provide their respective communities with services such as ante- 
natal care, epidemic control and other primary health care activities. 
Hospital and health post records indicate that malaria, malnutrition, tuberculosis and 
onchocerciasis are the most frequent causes of morbidity and mortality in the study 
area. Review of hospital data for the year 1994/95 revealed that 12,290 patients from 
the town and its surrounding areas visited the out-patient department. A third (4001) 
of patients presented with malaria alone constituting 32.6% of all ambulatory visits. 
More than 65% of malaria cases during that year were among the population between 
the ages of 15-44 years and about 21% were among children below the age of 4 
years. Of the total malaria cases seen during the year, 182 admissions (4.5%) were 
classified as cases of severe malaria and 24 (< 1%) died in hospital. 
The hospital's annual report indicated that malaria was the single most common 
cause for ambulatory visits and hospital admissions and the second most important 
cause of hospital deaths next to tuberculosis ( Annual Report, Shehdi Hospital, 1994). 
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A team comprising field technicians and surveillance personnel, who work closely 
but independently from the hospital, are responsible for malaria control activities 
which include passive and active case detection, control of epidemics and mass drug 
administration. During the year 1994/95, the malaria team examined a total of 20,642 
blood slides of which 7374 (54.0%) were positive for malarial parasites. 
falciparum was the predominant species, being found in 77.3% of positive slides. 
The age and sex distribution of positive cases showed that more than 80% were 
identified among those aged 10 years or above whilst children below 9 years old 
comprised about 20% of all positive cases. The ratio of affected males to females 
was approximately 2: 1. The malaria team collects and sends vectors to the regional 
office though information on the local vectors was not available. Seasonal spraying 
of insecticides is also run by this team, usually in collaboration with the hospital. 
Except for some focal breeding sites along the big rivers, mosquito breeding and 
outbreaks normally follow the rainy seasons. 
Traditional medical practices and local healers contribute to the health services in the 
study area. As people live scattered across large areas where transport and 
communication systems are unavailable, the meagre health service in the area is not 
accessible to many. It is not uncommon for the local people to seek formal medical 
help only after they have exhausted all local means available to them. For this reason 
many patients present late to hospital with either a terminal illness or severe 
complications. 
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Until recently, accessibility to health services was difficult for the general population 
as military activities in the area were intense and whatever care was available was 
largely for the military or civilians participating in the war. As the civil war and 
political conflict in the country have subsided, the situation has improved and by the 
end of the study improvements in the service and working conditions of the hospital 
were being observed, new building blocks were being erected and new diagnostic 
facilities were being installed. 
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2.2. Study populations 
The target populations for this study were women aged 15-49 years and children aged 
6-84 months of age. All women and children in the two study sites were identified 
from a census which had been conducted a little earlier. Women and the parents of 
children of the specified age groups who were potentially eligible for the study were 
approached individually with a brief explanation of the purpose of the study and were 
invited to participate. Those who accepted the invitation to take part in the first 
cross-sectional survey underwent a comprehensive health assessment including 
determination of their iron status. From the survey results, it was possible to identify 
those women and children whose iron status fell below the normal cut-off values and 
for whom iron supplementation was indicated. A set of inclusion and exclusion 
criteria were prepared separately for women and children as indicated below. 
Inclusion criteria 
Women and children who satisfied the following criteria were considered eligible for 
the study: 
inclusion criteria for women 
gge-. 15- 49 years 
anaeniia & iron status: Hb ý! 6.0 and <12 g/dL for non pregnant women 
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0 
e consent: 
Hb ý! 8.0-:! ý 11.0 for pregnant women andlor 
haernatocrit of : 536% andlor serum ferritin:! ý12.0 Vtg/l 
informed consent 
inclusion criteria for children 
age: 6-84 months 
anaemia & iron status: Hb ý! 6.0 and :! ý 11.0 gm/dl andlor 
haematocrit of : 536% andlor serum ferritin : 512.0 pg/l 
* consent: verbal from parents or guardian 
exclusion criteria for women and children : 
9 prgggana: pregnant women in their third trimester at the time of 
the first survey and those reaching the third trimester 
after starting treatment 
e health status: women and children who at the first assessment were 
found to have debilitating chronic diseases or with 
acute infectious diseases 
* residence: subjects who were newly resident (<3 months) in the 
study area and those unlikely to stay for the trial period. 
9 Hb level: subjects with very severe anaemia, Hb <6 g/dL 
(<8.0 g/dL for pregnant women) 
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2.3. TYPE OF THE STUDY 
The study comprised a randomised, placebo-controlled, double-blind field trial 
(RCT), preceded by a cross sectional (prevalence) survey. The census and the cross- 
sectional survey was conducted to identify and screen subjects in line with the 
selection criteria. A schematic diagram of the study design is shown in Figure 2. 
2.3.1. Census & Cross-sectional Survey 
The selected areas were first mapped and all residential houses were identified. To 
simplify the census and the collection of follow-up data, the town was divided into 
eight temporary zones (A-H) and the small village was similarly divided into two, 
(zones A-B). All residential houses were identified and given a 4-digit house 
number, unique to each house (e. g. A098, B142, F121 and in some cases B234a and 
B234b etc. ). Eight enumerators were recruited from the hospital and the malaria 
team and trained on how to conduct the census using the sketch map of both sites. 
Enumerators were assigned to specified zones and allocated a certain number of 
houses for which they were expected to conduct a de jure census using a structured 
census forms. The primary objective of the census was to determine the size, age and 
sex distribution of the population. It was also intended to identify houses with 
women aged 15-49 years and/or children aged between 6-84 months. 
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Each household with women and/or children within the specified age groups was 
selected from the census form and a list was prepared separately for women and 
children. During a house to house visit women and the parents of eligible children 
were briefed on the purpose of the study and were invited to take part in a cross- 
sectional survey to determine their eligibility for the randomised supplementation 
trial. Those women and children who accepted the invitation and consented to 
participate were assigned a unique identification number. During the cross-sectional 
survey, data on general socio-economic and living conditions, diet and general health 
of the population were collected. The health status assessment included 
anthropornetric measurements, determination of the magnitude and distributions of 
anaernia and the presence of malaria. The sampling frame for the randomised trial 
was based on the information obtained during this survey. 
2.3.2. Randomised placebo-controlled double blind trial (RCT) 
To determine the risk of malaria in relation to oral iron supplementation, a double 
blind, placebo-controlled trial was designed which constituted the core of this study. 
All subjects who satisfied the inclusion criteria were identified and two sampling 
frames, one for women and another for children, were prepared. Though the actual 
units of the study were individual women and children, sampling units for both 
frames were households. 
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The decision to use households as sampling unit was made to ensure that women and 
children in the same household were in the same supplementation group so that 
confusion with mixing of iron or placebo preparations would be avoided. To achieve 
a balanced allocation, households were first stratified according to the size and 
number of eligible members in each house. The sampling frame was again stratified 
into blocks of four houses and within each block, houses were assigned to either iron 
or placebo groups. Details on randomisation and allocation to treatments are 
presented later in section 2.3.6. 
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Figure 2. Study Design 
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children 6-84 mths 
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yes: 776 women and 
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2.3. type of the study: treatment schedule 
2.3-3. Treatment schedule 
Drug formulation & dosages. 
Iron supplementation for women was in the form of coated ferrous sulphate tablets 
while an elixir preparation of ferrous sulphate was given to children. Look-alike 
tablet and elixir placebo preparations, identical in all physical characteristics, except 
their iron content, were used. Tablets of 300 mg ferrous sulphate (60 mg base 
elemental iron) were given to women to be taken orally once a day for a period of 3 
months. Placebo tablets were also given out with similar instructions. Tablets were 
supplied in screw top plastic containers on which the name, house number and 
identification numbers of the subject were recorded. 
Children were given 1/2-1 teaspoonful (2.5-5.0 millilitres) of iron suspension (25 
mg/millilitre) which represents a dose of approximately 3 mg/kg, administered orally 
by their mothers once a day for three months. Exactly similar procedures were 
applied to the distribution and administration of the placebo. Syrup was supplied in 
bottles of 100 ml labelled with the name, house number and identification number of 
each child. 
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Supply and reissuing of medication was done every four weeks for women and every 
two weeks for children. Supplementation was generally unsupervised, but use of 
medications was monitored by interviewers on their scheduled visit every two weeks. 
Reminders on the importance of taking the medications were given by field workers 
and supervisors at all possible times and during treatment supply schedules. 
Replacements were made at times of spoilage of tablets or spillage of suspension. 
Possible side effects were recorded and reasons for loss to follow-up and dropouts 
were recorded. 
The groups who received iron or placebo and those who supplied the medication were 
kept blind to which group a subject was allocated. The hospital pharmacist, who 
possessed the code, was responsible for preparing and refilling containers and bottles 
without any contact with the subjects. The issue of bottles and containers was 
undertaken by a pharmacy technician or the nurse on duty on the day of the supply or 
re-supply. 
After the trial all women and children who received placebo were given iron for 
twelve weeks. In addition, iron was continued for those subjects in the iron group 
whose haemoglobin level did not reach the normal cut-off level. Similarly, pregnant 
women allocated to placebo who reached their third trimester before the conclusion 
of the trial were switched to ferrous sulphate. 
67 
2.3. type of the study. ý longitudinal observation 
2.3.4. Longitudinal observation 
After 12 weeks of supplementation, women and children who completed the 
supplementation trial were observed for a further nine months. Visits were made 
every other week to each household, focusing on the outcome measures of the trial. 
House to house interviews by the same interviewers continued until the end of the 
twelfth month follow up period. 
2.3.5. Outcome measures and operational definitions 
To measure the difference in risk of malaria among anaernic women and children 
given oral iron compared with those who received placebo, indices were chosen to 
measure exposure to the risk factor (oral iron) and its outcome (malariometric indices 
and other diseases). Measurement of exposure to oral iron was relatively objective 
and straight forward. Characteristics such as dosage, duration and route of 
supplementation were known before the trial, so that status of exposure was easily 
quantifiable. 
On the other hand, measurement of the outcome, mainly the disease malaria, was 
more difficult. The wide spectrum and complexity of the disease makes simple and 
precise quantification difficult. Though demonstration of parasites in the blood 
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establishes the presence of infection, ascertaining disease in those who are parasite 
positive remains a major problem. This is especially difficult in malaria endemic 
areas where the entire population is exposed to the risk of infection and likely to host 
the parasite. Although malaria in the study area is generally seasonal, there is all year 
round transmission and infection is likely to take place early in life. In such a 
situation parasitaernia was expected to be prevalent. 
From epidemiological research and clinical studies, disease status can be 
characterised using selected criteria and disease indicators which enable 
quantification and comparison between groups or studies. In this particular study, 
indicators which could best elicit the disease and define malarial status were chosen. 
A set of the commonest symptoms and signs of clinical malaria, (splenomegaly due 
to malaria and identification of parasites in the blood) were used to determine the 
disease status. Quantification of these measures was done to generate indices which 
in turn allowed comparisons between the iron supplementation and placebo groups. 
The chosen measures were believed to be adequate to pick up differentials between 
subjects and groups and to show the relative effect of iron supplementation compared 
with that of placebo. The outcome measures and their definitions chosen for the 
study are shown below. 
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2.3.5.1. Malaria 
A study subject was considered to have experienced a malarial illness only when one 
or more of the following were demonstrated during the study period: 
9 The subject (mother of the subject in the case of a child) presented during 
the clinical assessment sessions, with signs and symptoms suggestive of 
clinical malaria and on the basis of clinical judgement a doctor diagnosed 
clinical malaria and recorded this on the individual clinical assessment 
form. 
When during clinical assessment, a doctor detected an enlarged spleen in a 
child, which in the doctor's judgement, was due to infection with malaria. 
When during a blood film examination, the laboratory technicians 
detected plasmodia on a Giemsa stained thin or thick blood smear and 
report these findings on the form provided. 
9 When during the biweekly recall interview, a subject or the 
mother/guardian of a child, reported one or more symptoms and signs of 
clinical malaria as per the list on the structured questionnaire. 
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On the basis of these definitions the following indices were used to compare findings 
in the iron and placebo groups. 
o Point prevalence of clinical malaria - the proportion of women and children 
diagnosed as having clinical malaria on the day of clinical assessment. 
9 Parasite rate and parasite density - the proportion of women and children 
whose blood smear was positive for one or more species of Plasmodium 
parasites and in those who were positive, the mean parasite count per ýtl of 
blood. 
9 Spleen rate - the proportion of children with a palpable, enlarged spleen. 
e Incidence and duration of malarial episodes - the proportion of women and 
children with reported episodes of malaria as defined by fever and other 
common malarial symptoms and signs but in whom no blood film was done. 
2.3.5.2. Iron deficiency and anaernia 
The spectrum of iron deficiency ranges from asymptornatic depletion of iron in 
storage sites to an advanced form of severe anaernia. Various methods of measuring 
of iron levels relevant to the different stages of deficiency have been developed. 
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Choice of method depends primarily on the purpose of the measurement of the level 
of iron deficiency which it is necessary to detect and the feasibility of each 
methodology. 
The first stage of iron deficiency is the asymptornatic stage when body iron is 
depleted from the iron stores but when the haernoglobin remains normal. Measuring 
the serum ferritin concentration has proved to be a specific and relatively practical 
method of measuring this kind of iron deficiency in population surveys. A serum 
ferritin level of <12 ýtg/L is normally taken as the cut-off value below which 
deficiency of stored iron is considered to exist. Serum ferritin concentration can, 
however, be influenced by other clinical conditions such as malignancy, liver 
diseases and infections such as malaria which falsely elevate the serum ferritin 
concentration. 
The second stage of iron deficiency is the one that occurs when there is a restricted 
supply of iron for haernoglobin synthesis. This second stage is characterised by a fall 
in the plasma iron concentration and an increase in the serum level of the iron binding 
capacity. Evaluation of this serum iron level indicates the status of the circulating 
iron supply to the erythroid marrow. Change in the concentration of iron transport 
parameters begins as soon as the stored iron is completely exhausted, and among 
several techniques to measure iron deficiency at this stage, 
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detection of a serum iron concentration of <60 ýtg/dL of blood is used commonly. 
However, serum iron levels are depressed during acute phase reactions such as those 
induced by infections. The haemoglobin concentration and the red cell mass remain 
within normal range at this stage. 
The third stage is that of advanced stage of iron deficiency associated with overt 
anaernia. At this stage the haemoglobin concentration falls below the cut-off level 
that defines anaernia. Though it is seemingly arbitrary, anaernia has been defined by 
the World Health Organisation (WHO, 1968) for field applications as a haernoglobin 
of < 11.0 g/dL for children and pregnant women and < 12.0 g/dL for all other women. 
As there is no one single specific and sensitive indicator to determine the exact iron 
status at any of these stages, a combination of two or more parameters is frequently 
used. In this study, taking into account logistic and other practical issues as well as 
the recommendations from the World Health Organisation (WHO, 1968) and the 
Centres of Disease Control in Atlanta (CDC, 1989), the cut-off values of 
haernoglobin concentration shown in Table 2, were used to define anaemia. 
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Table 2- cut-off levels of haemoglobin to define anaernia 
Age/sex group Haemoglobin level (g/dL) 
Children 0.5-7 yr 
Adult females (pregnant) 
Adult females (non-preg. ) 
<1 1.0 
<1 1.0 
<12.0 
Sourcc: WHO, 1968 
Other parameters used to define iron deficiency and anaernia were: - 
iron dericiency and anaemia in women 
* serum ferritin level :! ý 12.0 [tg/L 
e haemoglobin concentration :! M. 9 g/dl (:! M. 0 for pregnant women) andlor 
e haematocrit level of <36% 
iron deficiency and anaemia in children 
9 serum ferritin level of : fý- 12.0 ýtg/L 
e haemoglobin concentration of :! M. Og/dL andlor 
9 haematocrit level of <36% 
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2.3.5.4. Severity and degree of Anaemia 
For the purpose of this study the severity of anaernia was categorised into three levels 
- mild, moderate or severe. This classification was based on percentiles of 
haemoglobin and haematocrit cut-off values of the recommended standard. 
Anaernia was considered to be mild if the haemoglobin fell between 80.0-100.0% of 
the standard, moderate if between 60.0-80.0%, and severe if <60.0% of the standard. 
Grades of severity for various age and sex groups are shown in Table 3 below. 
Table 3- severity of anaernia for different age and sex groups 
age/sex group 
mild 
Hb Hct 
moderate 
Hb Hct 
severe 
Hb Hct 
Children 6-84 months 
Pregnant women 
Non-pregnant women. 
8.8-10.9 28.9-36 
8.8-10.9 28.9-36 
9.6-11.9 28.9-36 
6.6-8.7 21.7-28.8 
6.6-9.5 21.7-28.8 
7.2-9.5 21.7-28.8 
:! ý6.5 
! ý6.5 
: ý7.1 
:! ý21.6 
! ý21.6 
! ý21.6 
Hb=haemoglobin in g/dL Hct=haematocrit in % 
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2.3-5.4. Other Variables 
Although the main aim of this study was to investigate the development of malaria in 
relation to oral iron supplementation in women and children, data on other conditions 
that might influence maternal or child health were collected. These included 
respiratory conditions, diarrhoea, helminthic infections and nutritional status. 
Definition of these conditions, as used in this study, are given below. 
2.3.5.4.1. Acute respiratory infections (ARI) 
A child was said to have experienced an episode of ARI when during the clinical 
assessment or biweekly morbidity interview he/she presented with one or more of the 
following: 
* fever, running nose, cough, wheezes, fast and difficult breathing, chest 
indrawing or ear pain and discharge from one or both ears. 
If the child was reported to have experienced fever, fast & difficult 
breathing and chest indrawing the episode was considered to be case of 
severe ARI. 
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2.3.5.4.2. Childhood diarrhoea & other gastrointestinal disorders 
A diarrhoeal episode was recorded when a child was reported to have experienced : 
9 loose stools 3 times or more during a day and/or a bloody stool with 
tenesmus. 
2.3.5.4.3. Intestinal Parasitic Infections (Helminthic infections) in children 
A child was considered to have been infected with intestinal parasites when the 
subject : 
9 was reported to have passed worms visible with the naked eye and/or when 
eggs or cystic form of a pathogenic intestinal parasite(s) had been noted 
during a microscopic stool examination. 
2.3.5.4.4. Obstetric/gynaecological & other genitourinary outcomes 
When a woman, (whether pregnant or not) reported one or more of the following 
conditions she was considered to have an obstetric/gynaecological problem. 
9 lower abdominal pain and frequent and painful micturition 
o vaginal discharge of unusual odour & colour, vaginal bleeding, 
e miscarriages, still births and complicated livebirths 
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2.3-5.4-5. Nutritional status 
Anthropometric data on women and children obtained during the study has been 
analysed in different ways to allow nutritional comparisons between the two 
treatment groups to be made. Measures of weight and height, hip and waist 
circumferences, generate different ratio measures including body mass index (BMI), 
waist and hip circumference ratio (WHR). BMI is defined as the ratio between the 
weight in kilograms and the square of height in metres. WHR is defined as the ratio 
between circumference measurements of the waist and the hip. Nutritional status 
among children was assessed using various indices generated from measurements of 
weight and height. Height-for-age (HA), weight-for-age (WA) and weigh t-for-heigh t 
(WH) have been expressed in either percentile, z-score (2.0 S. D), or median values 
in relation to the standard growth curves. WHO growth curves recommended for 
international use were used (WHO, 1986). 
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2.3.6. SAMPLING AND RANDOMISATION 
2.3.6-1. Sampling and sample size determination 
Separate sampling frames for women and children were prepared on the basis of the 
findings of the census and cross-sectional survey. Sampling units for both frames 
were individual women and children. However, allocating women and children of 
the same household into different supplementation groups could have resulted in the 
mixing and exchanging of treatments distorting the effect of supplementation and 
complicating the analysis and interpretation of the outcome measures. Thus, 
households rather than individual subjects were selected as the sampling unit to 
overcome this problem. Because households vary in the number of women and 
children, and to maintain the equal distribution of subjects into each supplementation 
groups, households in the frame were listed in the order of the size of eligible 
subjects in each house. 
To ensure a fair and balanced process of allocation into treatment groups, 
randomisation was by the technique of random permuted blocks of 4 households. To 
apply this technique, the treatment groups of Iron (1) and Placebo(P) were arranged 
in blocks of four. 
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There are six possible ways of permuting the two supplementation groups into blocks 
of four, 11PP, PP11, IPIP, PIPI, PllP and IPPI. In order to match the reading of 
random table numbers with these six combinations, numbers 1-6 were assigned to 
each block while numbers 7,8,9 and 0 were left out and passed if they appeared 
during reading of the random numbers table. Assignment of numbers were as follow: 
I= IMP 2= IPIP 3= IPPI 
PPII 5= PIPI 6= PIIP 
Numbers 7,8,9 and 0 disregarded. 
During reading of the random numbers table, if a number between I and 6 was 
picked, four households were assigned into either iron (1) or placebo (P) 
supplementation groups in accordance with the sequence corresponding to the picked 
number. If numbers 7,8,9, or 0 were picked they were ignored. For example, if the 
number 4 was picked from the random table, the permutation corresponding to 
number 4, i. e. PPII was selected and the next four houses in the frame were assigned 
into the placebo group (the first two households) and into the iron group (the next two 
households). The assignment process continued in this manner until all households in 
the sampling frame were assigned. All women and children were allocated to their 
supplementation group according to the designation of the household to which they 
belonged. 
80 
2.3. type of the study: outcome measures and definitions 
The required size of the study population was determined using a statistical formula, 
(Pocock, 1991), which took into consideration the prevalence of malaria (parasite 
rate) at baseline. 
In the cross-sectional survey at baseline, parasite rates for women and children were 
17.3% and 21.6% respectively. A difference in the incidence of malaria of 10% 
among women and children in the iron supplementation (exposed) group compared to 
those in the placebo (unexposed) group, was considered to be a clinically significant 
difference and sample size was calculated on this basis. 
Thus, a risk difference of 0.10 (d = 0.10 ) between the two groups, which applies 
equally to women and children was set. The study was planned to have a power of 
90% (1-0=0.9) and a significance level of 5% (6=0.05). 
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To calculate the required size (N) of women and children for each treatment group, 
the following mathematical formula was used; 
N- 
2p*(I-p)* 
f(a, b) 
d2 
where 
the proportion of those with malaria in the group without oral iron 
supplementation (unexposed) which, in this case, was 0.173. for women 
and 0.216 for children 
d= the difference between proportions in the two supplementation groups, i. e. 
between those supplemented with oral iron (Pd and those supplemented 
with placebo (pp) beyond which a true difference is considered to exist. 
For this particular study, a difference of d=(pj-p)=0.10 was used for both 
women and children. 
(a, b) =a function at significance level of cc = 0.05, and degree of certainty of 
0 =0.10 to detect real difference, which in this case is f= 10.5. 
According to the calculation, the total number of required women and children were 
620 (31Ox2) and 720 (360x2) respectively. To allow for possible withdrawals and 
losses to follow up, a further 10% of the calculated size for each category and 
treatment group was added to make the study size 682 women and 792 children. 
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Although a total of 2029 women and 1784 children aged 15-49 and 6-84 months were 
identified from the census, only 1301 women and 1026 children accepted the 
invitation to take part in the cross-sectional survey. At the first survey, 939 (72.3%) 
of the women and 868 (84.6%) of the children had a haernoglobin concentration 
below the defined normal cut-off point. After applying the full inclusion criteria, the 
number of women and children who qualified for the study were 776 and 841 
respectively. At this stage the number of women and children in excess of the 
required number of women (682) and children (792) were 94 and 49 respectively. In 
view of this small difference, it was decided to include all these women and children 
to give a study with a final size of 776 women and 841 children. 
2.3.7. Limitations of the study design 
Ideally, study of such a complex subject as the interaction between iron 
supplementation and malaria would have been addressed best by studies of a more 
complex design that incorporated clinical, epidemiological, experimental and 
biochemical tests to explain the iron-malaria relationships and the mechanisms 
involved. Planning and execution of such a study demands an enormous amount of 
financial and logistic resources and, to carry it out in the field, in a developing 
country such as Ethiopia is not possible at present. 
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The population included in the present study constituted anaemic women and children 
in a malarial endemic rural part of Ethiopia and they may not represent women and 
children who live in other non-malarious areas of Ethiopia. Results of the present 
study, could however, still be useful in planning and executing intervention 
programmes for women and children under similar circumstances in the rest of 
country and elsewhere. 
In designing and conducting epidemiological research of this type, there is always a 
chance of biases which can distort the results. In this study every effort was made to 
control and guard against possible confounders and the most common biases. 
2.3.7.1. Selection bias 
Selection of study subjects (women and children) was made on the basis of a set of 
inclusion and exclusion criteria. Allocation of subjects into either of the treatment 
groups was also based on randomisation which ensured comparability of treatment 
groups in all baseline characteristics. The study also ensured that none of the selected 
subjects in the placebo groups was on iron treatment and that exposure to iron was in 
control of the investigators. As subjects were followed prospectively outcome 
measures were preceded by exposure to iron supplementation. The possibility of the 
introduction of potential selection bias was therefore controlled and any distortion on 
effect estimation was unlikely. 
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2.3.7.2. Information bias 
Follow up and data collection among both the exposed (iron) and non-exposed 
(placebo) groups used identical methods and procedures. In addition, the study was 
double blind for neither the investigators nor subjects were aware of who was in 
which group. Therefore, information bias should have been controlled or absent. 
The need for women and children receiving placebo to continue with treatment for 12 
weeks without any effect on their anaernia was expected to lead to withdrawals and a 
compliance problem. Similarly, it was anticipated that some subjects in the group 
under iron supplementation would experience side effects leading to more drop outs 
than in the placebo group. A continuous effort was made to encourage every subject 
to remain in the follow up during the entire study period to prevent withdrawals and 
loss to follow up. 
In general, a randomised, placebo-controlled, double blind trial will by design take 
care of many of the distortions that may result from biases and confounders. Though 
dilution of true effect measurement, particularly in measuring malarial illness, was 
anticipated, the randomized design allowed such error to be randomly distributed 
among subjects and supplementation groups. 
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2.3.8. Ethical considerations 
Epidemiological and clinical trials involving human subjects have to be ethically 
justified and must meet ethical requirements. The following ethical issues were 
considered during the present study. 
* At present, the controversy on the role of iron and its alleged association with an 
increased risk of malaria is still unresolved. Thus, there is a need for more 
information on this topic. An epidemiological study to investigate such a 
controversial relationship is relevant because the results from such studies will 
help in the design of the control and prevention strategies of iron deficiency 
anaemia. 
e The choice of women and children as the study population was made because it is 
these groups who are most at risk of developing malaria and who are the main 
victims of anaernia and its sequelae. Their inclusion in the study was, therefore, 
appropriate. 
e Data collection methods and procedures used in the study were strictly in line with 
its stated objectives. The application of these methods was in accordance with the 
required standards for such procedures. Due to the nature of the study, subjects 
underwent multiple finger pricks and venipuncture to obtain blood specimens; 
maximum precaution was taken to reduce the risk of infections such as HIV. 
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Throughout the study, blood specimen collection was under aseptic conditions 
using sterile and disposable needles, syringes, lancets and other equipment. 
e In the process of conducting this study, the rights of individual subjects were fully 
respected. Enrolment into the study was by an initial communal consent following 
education on the purpose and nature of the study, the immediate and ultimate 
health benefits and on possible unwanted effects that might follow iron 
supplementation. Informed, verbal consent was secured from individual women 
and parents of all children who took part in the whole study. The right of 
individuals to withdraw from the study at any stage was fully respected. 
* It might be considered unethical to withhold or delay iron supplementation and/or 
put under placebo half of the subjects already known to have iron deficiency and 
anaernia. This was considered justified as there is substantial evidence to indicate 
that any haernatological benefit these women might achieved could be offset by an 
increased risk of infection. To ensure that no severely anaernic women or children 
were put at risk subjects with severe anaernia were not included in the trial but 
were given iron treatment. In addition, pregnant women in their last trimester, 
irrespective of their haemoglobin level, were treated with iron in order to avoid 
any risk of endangering the health of either the mother or the new-born. 
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In addition, all those who were assigned to placebo supplementation, were 
switched to iron supplementation after the trial for a period of 12 weeks. 
e Every subject in whom malaria or any other disease was detected during the study 
was given appropriate treatment depending on the availability of drugs. None of 
the subjects was denied treatment because of their participation in the study. The 
research activities had little or no interference on the delivery of local health 
service and did not have a rebound effect on the health services after the study has 
been completed. Involvement of hospital staff and the use of hospital facilities 
whenever these were needed was with prior arrangement and did not affect the 
normal duties of hospital staff. 
e Minor effects known to occur following oral ferrous sulphate include 
gastrointestinal irritations, which usually subside on treatment with antacids or on 
discontinuing the supplementation. Subjects were given free treatment for 
complaints such as gastric irritation and vomiting, diarrhoea or constipation. 
0 The study was approved by the Ethical Committees of the London School of 
Hygiene and Tropical Medicine and the Faculty of Medicine at Addis Ababa 
University in Ethiopia. 
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2.3.9. DATA COLLECTION 
Methods, Instruments and Procedures 
Data was collected using multiple methods and techniques considered appropriate to 
the study objectives. 
2.3.9.1 Interview method 
The face to face interview method was used extensively to collect data. This method 
was applied first in the collection of data on the demographic and household 
characteristics of the study population. Data on morbidity experiences of women and 
children during the entire study period were also collected using this method. For the 
census and the initial household survey, heads of households served as the source of 
information. Data on perceived morbidity among women was collected using the 
women themselves as respondents. For children, mothers were used as respondents. 
On rare occasions, when the mother of a child in the study was permanently or 
temporarily absent, the nearest care taker or guardian of the child was used as the 
primary source of data. 
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Structured questionnaires geared towards the objectives of the study were the primary 
instruments used during interviews. The design and development of questionnaires 
was based on an effort to maintain clarity, simplicity and precision. Questions were 
made unambiguous to minimise difficulties for interviewers and were kept short and 
precise to make them acceptable to the respondents. Expert advice and comment was 
sought and obtained on the contents and construction of questions. Questionnaires 
were field tested in the study area before being finally used. Data on morbidity 
during and after the trial were obtained by a fortnightly house to house visit. 
Two types of questionnaires were used. The first was used only once to collect data 
on the socio-clemographic and dietary habits of the study population and was 
administered during the census and household survey. The second consisted of the 
clinical assessment and the morbidity survey questionnaires developed to collect data 
on health conditions of study subjects during the supplementation trial and throughout 
the study period. 
The census and the general household data were collected by a temporary team 
recruited from the hospital staff and members of the malaria control team. Though 
most of them had previous experience in carrying out census and cross-sectional 
surveys, they were all given a short period of training specific to the objectives of this 
study. To assess the study population and to generate data on their health profile at 
baseline and at the end of the trial required more skilled personnel and procedures 
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Medical doctors and other technical staff working in the hospital were hired to collect 
clinical data. These were collected at two time points, at entry and at exit from the 
supplementation trial. Additional data were collected on women and children who, 
during the supplementation period, developed any illness for which they were 
examined and treated. 
Perceived morbidity data among women and children were collected every other 
week by field interviewers who were recruited and trained for this purpose. After the 
first comprehensive household survey, each household with a study subject(s), was 
visited 6 times during the trial and for a total of 26 visits throughout the entire study, 
including the post-supplementation follow-up. 
Criteria used in the selection of interviewers included completion of high school 
education, residence in the study area, social acceptance and similar experience in the 
past. It was estimated that for a single visit of a house with a study woman and a 
child, an interviewer would need an average of 25 minutes to complete both 
questionnaires. In the hot and humid weather conditions prevalent in the study area 
one interviewer could work effectively a maximum of only six hours. On these 
assumptions, and making allowances for unforeseen circumstances such as absence 
because of sickness and other social obligations, the work output of interviewers was 
calculated in order to decide on the required number of interviewers. 
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The number of interviewers was set at six, and three female and three male 
candidates were finally chosen. They were given a three day period of training on the 
purpose of the study and their role and responsibilities. Training included practical 
field exercises using the actual questionnaires employed in the study. 
The interview method was applied uniformly throughout the study period. Five of 
the interviewers were stationed in one of the study sites where there were 777 
households. The sixth interviewer was placed in the smaller village with only 120 
houses. The number of houses allocated to each interviewer was more or less the 
same with slight variations depending on the area and how houses were scattered. As 
morbidity data collection was on a fortnightly basis, the interviewer systematically 
divided houses he/she was assigned to visit into 14 so that each house was visited 
every 14 days. In case of short absences of respondents or closure of houses, the 
interviewer made arrangements for another visit without affecting their regular 
schedule. 
During each visit, the interviewer presented a series of questions to each woman or 
mother of the child on health conditions during the 14 days preceding each visit. 
Questions were based on the most commonest symptoms and signs which might best 
elicit the presence or absence of a malarial illness, acute respiratory or 
gastrointestinal tract in - ections. 
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Questions on pregnancy and related diseases including other genitourinary tract 
disorders were incorporated into the questionnaire for women in the study. 
Responses were recorded in the space provided on the questionnaire. After each 
round of visits, i. e. every two weeks, completed questionnaires were handed to the 
field supervisor stationed in the hospital who checked the completeness of forms. 
2.3.9.2. Clinical examination 
The second method of data collection was clinical evaluation of women and children 
in the study before, during and immediately after the supplementation trial. Cross- 
sectional baseline information on their medical history and a general physical 
examination of all women and children was undertaken before supplementation was 
started. During the course of supplementation, clinical data collection was limited to 
those who were sick or reported to have been sick. Those who were ill were referred 
to the hospital to be examined and treated. On the completion of twelve weeks of 
supplementation, clinical data were again collected from all subjects. 
Clinical evaluations of subjects were carried out in the hospital, where prior 
arrangements had been made so as not to interfere with routine hospital activity. In 
co-operation with the hospital administration, separate rooms for waiting and 
examination of subjects were organised. 
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As women and children in the first site, Shehdi, were too many to handle in a single 
day, they were grouped into a manageable size for one clinical session, and 
appointments issued to every participant. On arrival, women were met by nurses or 
health assistants who registered them and verified their identification numbers and 
then they were led to the examination room. The doctor undertook a full evaluation 
of the study subject and put his diagnostic remarks on the personal record of the 
subject. 
In the clinical evaluation, the instruments of data collection were the doctor's skill 
and basic diagnostic equipment such as stethoscope, sphygmomanometer and 
ophthalmoscope. A structured, individual medical record form specific to study 
objectives was designed on which doctor's findings and diagnostic remarks were 
recorded. 
For the second village, separate dates, (usually weekends) were chosen for clinical 
evaluation and a mobile team of doctors and other staff was organised. A convenient 
site in the village was sought and the school compound was found to be suitable and 
central for women and children in the village. All subjects were informed in advance 
of the time and place of the session and this was further reinforced by house to house 
reminders on the day of the visit. 
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2.3-9.3. Laboratory investigations 
Most of the laboratory tests required for the study were investigations on blood 
specimens. A major effort was made to co-ordinate blood specimen collection for the 
various tests so as to ensure minimum discomfort and harm to study subjects. 
Whenever women or children had their finger pricked, a specimen for haemoglobin, 
haernatocrit and blood film was taken at the same time. Three technicians for three 
tests were arranged side by side, so that one immediately followed the other in 
collecting the specimen for their respective test before the blood flow from the finger 
dried up. 
2.3.9.3-1. Determination of iron status and anaemia 
Iron deficiency and anaemia among women and children were estimated by 
measuring serum ferritin concentration, haernoglobin concentration and packed cell 
volume (haematocrit). 
(a) Serum Ferritin 
Baseline serum ferritin concentrations among women and children were estimated at 
the National Institute of Health Research in Addis Ababa using an enzyme-linked 
immunoassay method (ELISA). This laboratory was better equipped to do this test 
than the laboratory in Gondar College of Medical Sciences. 
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Venous blood: Large veins of the forearm were selected as the venipuncture site and a 
tourniquet applied high on the arm. A convenient site was cleaned with 70% alcohol 
and dried with sterile gauze. Vacutainer tubes were labelled with identification code 
numbers specific to each subject before blood was drawn. Experienced technicians and 
nurses using assembled vacutainers inserted the needle into the vein to automatically 
draw about 6-7 ml of blood. The needle was removed and test tubes with the blood 
sample were kept in an ice box. Serum was separated the same day and transferred into 
screw topped vials labelled with the same code number as that on the test tube. The 
serum was then transported to Gondar Hospital for storage at -20.0 T until it was 
finally transported to the central laboratory in Addis Ababa. 
Determination of serum ferritin concentration: This was performed by a senior 
technician in the laboratory in Addis Ababa with automated equipment using ELISA 
(Boehringer Mannheim GmbH, Diagnostica, Germany). 
(b) Haemoglobin concentration 
The Sahli method was used to measure haernoglobin. The Sahli method only requires 
capillary blood and was thus more acceptable to study subjects than other methods 
requiring venipuncture. Two rounds of haemoglobin measurements were conducted. 
In the first round, haernoglobin was measured on all women and children in order to 
select those who qualified for the supplementation trial. 
96 
2.3. type of the study data collection 
Secondly, it was with data from this round that the baseline information was 
generated with which post treatment measurements were compared. Measurement in 
the second round was only on subjects who completed the twelve weeks of 
supplementation. Procedures and methods of haemoglobin data collection were the 
same in both rounds. 
Blood specimen: Specimens from women and older children were obtained by 
pricking the third left finger. For younger children the big toe was preferred. The 
chosen pricking site was cleaned with 70% alcohol and allowed to dry before it was 
pricked with a sterile lancet. A sample of 0.02 ml of blood was drawn slowly into a 
graduated pipette. 
Determination of haemoglobin: The pipette with the blood was then dipped into the 
graduated glass tube containing 0.01% Hydrochloric acid (HCL) solution into which 
the blood was slowly released. The pipette was rinsed repeatedly with the reagent 
while it was in the tube to make sure that no blood was left in the pipette. Blood in 
the solution was stirred gently with a glass rod to ensure that the blood had been 
mixed thoroughly with the solution. After 3 minutes, distilled water was added drop 
by drop with a rubber-topped dropper until the colour of the mixture matched the 
standard comparator on both sides of the tube. The level of haernoglobin 
concentration was then read from the graduated tube and recorded against the 
identification of the subject. 
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Packed cell volume (haematocrit) 
The other laboratory test conducted on women and children was the Packed Cell 
Volume (Haematocrit) which provides a quick and convenient estimate of the degree 
of anaernia as the ratio between the volumes of red blood cells and whole blood. 
Blood specimen: The blood specimen for packed cell volume was collected 
immediately after the specimen for haernoglobin was obtained, without need to re- 
puncture the subject. After the specimen was collected, the capillary tube was sealed 
with a clay sealant compound by placing its other end perpendicularly and slightly 
rotating to ensure that the tube was well plugged. 
Determination of haematocril: The sealed capillary tube with the specimen was 
placed in a microhaernatocrit centrifuge with the sealed end towards the periphery. 
Position numbers, shown on the centrifuge where each sample was placed, were 
recorded on the data sheet against the identification details of that subject from whom 
the specimen was taken. Loaded with 24 specimens at a time, the centrifuge was run 
at 3000 rpm for 5 minutes. After centrifugation, each capillary tube was placed on a 
special reading device attached to the centrifuge. Reading was done by adjusting the 
plasma and red cells boundary against a calibrated reading device. Sample readings 
were recorded onto the record form adjacent to that subject's identification. 
Measurements of haematocrit was made during each round. 
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2.3.9.3.2. Haemoparasites (malaria) 
The malarial status of women and children before, during and after supplementation 
was assessed. 
Specimen collection: Specimens for blood film examination were obtained on the 
same day that specimens for other procedures were collected. Experienced 
technicians from the Malaria Control office prepared thick and thin blood smears on 
the same slide. Code numbers were written on the thin film with lead pencils. Dry 
slides were carefully wrapped in paper and transported to the Regional Malaria 
Control laboratory by the next day. Slides were stained with Giernsa stain and 
examined under a microscope. 
Determination of malarial parasites: Stained slides were examined by senior 
technicians in the regional malaria laboratory who screened 100 microscopic fields 
under oil immersion. Slides found to be positive were examined further to identify 
the species of Plasmodium present. For positive slides, parasite density was 
estimated by counting the number of parasites in the thick film until a total of 300 
white blood cells had been counted and calculation was done on the basis of an 
assumed WBC of 8000. Slides were reported negative for malaria parasites only 
after 200 microscopic fields of thick film had been examined. Results were entered 
into a data summary sheet prepared especially for this. 
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2.3.9.3.3 Intestinal parasites 
In order to identify children infested with intestinal parasites, stool examination was 
done once, using the ether-formalin concentration (RITCHE) method (WHO, 1991). 
Specimen collection: Mothers or guardians of all children were invited to bring their 
children to the hospital. On their arrival, they were provided with waxed paper cups 
and wooden applicators with instructions on how to collect faecal samples from their 
children. Stool samples of about 5-10 grams were then transferred into tight-fitting 
screw-topped glass vials containing 4 ml of 10% formaldehyde solution. 
Formaldehyde solution was used to preserve the faecal material which may have 
contained eggs, larva and cyst of parasites until it was examined finally. 
Identification code numbers of children were attached to each bottle. All stool 
samples were transported to the Gondar College of Medical Sciences laboratory 
where they were processed and examined. 
Microscopic stool examination: A gauze filter was fitted into a funnel placed on top 
of a centrifuge tube on which the faecal material was passed. After the filter was 
removed, about 3 ml of ether was added and the tube was centrifuged for I minute. 
After the debris was removed, a drop of the sediment was drained on a glass slide and 
covered with a cover slide. The slide was then mounted on the microscope and 
examined by moving systematically up and down until the entire coverslip area was 
examined with a low power objective (x 10). 
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2.3.9.4. Anthropometric measurements 
Anthropornetric data of women and children were collected at baseline and at the end 
of the supplementation trial. Data collected on women included weight, height, hip 
circumference and waist circumference. Waist measurement was made by a tape 
measure applied horizontally around the abdomen at the mid-point between the 
lowest rib margin and the iliac crest on the mid-axillary line. Women were asked to 
breathe normally preventing contraction of the abdominal muscle and the reading was 
taken to the nearest 0.1 centimetres. Hip circumference was measured on women 
standing erect by applying the tape measure around the buttock and noting the 
measurement that gave the maximum circumference. Reading was to the nearest 0.1 
centimetre. Weight measurement on each woman was carried out by two health 
assistants using a beam balance. The subject was instructed to remove heavy clothing 
and shoes and stand on a beam balance. Weight was recorded to the nearest 0.1 kilo 
gram. Height was measured to the nearest 0.5 centimetres using a graduated bar with 
sliding head piece attached to the beam scale. 
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Anthropornetric measurements among children included weight, height and mid-arm 
circumference. For older children, weight and height measurements and other 
procedures were similar to those used for women. Mid arm circumference was 
measured using a plastic measuring tape to the nearest 0.1 centimetre. The tape was 
put around the left arm of the child which was supported at the finger tip by the 
mother. Data from children who were too young to stand on their own were 
measured using a different set of measuring equipment. A hanging spring balance 
was used for measuring weight to the nearest 1.0 gram. Length was measured with a 
calibrated horizontal board with a sliding foot piece. The child was put in a supine 
position, the head against the fixed head piece and the sliding foot piece adjusted to 
the heel of the child. Length was recorded to the nearest 0.1 centimetre. 
2.3.9.5. Body temperature recording 
Women and children who complained of fever during biweekly morbidity visits had 
their axillary temperature measured with a digital electronic thermometer. 
Interviewers were trained how to measure and record body temperature. 
Temperature was measured only when subjects complained of fever. Temperature 
readings ý37.5'C were recorded as fever. 
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2.3.10. DATA QUALITY CONTROL 
Throughout the study period, a continuous effort was made to maintain the quality of 
data collection. Training of field workers was considered the most important way of 
achieving this objective. Permanently assigned interviewers and staff temporarily 
hired were trained on the specific roles required of them during the study. Detailed 
training sessions were carried out on all data collection methods and procedures 
before the actual work was started. Regular and random spot checks were used to 
control the quality of the data collection. A full-time field supervisor was available 
on the site for field workers to consult and he monitored their day to day activity. 
The principal investigator was also regularly available during the supplementation 
trial and at intervals of 2-4 weeks afterwards. Specific measures taken included the 
re-examination of blood slides by the same microscopists on about 10% of all the 
slides selected at random. Iron and placebo preparations were also inspected at two 
different times by hospital nurses who were invited to distinguish colour, taste and 
smell of preparations. 
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2.3-11. DATA PROCESSING AND ANALYSIS 
Data collected in the field were transferred to summary forms designed to simplify 
data entry. Data on each woman and child was entered into a personal computer using 
EPINFO versions 5/6 package. Data cleaning, including range and consistency 
checks, was conducted. Preliminary analysis was made in the University in Ethiopia, 
while detailed analysis was carried out at London School of Hygiene in the UK. 
Generally, the strategy of data analysis was a stage by stage approach. Assembling 
and summarising the information on villages, households and their immediate 
environment preceded the more detailed manipulation of socio-demographic and 
dietary variables. Characteristics and useful indices are expected to evolve at this 
stage to provide an overall picture of the population and study subjects. 
Following the cross-sectional survey, the iron status and prevalence of anaernia at 
baseline was determined. The frequency of iron deficiency, anaemia and malaria was 
worked out in order to plan the following components of the study. Iron deficient and 
anaernic populations were stratified by the degree of deficiency and severity of 
anaernia. Data was then examined further by cross tabulating selected socio- 
economic variables against one another, to identify possible correlates. 
104 
2.3. type of the study: data analysis 
The second stage of analysis was focused mainly on calculating different disease 
measures to make comparisons between treatment groups. The episodic point and 
period prevalence, i. e. the proportion of clinically ill before, during and after 
treatment and the incidence and duration of episodes of illness during the trial period 
were all computed in relation to oral iron and placebo supplementation. Age and sex 
specific indices, when appropriate, were also calculated to make comparisons 
between treatment and placebo groups, and between different levels of anaernia. 
Proportions of clinical malaria, parasite rate and spleen rates before and after 
treatment were calculated and relative risk and confidence intervals for each disease 
outcome in the iron treatment and placebo groups were compared. Data were further 
analysed by sub-grouping the treatment and placebo subjects by socio-demographic 
variables to see whether differences interacted between them with the iron/placebo 
effect. Chi-squared and student Mests were applied to test differences for any 
statistical significance. The effect of supplementation and response to iron treatment 
was assessed by comparing the mean change in haemoglobin concentration and PCV 
in the oral iron and placebo groups. For each study the haernatological change 
(difference between levels before and after treatment) was calculated and the overall 
mean difference for each group was determined. The overall effect was thus 
estimated by comparing mean estimates between the two treatment groups, and 
testing the difference for significance using student's ' t' test. 
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RESULTS 
3.1. CENSUS AND HOUSEHOLD SURVEY 
3.1.1. Socio-demographic characteristics of the population 
3.1.1-1. Demographic characteristics 
In the two study sites of Shehdi town and Aftil village, a de jure census revealed a 
total population of 8865 living in 2118 houses. The population distribution is typical of 
a rural developing country, where the young population forms the majority. Nearly half 
(47.3%) of the total population was below the age of 20 years. The population above 
the age of 55 was only 2.1% suggesting that the average life expectancy of the 
population in the study area is short. 
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A male to female sex ratio of 0.95 was found. This ratio, however, varied with age. Up 
to the age of 9 years the male to female ratio was almost 1: 1. This balance started to 
change towards a higher proportion of females after the age of 10 (Table 4). For 
example, in the age group of 20-29 years the female population was nearly twice the 
size of the male, with 100 females to every 56 males. The distribution reversed again 
over the age of 30 years when the male population outnumbered the female in each age 
group. 
TABLE 4. Age and sex distribution of the general population 
I age gp. (yr) males (0/6) females (%) total (%) sex ratio I 
0-4 677 (15.7) 618 (13.6) 1295 (14.6) 1.09 
5-9 545 (12.6) 544(11.9) 1089 (12.3) 1.00 
10-19 770 (17.9) 1041 (22.9) 1811 (20.4) 0.74 
20-29 654 (15.1) 1161 (25.5) 1820 (20.5) 0.56 
30-39 918 (21.3) 743(16.3) 1661 (18.7) 1.23 
40-49 471 (10.9) 310( 6.8) 781 ( 8.8) 1.52 
50 & above 276 ( 6.4) 133( 2.9) 409 ( 4.6) 2.07 
ALL AG ES 4311 (100) 4550 (100) 8865 (100) 0.95 
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It is generally assumed that in developing countries the population between 15-54 years 
of age comprises the relatively active and economically productive population group 
and that they are thus responsible to Support the entire population of a given area. In 
the study area, the dependent population of children <15 years and those aged >55 
years comprised 40.1% of the total population, giving a dependency ratio area of 1.67, 
suggesting that every 100 people of the productive age group support 67 additional 
people. 
During the census questions on births and deaths were asked. In the 12 months 
preceding the census, a total of 231 livebirths and 90 deaths were reported suggesting 
crude birth and death rates of 26 per thousand and 10.5 per thousand respectively. 
Taking these crude rates, the rate of natural population increase in the area was 
calculated to be about 1.6%. Seventy-seven percent of all deaths reported to have 
occurred during the past year were among those under 15 years. Forty-one percent of 
all children who died in the past year were below 1 year of age. Deaths were reported 
more frequently among females than among males (62.5% and 37.5% respectively). 
According to the respondents' beliefs, causes of deaths were various ranging from 
superstitious to organic causes. However, the most frequently mentioned probable 
causes of deaths were malaria (35.4%), diarrhoea and tuberculosis (8.3% each) and 
other respiratory causes (6.3%). 
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3.1.1.2. Socio-economic characteristics 
Following the census, a cross-sectional household survey was undertaken to investigate 
the general living conditions and dietary history of the population. After excluding 
commercial institutions and non-residential houses, a sample of 896 households, 
approximately 50% of all households, were selected for the survey. Family size in the 
study area varied greatly, ranging from 1-21 persons per household. On average a 
household consisted of 4.18 persons. Most heads of households and residents seemed 
to have moved into the study area relatively recently, with a mean duration of stay of 
only 9.3 years. 
The ethnic mixture of the study area is not as varied as that seen in the country as a 
whole. Highland Amharas and Tigreans who, through time, have moved down to the 
lowlands form the large majority of the population, constituting 84.7% and 8.6% 
respectively. Both groups are said to be of Semitic origin while the native Gumz, with 
only 6.8% of the total, are of Hamito-Nilotic origin. By and large the population follow 
Orthodox Christianity or Islam (77.7% and 22.0% respectively). Less than 1.0 % of the 
Gumz community identified themselves as having no religion. 
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Illiteracy in the area is high, but not as high as in other remote parts of Ethiopia. It was 
found that 27.8% of the adult population can read and write despite the fact that only 
2.7% had had some kind of formal education. The household and socio-economic 
characteristics of the study population, shown in Table 5, are generally similar to the 
pattern of rural populations in the rest of the country. Most people (73.3%), live in 
small houses which are single-room, rounded tukuls, where walls are made from wood 
with mud structure and thatched roofing. A minority of the population live in properly 
constructed houses with one or more windows and corrugated iron roofs. 
Houses are owned mostly by the people themselves and only 14.5% of households are 
rented. Though the study area is rural and agricultural, only 39.9% of the population 
have land of their own and the majority of heads of households are engaged in hired 
farm labour, unskilled manual labour and small scale trade. Most families have cattle 
of their own which play an important role in agricultural activities, and are a source of 
income through the sale of dairy products. Sanitation facilities are generally very poor 
and the majority of house-holds use the open field for defecation and other dry waste 
disposal. Only 12.8% of the households were found to have pit latrines. On the other 
hand, the supply of water in the area is adequate and easily accessible but only 52.1% of 
the households obtain their supply from a protected, deep well from which water is 
distributed through stand pipes. The remaining 33.8% of households fetch water from 
nearby rivers and other unprotected sources. 
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Table 5. Household characteristics of the study population 
Household Characteristics (N 896) Percent 
Ethnicity: ......... ......... ................. 
Amhara 84.7% 
Tigre 8.6% 
Gumz 6.8% 
Religion: 
Christian 77.7% 
Muslim 22.2% 
Education: 
Illiterate 72.2% 
Literate, read &/or write only 25.1% 
Literate, formal schooling 2.7% 
Marital status 
Married 77.6% 
Single 12.7% 
Divorced 9.8% 
Occupation: 
farming 43.5% 
unskilled manual work 23.0% 
local trade and small businesses 19.1% 
government & NGO (salaried) 14.2% 
all others 11.6% 
Housing: 
owned 85.5% 
rented 14.5% 
thatched roofing 73.3% 
roof with corrugated iron 26.7% 
with windows of 1 or more 22.1% 
without any window 77.9% 
with latrine of any kind 12.8% 
Water supply 
deep well (stand pipes) 52.1% 
river water 33.8% 
spring (unprotected) 14.2% 
Land ownership (owned) 39.9% 
Mean duration of residence 9.3 years 
Mean number of persons in the house 4.1 persons 
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3.2. DIETARY HISTORY IN THE STUDY AREA 
As part of the household survey, an assessment of the dietary history and eating habits 
of the community was made. Households were asked to provide details of the food 
eaten during the day prior to the interview and the frequency of consumption of 
selected groups of food items on all days other than holidays and feast occasions was 
recorded. Results of the survey showed that the overall diet of the study population is 
typical of most communities in Ethiopia and other parts of the developing world -a thin 
pancake known as "enjera" eaten with a spicy and hot stew known locally as "wot". 
Enjera can be made from flours of a range of cereals, but most commonly from 
fermented millet, sorghum, and maize paste. In the highlands and most urban centres in 
the country, enjera is made from the iron rich cereal, teff (Eragrostis Abyssinica). 
However, in the study area teff is neither grown nor easily available in the local market 
so meals are generally based on cereals with limited iron content. Less than 1.0% of 
households respondents said that they had eaten enjera made from teff during their 
meals the previous day. As shown in Table 6, the three main meals of the large 
majority of households (85.0-99.4%) in the previous day of the survey comprised foods 
which were based on millet and sorghum. 
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Table 6. Composition of meals during the day prior to the survey. 
food groups (composition) 
Cereals (millet, maize, sorghum) 
Legumes (beans, pea, lentils) 
Vegetable (cabbage, pumpkin, potato) 
Meat (beef, lamb, chicken) 
Dairy products(milk, cheese, yoghurt) 
Breakfast Lunch Dinner 
(percentage of households) 
99.4 95.6 85.0 
28.8 
9.4 
1.8 
2.2 
36.4 
11.0 
1.3 
0.8 
33.1 
15.0 
2.6 
0.7 
Meat and dairy products were eaten rarely and fresh vegetables infrequently. As the 
population is mainly Orthodox Christian they adhere strictly to fasting with abstention 
from all food items of animal products, including fish, milk and butter for up to 220 
days (about 60.0%) of the year. The dietary survey was conducted during the non- 
fasting period but nevertheless only 1-3 % of households consumed meat in any one of 
their meals during the day before the interview. As shown in Table 7,54.1% of 
households reported that, on average, they ate meat only once a week even during non- 
fasting seasons. 
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During the dietary survey, women were asked to identify particular food items 
considered good or bad for pregnant women and children. Most women knew what 
was good for women during pregnancy. Over 60% of respondents identified meat and 
other animal products as useful during pregnancy. Liver, an excellent source of haem 
iron, was identified by 20.0% of women as the single most important source needed to 
replace blood losses during pregnancy and birth. Fruits and vegetables were also 
mentioned by 20.6% and 27.8% of the respondents as good foods for pregnancy. Foods 
reported to be harmful for pregnant women were hot and spicy foods, alcohol and too 
much salt, which were considered bad for pregnancy and bad for the foetus by 43.5%, 
3.7% and 9.9% of respondents respectively. 
Nearly all mothers mentioned meat, eggs, and milk as good food for children, while 
71.1% said breast feeding is good for infants. Bottle feeding was mentioned by 20.3% 
of mothers as being good for their children, a surprisingly high percentage. About 
30.2% of mothers said they liked to feed their new-born child with raw butter, a 
traditional feeding practice in Ethiopia which is known to be harmful. 
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Table 7. Frequency of consumption of selected categories of diet 
frequency of intake of selected food items 
(percentage of households) 
4: 1/ wk 2/ wk >3 per wk Food items, x": 
Meat/chicken 54.1 30.6 14.2 
Milk & other dairy product 19.0 27.9 51.6 
Fat (mainly veg. oil) 3.6 0.5 95.0 
Vegetables 32.6 26.0 40.5 
Legumes 2.7 8.5 86.3 
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3.3. SCREENING AND SELECTION OF SUBJECTS 
Following the census, a cross-sectional survey was conducted in April 1994 to 
determine the iron status of women aged 15-49 and of children aged 6-84 months. 
This survey was necessary to identify potentially eligible subjects for the trial and to 
form the sampling frame for the study. Baseline information on several variables was 
also collected at this stage, for comparison with the results obtained during the 
randomised, placebo-controlled supplementation trial that followed. 
A total of 1301 women aged 15-49 years and 1026 children aged 6-84 months 
resident in the two study sites of Aftit and Shehdi responded to the invitation and gave 
their verbal consent to take part in the first cross-sectional survey. Assessment of the 
iron status of the study subjects relied on the measurement of haernoglobin, 
haernatocrit and serum ferritin concentration. The first two measurements were made 
on all women and children while serum ferritin was determined in only 660 women 
and 310 children. This was mainly because the procedure used for serum ferritin 
determination required 5-10 millilitres of venous blood, and collection of that much 
blood by venipuncture was not acceptable to many participants, particularly children 
and their parents. 
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The magnitude of the problem of anaemia among both women and children varied 
according to the method used to define anaernia. As shown in Table 8,72.3% of the 
women and 84.6% of children were classified as anaemic using haernoglobin level, 
while using their haernatocrit level as a criterion, only 48.6% women and 57.2% 
children were anaernic. Measurement of serum ferritin concentration, on the other 
hand, categorised very few women or children as iron deficient. The geometric mean 
(s. d) serum ferritin concentration was found to be 46. (1.98) [tg/L for women and 42.9 
(2.0) pg/L for children. When a serum ferritin level of <12 pg/L was used as a cut 
off value to define iron deficiency, only 4.4% and 7.3% of women and children 
respectively were found to be iron deficient. It was revealed that all women and 
children with low haernatocrit and/or ferritin levels had low haernoglobin, but not all 
subjects with low haernoglobin showed lower values in the other two assays. 
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Table 8. Prevalence of anaemia among women and children. 
women (n=1299) * children (n=1026) 
haernatological indices 
Haemoglobin <1 1.9 gm/dL 
Haemoglobin <1 1.0 gm/dL 
Haematocrit <36 % 
Serum Ferritin <12 [tg/L** 
number (%) 
939(72.3) 
632(48.6) 
29( 4.4) 
number 
868(84.6) 
587(57.2) 
22( 7.3) 
* two blood samples were discarded. ** n=660 women; & 310 children 
Selection of subjects & allocation to treatment 
Selection of women 
Based on the screening results, all women and children whose haernoglobin levels 
fell below the respective cut-off values were considered eligible for the study. 
Accordingly, 939 women were initially identified for enrolment. Applying the 
selection criteria, a total of 163 of these women were excluded; 43 were pregnant (37 
in the third trimester and 6 with Hb <8.0 g/dL), 37 had severe anaernia with a 
haemoglobin below 6.0 g/dL, 36 women were unwilling to take part, 31 women were 
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unsuitable due to either chronic or acute illnesses and a further 16 were unavailable 
or left the area before randomisation. Thus, 776 women were available for the 
supplementation trial; 391 and 385 women were randomly allocated into iron and 
placebo treatment groups respectively. The age distributions of women allocated to 
the two treatment groups are shown in Table 9. Women in both treatment groups were 
relatively young, nearly two thirds were below the age of 30 years. The mean ages of 
women in the iron and placebo groups were 27.6 and 27.0 years respectively. W omen 
in both groups were generally comparable in their age structure. 
Table 9. Age distribution of women by treatment group 
Treatment Group 
Age group(yrs) IRON(%) PLACEBO(%) TOTAL 
.............. ............. ... ........ ........... ............... ............................ . 15-19 
.... 
.... 69(17.6) 54(14.0) 1.2.3(15.8)" 
20-29 152(38.9) 168(43.6) 320(41.2) 
30-39 131 (33.5) 122(31.7) 253(32.6) 
40-49 
. 
39( 9.9) 
.............. - ......... .. . 
41 (10.6) 80(10.2) 
... ...... .... .... ALL AGES 
...................... ........... ......... . ........ ........... ....... 391 (100.0) . ........ 385(100.0) ......... 776(100.0) .................. 
119 
3.3. screening and selection of subjects 
Following randomisation, women in the two treatment groups were further compared 
for their similarity in terms of selected variables, particularly those related to their 
reproductive characteristics (Table 10). All but 15.7% of the women had experienced 
pregnancy at least once, with a mean number of 3.1 pregnancies. Of those women who 
gave a history of previous conception, 14.4% reported that they had been pregnant 
once. During the survey, 115 women (11.9%) were found to be pregnant while 502 
(64.7%) of women said they were lactating. 
The proportion of women in the area using modern contraceptives was extremely low. 
The proportion of all women who reported using oral contraception was 4.0%. When 
women in the two groups were compared, those allocated to the placebo group had a 
higher use of contraceptives (5.5%) than their counterparts in the iron group (2.8%). 
ý' =7.0, p=0.007). 
With the exception of and this difference is statistically significant, (X2 
contraception, women in both treatment arms were comparable in all other variables. 
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Table 10. Reproductive characteristics of women by treatment group 
Treatment Group 
Characteristics Iron (N=391) Placebo(N=385) 
Mean Gravida 3.03 3.42 
Mean Para 2.64 3.04 
Mean number of live children 2.34 2.44 
Mean number of abortions 1.30 1.50 
Mean age of last child(yrs) 2.70 2.90 
Proportion of women lactating 63.5% 65.1% 
Proportion of women pregnant 12.5% 10.9% 
Proportion of women on contraceptive 2.8% 5.5% 
3.3.1.2. Selection of children 
Selection and allocation of children into iron and placebo treatment groups was 
conducted in a similar way as that used for women. Out of 1026 children who were 
screened for haernatological parameters, the haernoglobin of 868 children fell below 
the cut-off point of 11.0 gm/dL and these children were identified as potentially 
eligible for se ection. 
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However, 27 children failed to meet all the required selection criteria; 13 had severe 
malnutrition and severe anaernia (Hb < 6.0 g/dL), 9 children had acute illnesses and 
the parents of 5 children would not allow their children to take part. A total of 841 
children, 452 males and 389 females, with a mean age of 45.2 months were finally 
available for selection and randomisation; 431 and 410 children were allocated into 
iron and placebo treatment groups respectively. The age and sex distributions of 
children in the two treatment groups are shown in Table 11. Children assigned to 
each treatment group were very comparable in their age and sex structure. 
Table 11. Age-sex distribution of children by treatment group 
Treatment Group 
Age group IRON PLACEBO(%) 
(months) males females males females TOTAL(%) 
.......... . ................. . .......................... 6-11 . 31(3.7) ...... 24(2.8) 24(2.8) 23(2.7) 
.. ... 102 
............. 
(12.1) 
12-23 40(4.9) 31(4.6) 42(5.0) 30(3.6) 143 (17.0) 
24-35 27(3.2) 33(3.9) 40(4.7) 30(3-6) 130 (15.4) 
36-47 29(3.4) 37(4.4) 28(3.3) 34(4.0) 128 (15.2) 
48-59 32(3.8) 30(3.6) 29(3.4) 28(3-3) 119 (14.1) 
60-71 30(3.6) 23(2.7) 30(3.6) 26(3.1) 109 (12.8) 
72-83 36(4.3) 28(3.3) 34(4.0) 12(1.4) 110 (13.1) 
ALL AG ES 225(52.2) 206(47.8) 227(55.4) 183(44.6) 841 (100) 
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3.4. CROSS SECTIONAL SURVEY RESULTS AT BASELINE 
Haernatological parameters (iron status) 
Haernatological indices used to define anaemia and to determine the degree of 
severity of anaernia, were those recommended by the World Health Organisation 
(WHO). Accordingly, measured values of haernoglobin and haernatocrit were used 
to define the iron status and anaernia of study subjects as either normal (ý! 100%), or 
as having mild (81-99%), moderate (61-80%) or severe (! ý60%) anaemia. A serum 
ferritin concentration, of 12 ýtl/L was used to define iron deficiency in both women 
and children. 
Haernatological indices of women 
Haernatological measurements were made in study women to determine their iron 
status and degree of anaernia before they started supplementation. The distribution of 
haemoglobin and the level of anaernia showed a similar pattern among women 
assigned to either of the supplementation groups ( shown in Table 12) with means 
(standard deviation) haernoglobin levels of 8.52 (1.3) and 8.55 (1.4) g/dL among 
women in the iron and placebo groups respectively. Baseline measurements of 
haernatocrit showed a similar picture. The mean haernatocrit level in women in each 
group was 29.2% (Table 13). 
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The geometric mean serum ferritin concentration of all women was 46.03 pg/L, and 
less than 5.0% of women had a serum ferritin below the cut-off value of 12 Vtg/L. The 
mean (s. d. ) serum ferritin levels of women assigned to receive either iron or placebo 
were very similar, 45.5 (1.9) ýtg/L and 46.5 (2.0) ýtg/L respectively. 
Table 12 Distribution of anaernia among women as measured by Hb 
at baseline 
haernoglobin g/dL 
(degree of anaernia) 
ý 7.1 (severe) 
ý 7.2-9.5 (moderate) 
9.6-11.9 (mild) 
12.0 (normal) 
Mean (sd) Hb in g/dL 
234 (59-8) 239 (62.1) 
87 (22.3) 83 (21.6) 
0 (00.0) 0 (00.0) 
8.52 (1.3) 8.55 (1.4) 
t=O. 3, p =O. 75 
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Table 13. Distribution of anaemia among women as measured by 
haematocrit at baseline 
haematocrit (%) 
(level of anaemia) 
Treatment group 
Iron (n=391) Placebo (N=385) 
number (%) number (%) 
23 (5.9) 35 (9-0) 
168 (42.6) 138 (35.8) 
158 (40.4) 180 (46-8) 
> 36 (normal) 42 (10.7) 32 (8-3) 
............ ........ ................. ............... .............. .............................. ............ .......... .......................... ................... Mean (sd) Hct. % 29.2 (5.4) 29.2 (5.4) 
125 
3.4. baseline results: haernatological parameters 
3.4.1.2. Haematological indices among children 
Specimens from 41 of the 841 children in the study (21 from the iron and 20 from 
placebo group) were either inadequate or unavailable and it was possible to estimate 
iron status in only 800 children. Distributions of haernoglobin and haematocrit 
measurements are shown in Tables 14 and 15. The means (s. d. ) haemoglobin at 
baseline was 8.27 (1.2) g/dL for children in the iron group and 8.27 (1.3) g/dL for 
those in the placebo group. Mean haernatocrit levels were 26.4 (4.3) % and 26.4 (4.7) 
respectively. 
Using haemoglobin as a measure of anaernia, 63.4% of children in the iron and 
61.8% of those allocated to placebo treatment were moderately to severely anaemic, 
compared with figure of 70% and 69.2% using haernatocrit values to define anaernia. 
In addition, 1.5-2.3% of children with anaemia, defined by haernoglobin, fell into the 
normal category (Hct >36%) when haernatocrit was used as a measure of anaemia 
(Table 15). 
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Only 7.4% of the 310 children assessed had a serum ferritin value below the cut-off 
point of < 12 ýtg/L. The geometric mean (s. d) serum concentration among children 
was 42.0 (2.2) [tg/L with values ranging from 2.2 to 196.3 ýtg/L. Mean (s. d. ) values 
were similar in iron and placebo supplementation groups, 42.7 (1.9) [tg/L and 40.5 
(2.2) ýtg/L respectively. 
Table 14 Distribution 
haemoglobin. 
of anaernia among children defined by 
haemoglobin (g/dL) 
& degree of anaernia 
:! ý6.5 (severe) 
6.6-8.7 (moderate) 
8.8 -10.9 (m iI d) 
: ý! l 1 (normal) 
Mean (sd) Hb. 
Treatment group 
Iron (N=410) placebo (N=390) 
number (%) number (1/6) 
49 (12.0) 50 (12.8) 
211 (51.4) 
150 (36.6) 
0(0.0) 
8.27 ( 1.2) 
191 (49.0) 
149 (38.2) 
0(0.0) 
8.27 ( 1-3) 
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Although there was a slight variation between groups in the distribution by severity of 
anaernia there was no statistically significant difference among children in the two 
supplementation groups. 
Table 15 Baseline distribution of anaemia among children as 
measured by haematocrit levels. 
haematocrit (%) & 
deqree of anaemia 
:! ý 21.6 (severe) 
21.7-28.8 (moderate) 
28.9-36 (mild) 
36 (normal) 
Mean (sd) Hct. 
Treatment group 
Iron (N=410) Placebo (N=390) 
number (%) number (%) 
58 (14.1) 71 (18.2) 
229 (55.9) 
117 (28.5) 
6 (1.5) 
26.4 (4.3) 
199 (51.0) 
111 (28.5) 
9 (2.3) 
26.4 (4.7) 
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3.4.2. Anthropornetric status of women and children at baseline 
3.4.2.1. Nutritional status of women 
As an indirect indicator of the adequacy of dietary intake, height, weight, hip and 
waist circumferences were measured in study women during the baseline survey. 
Nutritional indices of body mass index (BMI), and waist-hip ratio (WHR) were 
computed from the anthropometric data. The results of anthropometric 
measurements on study women are summarised in Table 16. As anticipated, study 
women were, in general, under weight and short in stature, with a mean (s. d) weight 
of 47.8 (6.3) kgs and mean (s. d) height of 157 (6.0) cms. The prevalence of a low 
BMI (! ý 18.5 ) among all women was 36.7%. The mean ratio between waist and hip 
circumferences (WHR) was 0.826, which suggests that study women had little 
adipose tissue. The overall picture was that of a marked degree of malnutrition 
implying that there had been food shortages in the past. When the baseline 
nutritional status of women assigned to either supplementation group was compared, 
no significant differences between them were found (Table 16). 
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Table 16. Anthropometric status of women before treatment 
Anthropometric indices 
Mean weight(sd) Kgs 
Mean height(sd) crns 
Treatment Group 
Iron Placebo 
(N=391) (N=385) P 
48.2 (6.6) 47.4 (6.1) 0.08 
157.0 (6.0) 157.0 (6.1) 0.90 
Mean waist circumference (cm) 73.3 (5.7) 72.2 (5.9) 0.08 
Mean hip circumference (cm) 88.1 (5.9) 88.1 (5.7) 0.90 
Mean Body Mass Index (sd)* 19.5 (2.3) 19.2 (2.3) 0.06 
ý Mean Waist-Hip ratio 0.831 0.821 0.08 
Waist- Hip Ratio (WHR) is the ratio between waist anci nip circuMTerences in cenumetres. 
Body Mass Index (BMI) is weight in kgs divided by the square of height in meters. 
3.4.2.2. Nutritional status of children 
At baseline all children (841) were measured for height, weight and mid-arm 
circumference. The mean (s. d) weight and height of the children in the study were 12.5 
(4.0) kgs and 91.5 (15-8) cms respectively. Anthropornetric indices of height-for- 
weight (hw), height-for-age (ha) and weight-for-age (wa) were also computed on the 
basis of the standard deviation (z-score) method in reference to -2.0 SD of the standard 
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as recommended by WHO. The prevalences of low (< -2.0 SD) hw, ha and wa among 
study children at baseline were 19.6%, 45.0% and 47.8% respectively. Though each 
measure indicates a different form of under nutrition, it is obvious that all the three 
indices show a high degree of malnutrition among children in the study. Results of the 
baseline measures suggested that children in the study had nutritional deficiencies that 
reflected chronic food shortages in the past as well as a poor diet at the time of the 
survey. Slow skeletal growth and development for age, often associated with 
nutritional problems of long duration, were indicated by the high prevalence of low 
height-for-age of 44.9%. Male children were slightly shorter for their age than females, 
particularly between the age of 6-12 months, with sex-specific prevalences of low 
height-for-age 46.0% and 43.7% for males and females respectively. However, the 
difference is not statistically different, (X 
2 
=0.41, p=0.51). Undernutrition among 
children was further assessed using Waterlow's (1977) classification, by cross- 
classifying the z-score values of weight-for-height and weight-for-age, into four broad 
categories of nutritional status as shown in Figure 3. 
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Figure 3 Cross-tabulation of anthropornetric z-scores of children and 
classification of malnutrition * 
height-for-age height-for-age 
z-score >-2 SD <-2 SD 
weight-fdr-height normal to mildly 
ý! -2 SD malnourished stunting 
weight-for-height wasting & 
<-2 SD wasting stunting 
* Source: Waterlow, 1977 
Summary estimates of each of these categories of malnutrition are shown in Table 17; 
over a third of all children were found to suffer from one or other form of 
malnutrition. Children assigned to the iron group appear to have suffered more from 
the chronic form of undernutrition compared to those in the placebo, as prevalences 
of stunting were 17.6% and 22.6% respectively, but the difference between groups is 
not statistically significant. 
On the other hand, wasting and stunting combined, which is the severest form of 
undernutrition, was seen in 3.4% and 3.9% of the children in the iron and placebo 
groups respectively. Mid arm circumference measurements were similar in the two 
groups with mean circumferences of 14.3 and 14.0 cms among children in the iron 
and placebo groups respectively. 
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Table 17 Anthropometric status of children before supplementation 
Treatment Groups 
Nutritional Iron Placebo 
status 
... 
(N=431) 
... 
(N=410) 
. 
eight in kgs iý'ean (s. d. ') w-1 
.. . 
12.5 (4.0) .............. 12.4(3.9) 
Mean (s. d) height in cms. 91.7 (15.0) 91.3(15.7) 
Normal to moderately 
malnourished 64.6 60.8 
Wasting (0/o) 14.4 12.7 
Stunting (%) 17.6 22.6 
Wasting & stunting(%) 3.4 3.9 
.... . ...... ...... 
t=O. 4 0.7 
t=0.4 0.7 
1.28 0.25 1 
0.52 0.47 
3.34 0.06 
0.11 0.74 1 
Mean arm cf. in cm (sd) 14.3( 3.6) 14.0( 1-3) t=2.53 0.11 
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3.4.3. General health status of women and children at baseline 
A cross-sectional health assessment was undertaken for all the 776 women in the 
study before they started their respective supplementation. On the day of clinical 
assessment a total of 262 (33.8%) women presented themselves with some kind of 
illness indicating that there was a high degree of ill health among women in the study 
area. The number of women with selected categories of illness is presented in Table 
18. Although all women were known to have varying degrees of anaernia, as 
determined by laboratory measurements, only 90 (11.5%) women were considered to 
be anaernic using clinical signs and symptoms as defining criteria. The prevalences 
of clinically diagnosed anaernia among women in the iron and placebo groups were 
(X2 =5.15, p=0.02). 14.1% and 9.1% respectively, a statistically significant difference ., 
Clinical malaria was diagnosed in 12.8% and 12.5% of women in the iron and 
placebo groups respectively. The distribution of all other categories of illness was 
fairly similar in both groups. Women assigned to the iron and placebo 
supplementation did not show any significant difference in the overall burden of 
morbidity at baseline (34.5% and 33.0% respectively) (X2 =0.21, p=O. 70). 
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Table 18 Health status of women for selected diseases at baseline 
Diseases 
all illness on examination day 
anaemia 
malaria 
GUTI* 
55 14.1 35 9.1 5.15 0.02 
50 12.8 48 12.5 0.00 0.99 
13 3.3 6 1.6 2.63 0.11 
* GUTI= genito urinary tract infection 
The health status of children was also assessed clinically in all except for 23 study 
children who were not available on the examination day. On the day of examination, 
423 children (51.7%) were found to have one or more illnesses of varying severity. 
Numbers of cases of selected diseases among children assigned to the two treatment 
groups are shown in Table 19. The overall prevalence of all illnesses was similar in 
iron and placebo groups, 52.4% and 51.0% respectively. Individual diseases were also 
found to be distributed similarly in children assigned to receive iron or placebo. 
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Table 19. General health status of children at baseline. 
lron(N=422) Placebo(N=396) 
Diseases number(%) number(%) )C2 p 
children with Illness 
anaemia 
I malaria 
I 
splenomegaly 
IARI* 
I diarrhoea 
221 52.4 202 51.0 0.10 0.74 
83 (19.7%) 70 (17.7%) 0.41 0.52 
48 (11.4%) 53 (13.4%) 0.59 0.44 
82 (19.4%) 78 (19.7%) 0.0 0.99 
82 (19.4%) 83 (21.0%) 0.21 0.64 
69 (16.4%) 69 (17.4%) 0.10 0.75 
* ARI = acute respiratory infection 
3.4.4. Intestinal parasites among children 
At baseline, stool specimens were examined to determine the prevalence of intestinal 
parasitic infections among children. Specimens were available from only 493 
(58.6%). Samples from the remaining 348 children were not examined as they were; 
specimen not available (287), insufficient (39) or because containers broke during 
transportation (22). Of the 493 stool samples examined, 157 (31.8%) showed one or 
more pathogenic intestinal ova or parasites. 
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Hook worm and Hymenolopis nana infections were the commonest parasites found 
affecting 13.4% and 7.7% of children respectively. Thirty-six stools contained more 
than one parasite. The distribution of intestinal parasitic infections is shown in Table 
20. 
Table 20 Percentage distribution of intestinal parasites among 
children (N=493) 
Total negative 
Total positive 
336 (68.2%) 
157 (31.8%) 
distribution of intestinal parasites among those tested positive 
parasite number (%) 
hookworm 66(13.4) 
Hymenolepis nana 38( 7.7) 
Ascaris lumbercoids 32( 6.5) 
Strongyloidis stercoralis 28( 5.7) 
Giardia lamblia 11 ( 2.2) 
Scistosoma mansoni 9( 1.8) 
all others * 9( 1-8) 
* all other includes: 5E hystolifica, 4 Trichuris tricuria 
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3.5. GENERAL HEALTH STATUS DURING SUPPLEMENTATION 
The health of women and children during the supplementation period was followed in 
two ways. Firstly, study subjects were visited every other week and asked about 
symptoms and signs suggestive of malaria and other common maternal and childhood 
diseases since the last visit. Secondly, hospital data on study subjects who sought and 
obtained medical assistance during the supplementation period were secured. At the 
biweekly morbidity assessment details on any morbid experiences which had 
occurred during the period between visits were recorded as present or absent and if 
present, the duration of that specific episode was also recorded. Except for episodes 
of fever, which in most instances were verified by measuring axillary temperature, 
other illnesses were recorded as perceived and described by the subject (or by the 
parent of a child). From the morbidity data set, the frequency and mean number of 
episodes of illness per subject and the mean duration per an episode were calculated 
for women and children in each of the two supplementation groups. The frequency 
of hospital visits and proportions of visits by diagnosis were calculated for subjects in 
each group. Morbidity data for women and children are presented separately. 
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Health status of women during the period of 
supplementation (biweekly morbidity) 
Seven hundred and fifty-three of the 776 women enrolled (382 receiving iron and 371 
receiving placebo) were visited six times during the supplementation period. 
Twenty-three women (9 in the iron and 14 in the placebo) were lost to follow up. 
Fifteen women either moved out of the area or were unavailable on consecutive visits 
and 8 women refused to continue to participate for personal reasons such as work- 
related inconvenience or death of a family member. The frequency of episodes of 
malarial symptoms and signs (fever, headache, chills and rigors, back and joint pains) 
and the duration of each episode was recorded and results are surnmarised in Table 
21. The follow-up period for all women was a total of 9034 person-weeks (753 
women x 12), comprising 4584 person-weeks for the iron group and 4452 person 
weeks for those in the placebo group. The incidence rates of illness episodes among 
women in both groups are shown in Table 22. 
A total of 449 (59.6%) women in both groups reported at least one episode of fever 
during the 12-week period of follow-up. An episode of fever was reported by 244 
(63.9%) women in the iron and 205 (55.3%) women in the placebo group, RR=1.16, 
(95% CLI. 03-1.30), (X2=5.8, p=0.01). The distribution of fever episodes among 
women in the two groups revealed a similar picture, higher in the iron group. 
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Six hundred and fifty-two episodes were reported by women who were receiving iron 
and 514 episodes by those in the placebo group, with a mean number of 1.71 and 1.38 
febrile episodes per women in the iron and placebo groups respectively, RR= 1.23, 
(95% Cl: 1.11-1.37), (X 2=14.2, p<0.001). When the distribution of fever episodes 
were categorised, as shown in Table 23, a linear trend was observed indicating that 
febrile episodes were more likely to be experienced by women receiving iron 
supplementation than those who received the placebo, (y, 2 =10.7; df=4, p=0.029). 
Analysis of the duration of febrile episodes showed that women in the iron group 
spent 2645 days with fever in contrast to those in the placebo who had 1917 days of 
fever. The mean durations per episode of fever among women in the iron and 
placebo groups were thus 4.06 and 3.72 days respectively. Analysis of durations of 
febrile episodes (Table 24) showed no statistically significant difference between 
(X2= 
women in the iron supplementation and placebo groups 10.3; df=6, p=0.123). 
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Table 21 Distribution of women with at least 1 episode of illness 
suggestive of malaria during 12 weeks of supplementation 
TREATMENT GROUP 
IRON PLACEBO 
(N=382) (N=371) 
malarial episodes no. % no. % RR (95%Cl) 
2P 
fever 244 63.9 205 55.3 1.16 (1.03-1.30) 5.80 0.011 
headache 299 78.3 256 69.0 1.13 (1.04-1.24) 8.33 0.003 1 
chills &/or rigor 239 62.6 200 53.9 1.16 (1.03-1.31) 5.79 0.01 1 
back/joint pain 267 69.9 227 61.2 1.14 (1.03-1.27) 6.32 0. Ol ý 
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Table 22 Incidence rates for episodes of illness suggestive of 
malaria per person-week among women during 12 weeks of 
supplementation 
TREATMENT GROUP 
Malarial IRON (N=382) PLACEBO (N= 371) 
episodes 
........ 
no. rate/pw no. rate/pw 
.. 
RR(95%Cl) 
........................... 
x2P 
febrile episodes 652 0.14 514 0.12 1.23(l. 11-1.37) 14.2 <0.01 
headache 1140 0.25 964 0.22 1.15(l. 07-1.24) 12.9 <0.01 
chills &/or rigor 523 0.11 413 0.09 1.23(l. 09-1.39) 10.8 <0.01 
back/joint pain 735 0.16 609 0.14 1.17(l. 06-1.29) 9.7<0.01 
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Table 23 Distribution of reported fever episodes among women 
during 12 weeks of supplementation 
number of IRON (n=382) PLACEBO (n=372) 
episodes number % number % 
0 137 36.0 169 45.2 
1 67 17.5 70 18.9 
2 58 15.2 50 13.5 
3 51 13.4 30 8.0 
68 17.8 55 14.7 
=10.76 (df=4); p= 0.029 
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Table. 24 Mean duration (days) of febrile episodes among women 
during the supplementation period by treatment group 
( N=244 in the iron group and 205 in the placebo) 
Mean duration in days 
........ ......... ................. ............. .......................................... ...................................... ...................................... ........................................................................................... ............. ........... ................ ... 
j'T'r'e*at'm'e'n"t'g* 
r'ou'p` 4-6 7-9 10-12 .1.3-1 5 16-18 .1.9TOTAL 
................................................................. ... ................... ............. .................. ........................................................................ .......... .................. ....... ...... .................................... .... ........................................................................ ...... .... ........... ........ I ...... I ............................. ................................................................. ....... ...... ........... ..... I............................ .............................. ... .... I. ý ............... ...... ........ ......... I ............. . ... I ............ ...... ............ ......... .................. ................... ............. ...... 
hRON 
54 44 31 29 22 
-'-23 
41 2*44 
(22.1) (18.0) (12.7) (11.9) 9.0) 9.4) (16.8) 100-0) 
PLACEBO 63 26 37 22 18 15 24 205 
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3.5.2. Health status of children during the supplementation period 
(fortnightly morbidity) 
Morbidity data were obtained for all study children except for 54 children (26 from iron 
and 28 from placebo) who were lost to follow-up. The frequency of probable malarial 
episodes among children in the two groups is shown in Table 25. A total of 279 
(68.9%) children in the iron group and 225 (58.9%) children in the placebo group were 
reported to have experienced at least one episode of fever, RR=1.17 (95% CI: 1.05- 
1.30); (X 2 =8.09, p=0.004). 
Table 25 Distribution of children with at least 1 episode of illness 
suggestive of malaria during 12 weeks of supplementation 
TREATMENT GROUP 
IRON PLACEBO 
(N=405) (N=382) 
malarial episodes 
.......... 
no. 
....... 
no. 
....... 
RR(95% CI) 
. *::::::.:.:.:. "-".:.:.:.:. ............ 
x2P 
: ... .... . ..... 
Fever 
...................... .................... 
279(68.9) 
... ................... 
...... ... 
225(58-9) 
.. 
1.17(l. 05- 1.30) 8.090-004 
III feeling 215(53.1) 171 (44.8) 1.19(l. 03- 1.37) 5.440.019 
Chill/rigor 154(38.0) 114(29.9) 1.27(l. 04- 1.55) 5.730-016 
Generalised pain 139(34.4) 98(25.7) 1.32(l. 06- 1-64) 6.510.010 
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The incidence rates of episodes suggesting malarial illness are shown in Table 26. As 
indicated in the table, a total of 708 and 611 fever episodes occurred among children in 
the iron and placebo groups in a follow up period of 4860 and 4584 person-weeks 
respectively. Thus, the calculated incidence rates for febrile episodes among children 
in the two groups were 14.6% and 13.3% respectively with a rate ratio of 1.09 (95%CI: 
0.99-1.21), (Z, 2 =2.9 1; p=0.08).. 
Table 26 Incidence rates for episodes of suspected malaria per 
person-week (pw) among children during supplementation 
malarial 
episodes 
I Fever 
III feeling 
Chill/rigor 
Generalised pain 
TREATMENT GROUP 
IRON PLACEBO 
(N=405) (N=382) 
2 
x no. rate /pw no. rate /pw RR 95%Cl p 
708 0.15 611 0.13 1.09 (0.99-1.21) 2.9 0.08 
431 0.09 339 0.74 1.20(l. 05-1-37) 6.6 0.01 
288 0.06 209 0.05 1.30(l. 09-1.55) 8.6 <0.01 
203 0.04 137 0.03 1.40(l. 13-1.73) 9.3 <0.01 
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The distribution of febrile episodes (Table 27) among the two groups of children 
showed that those in the iron group experienced more episodes compared with those 
in the placebo, (X 2 =10.3; p=0.029). 
When the duration of fever was investigated it was noted that iron supplemented 
children had experienced a total duration of 2841 days of fever against 2168 days 
among placebo supplemented children. Thus, the mean duration of illness was 4.01 and 
3.54 days per an episode among iron and placebo groups respectively. Analysis of 
durations of febrile episodes by grouping into 3-days showed no significant difference 
between children in the two groups, (y, 2 =2.32; p=0.88) (Table 28). 
Table 27 Distribution of reported fever episodes among children 
during 12 weeks of supplementation 
IRON (n=405) PLACEBO (n=382) 
number of episodes number % number % 
...... I .......................................... . ................................. -. - ......... . ..................... ............... ...... 0 
....................... ..................... ...................... 126 ......... ....... .......................... ...... (31.1) 156 (40.8) 
1 81 (20.0) 57 (14.9) 
2 82 (20.2) 59 (15.4) 
3 50 (12.3) 46 (12.0) 
>4 64 (15.8) 64 (16.7) 
2 
X, =10.73; (df=4)p=0.029 
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TABLE. 28 Distribution of children by mean duration (days) of febrile 
episodes over the supplementation period 
( N=279 in the iron group and 225 in the placebo) 
Mean duration of fever in days 
......... .-........ ........................... ........................... .................................... ... ........................................... I ........................... ................................................ ........................... I .......... ........................... ........... Treatment group 1-3 4-6 7-9 10-12 13-15 16-18 ý! lq TOTAL 
..................... ......................... .I....... I ...... --l- ................. -1.1 .... .... ............. .... .......... .......................................................................................... .............................. .... .... ........... ....... ........ ........ . ........................ . ....... ... . ....... ..... ........ ........ ........ ................................. I ....................... .... ......... ..... ... ........... I ............................................................................. ............. ............ ............ ....... ......... 
IRON 63 55 47 25 25 22 42 279 
(22.6) (19.7) (16.8) 8.9) 8-9) (07.9) (15.0) (100-0) 
PLACEBO 52 40 40 26 22 14 28 225 
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3.5.2. Hospital visits and medical help during supplementation 
During the twelve weeks of supplementation a total of 94 women, 46 from the iron and 
48 from the placebo group sought medical help from the hospital for a variety of health 
conditions and diseases. Similarly, 73 children, of whom 41 were from the iron and 32 
from the placebo group made visits to the hospital. The distribution of diseases and 
categories of conditions diagnosed among women and children who attended the 
hospital is summarised in Table 29. The proportions of women in the iron and placebo 
group who obtained medical help from the hospital were 12.0 % and 12.9% 
respectively (X 2=0.07; p=0.79). The usage of hospital services by children was also 
very similar among those in the iron and placebo groups (10.1% and 8.4% 
respectively), 
(X2=0.52; p=0.47). The morbidity pattern among women and children 
who visited the hospital during the supplementation period was similar in the two 
groups. The distribution of diseases (Table 29) showed no significant difference 
between supplementation groups. 
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Table 29. Distribution of diseases diagnosed in the hospital during the 
trial 
women 
iron 
(n=382) 
.......... .. XXX 
no. (%) of hospital visitors 46 (12.0) 
Reason for visit (Diagnosis) 
malaria 24 
PUO* 8 
ARI - 
other respiratory 3 
diarrhoea 5 
GUTI** 24 
other Gl*** 20 
ob/gy **** 13 
all other illnesses 
................ 
.... .. 
39 
.... 
placebo 
(372) 
48(12.9) 
24 
6 
children 
iron placebo 
(n=405) (n=382) 
41 (10.1) 
41 
32(8.4) 
32 
20 16 
3 20 16 
6 37 31 
10 -- -- 
14 36 36 
9 
36 
...... ..... 
22 15 
PUO= fever of unknown origin 
GUTI=genito urinary tract infections 
other Gi= gastro intestinal problems including intestinal parasitic infections 
ob/gy- obstetric and gynaecological disorders 
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3.6. POST SUPPLEMENTATION RESULTS 
Haematological measurements 
Women and children who successfully completed their respective treatment schedule 
were re-evaluated to measure changes in haernatological parameters that may have 
resulted from supplementation with iron. Results for women and children are presented 
separately. 
Haernatological status of women after supplementation 
A total of 737 women completed supplementation, an overall response rate of 94.9%. 
Three hundred and seventy-four (95.7%) of the iron and three hundred and sixty- 
three (94.3%) of the placebo treated women had their haernoglobin and haernatocrit 
levels measured following supplementation. 
Haernatological findings after supplementation are shown in Tables 30 and 32. More 
women in the iron than in the placebo group had an improvement in their 
haernatological status. Mean haemoglobin (sd) were 9.93 (1.52) g/dL and 8.82 (1.46) 
gm/dL in the two groups respectively (t=10.1, p<0.0001). Haernatocrit measurement 
showed a similar pattern of improvement with means (sd) of 32.6 (5.4) % for women 
in the iron group and 29.9 (4.9)% for those who received placebo ( t= 7.9, p<0.0001). 
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Prevalences of severe anaernia were 5.1% and 13.5% in the iron and placebo groups 
respective y, (X 2=14.6; p<0.001). More women in the iron group fell into the 
category of mild anaernia (Hb 9.6-11.9 g/dL) or normal haernatological status (Hb 
ý! 12.0 g/dL) than did women in the placebo group. Women with mild anaernia (Hb of 
ý! 9.6 g/dL) improved significantly from 22.3% at baseline to 52.9% after 
supplementation, compared with women in the placebo among whom there was little 
improvement, an increase from 21.6% to 29.2%. There was a highly statistically 
significant difference between the proportion of women in the two supplementation 
groups who had either mild anaernia or normal Hb level, 62.5% in the iron group and 
30.6% in the placebo group, (y, 2 =75.7; p<0.0001). The improvement of anaernia 
following iron supplementation was further demonstrated by the haernatocrit levels 
shown in Table 31. When the haernatocrit level was used to examine the response to 
iron, the pattern emerged very similar to that shown when haernoglobin level was 
used. 
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Table 30 Haemoglobin level of women before & after supplementation 
IRON PLACEBO 
Haemoglobin before after before after 
(g/dL) severity (N=391) (N=374) (N=385) (N=363) 
< 7.1 severe 70(17.9) 19( 5-1) 63(16.4) 49(13.5) 
7.2-9.5 moderate 234(59.8) 121 (32.4) 239(62-1) 203(55-9) 
9.6-11.9 mild 87(22.3) 198(52.9) 83(21.6) 106(29.2) 
>12 normal o( 0.0) 36( 9.6) o( 0.0) 5(1.4) ý 
Mean Hb(sd) 8.5( 1.3) 9.9( 1.5) 8.6( 1.4) 8.8( 1.5) 
t=13.8 P<0.0001* t= 1.89 p=O. 06** 
comparison between baseline and post supplementation Hb in tne iron group 
** comparison between baseline and post supplementation Hb in the placebo group 
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Table 31 Haernatocrit levels of women before and after treatment 
IRON PLACEBO 
Haematocrit before after before after 
(%) severity (N=391) (N=374) (N=385) (N=363) 
<21.6 severe 24( 6-1) 6( 1.6) 35( 9-0) 15( 4.1) 
121.7-28.8 moderate 
128.9-36.0 mild 
1 
>36.0 normal 
ý Mean Hct(sd) 
168(43.0) 82(21.9) 138(48.8) 131 (36-1) 1 
157(40.1) 198(52.9) 
42(10.7) 88(23.5) 
29.2(5.4) 32.6(5.4) 
t=8.7 P<0.0001* 
180(46-8) 195(53.7) 1 
32( 8.3) 22( 6.1) 1 
29.2(5.4) 29.6(4.9) 
t=1.05 p=0.28' 
comparison between baseline and post supplementation Hct In tne iron group 
** comparison between baseline and post supplementation Hct in the placebo group 
154 
3.6. post supplementation haematological results 
The effect of iron supplementation on individual women was assessed further by 
comparing values measured at baseline with values at the end of supplementation. 
Marked changes in haemoglobin were seen in favour of women supplemented with 
iron compared with the changes obtained in those supplemented with placebo (Table 
33). Nearly half, 45.5%, of placebo treated women did not show any improvement, 
compared to only 17.4% of women in the iron group who did not show a positive 
change after supplementation. The overall gain in haernoglobin was markedly higher 
among the iron supplemented women than among those in the placebo group, 
(X2=1 15, p<0.0001). Women who were supplemented with iron gained on average 
1.43 g/dL of haernoglobin compared to an average of only 0.28 g/dL gained by those 
who received placebo, (1=12.5, p<0.001). The benefit of iron treatment can also be 
seen from the marked difference of the proportion of women whose haernoglobin 
level increased by ý! 2.1 g/dL, 28.3% and 5% among those in the iron and placebo 
treatment groups respectively. Haernatocrit levels after supplementation showed a 
similar picture (Table 31). 
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Table 32 Gain in haemoglobin among women after supplementation 
haemoglobin Iron (N=374) placebo (N=363) 
gain (g/dL) no. % no. 
............... . ............ ......................... -"-"'. '. '. '. ', '. '. ` ........... * ...... no change 
.............. ....................... ............................ ....... ................................ 65 17.4 
.......... .......... .......... ....................... ..... ....... .... ................. ...................... ........ 165 45.4 
0.1-1.0 75 20.0 106 29.2 
1.1-2.0 119 31.8 94 20.4 
ý2.1 115 28.3 18 5.0 
.......... ........... *- .......... Mean Hb change (g/dL) 
.............. ....... 1.43 0.28 
t= 12.6, p <0.00 1 
The degree of anaernia observed at baseline also changed dramatically among women 
in the iron group compared with those treated with placebo. At baseline, severe 
anaernia (Hb < 7.1 g/dL) was of similar magnitude among women in the iron and 
placebo treatment groups, 17.9% and 16.4% respectively. After supplementation, 
however, the proportion of iron treated women with severe anaernia decreased to 
5.1% while the placebo group remained with slight decrease at 13.5% (Tables 31 and 
33). 
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Table 33 Distribution of women and change in the status of their 
anaemia after supplementation 
Anaernia after supplementation 
severe moderate mild normal 
(Hb <7.1) 
::: XXXX-* . 
(7.2-9-5) 
.......... : ýiiiý: iiiiiiiiiýi ... ......... ...... 
(9-6-11-9) 
, 
(ý. A, 2.0) Total 
....................... 
10( 2.7) 45(12.0) 14( 3.7) 0 0.0) 69 (18.4) 
28( 7.7) 30( 8.3) 0( 0.0) 0 (. 0.0) 58 (16-0) 
moderate (7.2-9.5) 
iron 
placebo 
mild (9.6-11.9) 
iron 
placebo 
normal (ý! l 2.0) 
iron 
placebo 
Total 
iron 
placebo 
9( 2.4) 
21 ( 5.8) 
o( 0.0) 
o( 0.0) 
o( 0.0) 
o( 0.0) 
19( 5.0) 
49(13.5) 
74(19.8) 
146(40.2) 
2( 0.5) 
27( 7.4) 
o( 0.0) 
o( 0.0) 
121(32.4) 
203(55-9) 
127(34.0) 15 ( 4.0) 225 (60.2) 
59(16.2) 0( 0.0) 226 (62.3) 
57(15.2) 21 ( 5.6) 80 (21.4) 
47(13.2) 5( 1.4) 79 (21.8) 
o( 0.0) o( 0.0) o( 0.0) 
o( 0.0) o( 0.0) o( 0.0) 
198(52.9) 36 ( 9.6) 374 (100) 
106(29.2) 5(1.4) 363 (100) 
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The response to iron supplementation by women with severe anaernia at baseline was 
shown to be significantly higher than that seen in those who had either moderate or 
mild anaernia. The mean haemoglobin rise in women with severe anaernia at baseline 
was almost 2.0 g/dL compared with rises of 1.662 g/dL in those with moderately 
severe anaemia and 1.087 g/dL in those who were mildly anaemic. When response 
was examined by severity (Table 33), it clearly shows that those who had severe 
anaemia before supplementation showed the highest response than those who had 
either moderate or mild degree of anaernia. Furthermore, those with moderate 
anaernia responded better than those with mild anaemia at baseline. The distribution 
of the mean haernoglobin rise in relation to the severity of anaemia at baseline among 
women in the two supplementation groups is shown in Table 34. 
Table 34. Mean haemoglobin gain among women with different levels 
of anaemia 
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3.6-1.2. Pregnant women 
A total of 91 pregnant women were studied and were allocated to receive 
supplementation, (49 on iron and 42 on placebo), and 85 (46 on iron and 39 on placebo) 
completed their respective treatment. Pregnant women had a relatively high level of 
haernoglobin (Hb 8.0-11.0 g/dL) at entry to the supplementation trial as the criteria, 
particularly the haernoglobin level, used to select pregnant women was slightly 
different from that used in non-pregnant women. 
The response to iron supplementation among pregnant women, examined separately, 
showed that those in the iron group achieved higher haemoglobin levels and improved 
(X2 their anaernia compared with those in the placebo group , =6.46; p<0.05). 
However, because the number of pregnant women allocated into the two treatment 
groups was small, it was not possible to compare the level of response with that of non- 
pregnant. The distribution of pregnant women by severity of anaernia and 
supplementation group is shown in Table 35. 
159 
3.6. post supplementation haematological results 
Table 35 Haernatological response of pregnant women compared with 
values at baseline 
baseline post-supplementation 
Haemoglobin all pregnant iron placebo 
(g/dL) severity (N=91) (N=46) (N=39) 
8.0-8.9 24(26.4) 3( 6.5) 6(15.4) 
9.0-9.9 61 (67.0) 14(30.4) 19(48.7) 
10.0-10.9 6( 6.6) 27(58.7) 14(35.9) 
ý! i 1.0 0( 0.0) 2( 4.3) 0( 0.0) 
2 =6.46; p<0.05) 
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3.6.1.3. Haematological status of children after supplementation 
Although children aged 6-84 months assigned to the iron and placebo supplementation 
groups had a similar iron status and degree of anaernia at baseline, the picture changed 
markedly after supplementation. Children who were supplemented with iron showed a 
pronounced gain in their haernoglobin compared with those in the placebo group. 
Following supplementation, the mean (sd) Hb of iron supplemented children was 9.68 
g/dL (1.2) compared with a mean haemoglobin of 8.52 g/dL (1.2) among those in the 
placebo group. The distribution of children in each supplementation group by severity 
of anaernia is shown in Table 36. 
Children on iron supplementation improved their haernoglobin by an average of 1.38 
gm/dL compared to the 0.22 g/dL gained by children in the placebo group (Table 37). 
The proportion of children in the placebo group whose haernoglobin did not improve 
ý., =209; p was 56.1% compared with only 
6.5% of children supplemented with iron (X2 
<0.0001). The proportions of children in the iron and placebo groups who gained a 
haernoglobin concentration of more than 1.0 g/dL were 67.9% and 13.7% respectively 
(X2=224; p <0.0001). 
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The mean Hb rise was also higher in those children who had severe anaemia at baseline 
compared with those with moderate or mild anaernia. For iron supplemented children 
the mean Hb rise was 1.73,1.50 and 1.10 g/dL in those with severe, moderate and mild 
anaernia respectively. The distribution of children by severity of anaernia and 
supplementation group shown in Table 39 demonstrates further that the response to iron 
was relatively higher in those who were severely anaemic at baseline compared with 
those who were either moderately or mildly anaemic. 
Table 36. Distribution of children by degrees of anaemia before & after 
supplementation 
degree of 
anaemia(Hb g/dL) 
I severe (< 6.5) 
I moderate( 6.6-8.7) 
IiId (8.8-10-9) 
I normal(> 11.0) 
I Mean Hb(sd) 
TREATMENT GROUP 
IRON PLACEBO 
before after before after 
(N=41 0) (N=368) (N=391) (N=374) 
49(12.0) 
211 (51.5) 
150(36.6) 
o( 0.0) 
8.3(l. 2) 
1(0.3) 
82(22.3) 
218(59.2) 
67(18.2) 
9.7(l. 2) 
50(12.8) 
191 (49.0) 
149(38.2) 
o( 0.0) 
8.3(1-3) 
28( 7-5) 
179(47.9) 
150(40.1) 
17( 4-5) 
8.5(l. 3) 
t=16.1 P<0.0001* t=2.1 P=0.03' 
compan son Detween Dasellne ana pos[ suppiemenwivri vdiuu, ý; irl Irle iron group 
comparison between baseline and post supplementation values in the placebo group 
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Table 37 Gain in haemoglobin among children after supplementation 
haernoglobin 
(g/dl) 
no change 
0.1-1.0 
1.1-1.9 
ý! 2.0 
Mean Hb change (g/dL) 
Treatment group 
Iron (N=368) placebo (N=374) 
no. % no. % 
24 6.5 
94 25.5 
170 46.2 
210 56.1 
113 30.2 
47 12.6 
80 21.7 4 1.1 
1.38 0.22 
t=21.3 p=<0.0001 
The distribution of haernatocrit levels (Table 38) also indicated that a significantly 
higher level was achieved by those in the iron group from a mean haernatocrit level of 
26.4% at baseline to 31.6% after supplementation (t=13.8; p<0.0001) compared with 
26.4% to 28.6% in those in the placebo group (t=1.95; p=0.06). The overall pattern of 
response of children to oral iron supplementation was very similar to that observed in 
women. 
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3.6. post supplementation haematological results 
Table 38. Haernatocrit levels of children before and after 
supplementation 
IRON PLACEBO 
Haematocrit before after before after 
(%) severity (N =41 0) (N=368) (N=390) (N=374) 
<21.6 severe 58(14.1) 6( 1-6) 71 (18.2) 28( 7.5) 
21.7-28.8 moderate 229(55.9) 89(24.2) 199(51-0) 152(40.6) 1 
28.9-36.0 mild 117(28.5) 231 (62.8) 111 (28.5) 173(46-3) 1 
>36.0 normal 6( 1.5) 42(11.4) 9( 2.3) 21 ( 5.6) 
Mean Hct(sd) 26.4(4.3) 31.6(4.6) 26.4(4.7) 28.6(4.9) 
t=16.3 P<0.0001* t=6.3 p=O. 06** 
comparison between basellne ana post suppiemenrarion rici in [FI& Irurl yruup 
** comparison between baseline and post supplementation Hct in the placebo group 
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Table 39 Distribution of children and change in their status of 
anaemia after supplementation 
Anaemia after supplementation 
severe moder. mild normal 
Anaemia at baseline (Hb <6.5) (6.6-8.7) 
..... 
(8.8-10.9) (ý! l 1.0) Total 
... ......... ........ . ... .... . ........ ........ .... . .............. ..................... severe (Hb <6.5) 
.................... ... .......... - ..... ............... . . ............................. ............................ 
iron 1 0.3) 40 (10.9) 2( 0.5) 0( 0.0) 43(11.7) 
placebo 23 6.1) 23 ( 6.1) 0( 0.0) 0( 0.0) 46(12.3) 
moderate ((Hb 6.6-8-7) 
iron 0( 0.0) 40 (10.9) 139 (37.8) 7( 1.9) 186(50.5) 
placebo 4( 1.1) 143 (38.2) 32 ( 8.6) 0( 0-0) 179(47.9) 
mild (Hb 8.8-10-9) 
iron 0( 0.0) 2(0.5) 77 (20.9) 60 (16-9) 139(37.8) 
placebo 1(0.3) 13 ( 3.4) 118 (31-6) 17 ( 4.5) 149(39.8) 
normal (Hb ý! 11.0) 
iron 0( 0.0) 0( 0.0) 0( 0.0) 0( 0.0) 0( 0.0) 
placebo 0( 0.0) 0( 0.0) 0( 0.0) 0( 0.0) 
...................... .. 
0( 0.0) 
.... ............ 
Total 
. .... ..... ........................ 
iron 1 0.3) 82 (22.3) 218 (59.2) 67 (18.2) 368(100) 
placebo 28 7.5) 179 (47.9) 150 (40.1) 17 ( 4.5) 374(100) 
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3.6.2. Post-supplementation anthropornetric status 
After 12 weeks of supplementation, second anthropornetric measurements were made 
in women and children to see whether nutritional status had changed during the 
supplementation period. 
3.6.2.1. Anthropometric status of women after supplementation 
A summary of anthropornetric measures and selected indices before and after 
supplementation is shown in Table 40. Women in each treatment group did not show 
any significant changes in either weight or height or other anthropornetric indices 
such as the BMI or WHR. 
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Table 40 Anthropometric indices of women before & after treatment 
Treatment Groups 
Iron Placebo 
Anthropometric before after before after 
indices (n=391) 
............. 
(n=374) (n=385) (n=363) 
Mean weiaht (ka) 48.2 .......................... 48.5 47.4 48.1 
Mean height (cm) 157.1 
Mean waist circumference 73.1 
Mean hip circumference 88.1 
Mean Waist-Hip ratio* 0.831 
157.3 157.0 157.0 
73.3 72.2 73.1 
88.1 88.1 87.9 
0.832 0.821 0.850 
Mean Body Mass Index** 19.5 19.6 19.2 19.7 
ratio between waist & hip circumterences in cm 
weight in kg divided by the square of height in meters 
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3.6.2.2. Anthropometric status of children 
The nutritional status of 758 children (369 iron and 389 placebo) was assessed by 
anthropornetry following completion of treatment. Children treated with iron or 
placebo had mean weight and height measurement of 13.4 kgs and 95.0 cms and 13.3 
kgs and 93.6 cms respectively. Weight and height measurements of each child were 
adjusted for z-score values to obtain weight-for-height, weight-for-age and height-for- 
age indices. Post supplementation values for children in iron and placebo 
supplementation groups are shown in Table 41. No significant differences in any 
anthropornetric measurement were found between treatment groups. 
Table 41 Distribution of low weight-for-age and low height-for-age 
among children by supplementation group at the end of the 
supplementation 
Z-score IRON GROUP PLACEBO GROUP 
wt-for-age(%) ht-for-age(%) wt-for-age(%) ht-for-age(%) 
> -2 S. D. 245(66.2) 280(75.7) 269(69.2) 280(72.0) 
< -2 S. D. 125(33.8) 90(24.3) 120(30.8) 109(28.0) 
Total 369(100.0) 369(100.0) 389(100.0) 389(100.0) 
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3.6-3. HEALTH STATUS AFTER SUPPLEMENTATION 
Following completion of supplementation with either iron or placebo, clinical 
assessment sessions similar to those undertaken at baseline were conducted to 
determine the health status of women and children. 
3.6.3.1. General Health status after supplementation (Clinical Assessment) 
Women 
All women who completed treatment were assessed at the end of the period of 
supplementation. On the day of examination, 282(38.5%) women were identified as 
suffering from one or more illnesses of varying degree and severity. Those in the 
iron group were ill significantly more than those in the placebo treatment group 
(Table 42). The proportions of women with illness were 43.5% (158/363) and 33.9% 
(124/366) among the iron and placebo treatment groups respectively; RR=1.28, (95% 
CI: 1.07-1.55), (y, 2 =7.14; p=0.007). 
169 
3.6. post supplementation health status 
Table 42 Post treatment status of women for selected diseases 
(clinical assessment at the end of supplementation) 
Diseases 
....... .... ... ....... Illness present 
anaemia 
malaria 
GUTI* 
All others** 
52 14.3 74 20.2 0.72 (0.5-1.0) 4.03 <0.05 
88 24.2 67 18.3 1.32 (1.0-1.8) 3.49 0.06 
13 4.1 10 2.1 1.31 (0.6-2.9) 0.20 0.65 
65 17.9 50 13.7 1.31 (0.9-1.8) 2.16 0.14 
*=Genito urinary tract infection ww=al/ sorts ot diseases: 
3.6.3.1.2. Children 
A total of 747 children completed their 12 weeks of supplementation and were 
available for post-treatment evaluation. The overall response rate and compliance to 
treatment for children was 88.8%(747/841). At the end of supplementation 
368(85.3%) children in the iron group and 372 (90.2%) children in the placebo group 
respectively were available for the clinical assessment. 
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Of those children who underwent clinical assessment, 386(52.3%) children were 
diagnosed as having one or more ailments. The distribution of children in the two 
supplementation groups by diagnosis of selected diseases is presented in Table 43; 
63.4% of children in the iron group and 41.4% in the placebo group were diagnosed 
as having one or more diseases (X2 " =33.8; p<0.001). Prevalences of anaemia, malaria, 
splenornegaly, acute respiratory diseases (ARI), diarrhoea and intestinal parasitic 
infections were compared. Malaria and splenomegaly but none of the other 
conditions were found significantly more frequently in children who had been 
supplemented with iron. 
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Table 43 General Health status of children after supplementation 
Treatment Group 
iron (n=366) Placebo (n= 372) 
Diseases no. no. (%) RR (95% Cl ) )C2 P 
........... I ....... ............. .............................. ....... Illness present 
.... ........... , ........ 
232(63.4) 
............................... .. 
154(41.4) 
........................................ 
1.53 (1.3-1.8) 33.8 
.......... 
<0.001 
.............. 
anaemia 
... . ..................................... 39(10.7) 
..................... . ....................... 54(14.5) 0.73 (0.5-1.1) 
........ 
2.16 
... ... 0.14 
malaria 72(19.7) 49(13.2) 1.49 (1.1-2.1) 5.07 0.02 
splenomegaly 100(27.3) 71 (19.1) 1.43 (1.1-1.9) 6.36 0.01 
ARI 47(12.8) 44(11.8) 1.09 (0.7-1.6) 0.08 0.72 
Diarrhoea 45(12.3) 50(13.4) 0.91 (0.6-1.3) 0.15 0.72 
intest. parasite 26(07.1) 25(06.7) 1.06 (0.6-1.8) 0.01 0.95 
All other diseases 71 (19.4) 36(09.7) 2.00 (1.4-2.9) 13.0 0.001 
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3.6.3.2. Clinical Malaria And Parasitaernia 
3.6.3.2.1. Malaria in women after supplementation 
On the assessment day, clinically apparent malaria was diagnosed among 155(21.3%) 
of all women, of whom 88(56.8%) were women who had received iron 
supplementation. Rates of malarial illness among women in the iron and placebo 
were 24.2%(88/363) and 18.3%(67/366) respectively, RR=1.32,95% CI=1.0-1.76, 
(72 =3.83, p=0.05). Estimates of clinical illness from malaria and other malariometric 
indicators are shown in Table 44. 
One hundred and ninety of a total of 737 thin and thick film examined were positive 
for one or more species of malaria parasite, an overall parasite rate of 25.7%. Nine 
slides from women who stopped treatment early were excluded and the parasite rate 
among 729 women who completed treatment was 24.8%(181/737). The parasite rate 
among women in the iron group was 29.4% (107/363), while it was 20.2%(76/366) 
among those in the placebo group, RR=1.47,95% CI=1.14-1.90, (X 
2 =9.21; p=0.002). 
Mean parasite density was also calculated in both groups and shown to be 6,145 and 
41512 parasites per [tl of blood among women treated with iron and placebo 
respectively but this difference is not statistically significant. 
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Table 44 Distribution of malariometric indices among women after 
supplementation (clinical assessment) 
TREATMENT GROUP 
Malariometric Iron Placebo 
measures (n=363) (n=366) RR (95%Cl) p 
Malarial symptoms & signs on examination day 
fever ý37.50C 103(27.1) 67(18.1) 1.7 (1.2,2.5) 0.001 
headache 89(23.8) 79(21.8) 1.1 (0.8,1.6) 0.39 
chilIS/rigors 56(14.9) 43(11.8) 1.3 (0.8,2.0) 0.17 
back/joint pain 70(18.7) 70(19.3) 0.9 (0.7,1.4) 0.96 
nausea/vomiting 103(26.3) 88(22.9) 1.2 (0.9,1.5) 0.21 
Doctor's final diagnosis 
clinical malaria 88(24.2) 67(18.3) 1.3 (1.0,1.8) 0.06 
Parasitological 
positive for parasite 107(29.4) 74(20.2) 1.5 (1.4,1.9) 0.04 
parasite count /Vtl (GM)* 6,145 4,512 t= 1.37 , P=a 17 
* GM =geometric mean 
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3.6.3.2.2. Malaria in children after supplementation 
Malaria was diagnosed in 72 children (19.7%) in the iron group and in 49(13.2%) in 
the placebo group on assessment at the end of the supplementation period, RR=1.49, 
95% CIJ. 07-2.08ý (Z 2 =7.02; p=0.01). Similarly, splenornegaly was detected more 
frequently among the iron supplemented than among the placebo supplemented 
children, 27.3% versus 19.1% respectively, RR=1.43, (95% CI: 1.10-1.87), (X2=6.6; 
p=0.011). A total of 776 blood films were collected. Thirty-six slides were either 
broken or found inappropriate for examination and were excluded. A total of 740 
slides were examined and 228 were positive for one or more malaria parasites, an 
overall positivity of 30.8%. Positivity in 368 slides from children in the iron group 
was 34.5% against 27.1% positivity among 372 children in the placebo group, a rate 
ratio of RR=1.28 (95%Cl: 1.03-1.58) (X 2 =5.01; p=0.02). The geometric mean 
parasite count was higher among children in the iron group than among those in the 
placebo group, 15,059 and 8,224 parasites per ýd of blood respectively and this 
difference was statistically significant (t=2.4, p=0.01). A summary of malariometric 
indices in children in the two supplementation groups is shown in Table 45. 
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Table. 45 Malariometric indices among children after supplementation 
Doctor's final diagnosis 
clinical malaria 72(19.6) 49(13.2) 1.49 (1.1,2.1) 5.07 0.022 
splenomegaly 100(27.2) 71 (19.1) 1.43(1.1,1.9) 6.57 0.011 
Parasitological 
positive for parasite 127(34.5) 101 (27.1) 1.28(1.0,1.6) 3.76 0.052 
parasite count /ýtl (GM) * 15,059 8224 t=2.4, p=0.01 
GM =geometric mean 
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DISCUSSION 
4.1 Introduction 
As one of the universally accepted strategies to prevent iron deficiency and anaernia, 
iron supplementation has long been advocated and used widely, particularly in 
developing countries, where alternative approaches are either not available or 
difficult to implement. However, in recent years studies have indicated potential 
adverse effects of iron supplementation and underlined the need to reconsider 
intervention programmes which involve iron. The suspicion that iron 
supplementation can increase the risk of malaria in particular has led to a growing 
concern which laid the basis for the present study. 
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The present study showed that anaernia due to nutritional deficiency and secondary to 
malaria was highly prevalent among women aged 15-49 years and among children 
between the age of 6-84 months in a rural area of Ethiopia. After twelve weeks of 
oral iron supplementation, anaernic women and children significantly improved their 
haematological status. 
The results of this study have also demonstrated that iron supplemented women and 
children had a higher malarial experience compared with those supplemented with 
placebo. The discussion presented in this chapter focuses on three main issues. 
Firstly, it discusses the nutritional history and eating habits of the study population in 
order to highlight the actual and potential sources of dietary iron in the study 
community. It also reassesses the prevailing view that iron deficiency is not a major 
cause of anaemia in Ethiopia. Secondly, the haernatological response to iron 
supplementation by women and children is discussed and factors which may 
potentially determine the outcome of intervention programmes are identified. 
Finally, the adverse effects of oral iron supplementation on the health of women and 
children, particularly on morbidity from malaria are discussed. Lastly, the discussion 
describes briefly the continuing uncertainty about the explanations for the interaction 
between oral iron supplementation and increased malarial morbidity in order to 
stimulate further investigations. 
178 
4.2. discussion: dietary iron, iron deficiency and anaemia 
4.2. Dietary iron, iron deficiency and anaemia 
In Ethiopia anaernia has not been investigated thoroughly and the magnitude of the 
problem, its impact and causes are incompletely known. However, there are strong 
indications that anaernia is one of the major public health problems in the country 
(MOH, 1991; Zein and Assefa, 1987; Zein, 1991). The aetiology of anaernia is 
multifactorial, but iron deficiency due to an inadequate supply to an increased 
demand or to both has been recognised as the most common cause in developing 
countries (Demaeyer, 1989; Royston, 1982; Cook and Finch, 1979) and this is likely 
to be the case in Ethiopia. Unlike other regions where genetic defects of red blood 
cells contribute to the aetiology of anaernia, such as thalassaimia in north Africa and 
the Middle East, and sickle cell trait in western Africa (DeMaeyer and Adiels- 
Tegman, 1985; Fleming, 1989; Facer and Jenkins, 1989), little is known about the 
contribution of these conditions to anaemia in Ethiopia. Although a few hospital 
based studies indicated the rarity or absence of genetic traits as causes for anaernia in 
the country (Perine and Tesfamichael, 1974; Abdulkadir, 1977; Shamebo, 1987), 
there is not enough evidence to exclude a role for genetic factors entirely. 
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In view of the wide distribution of parasitic diseases such as malaria and hookworm, 
and because the staple diet of most Ethiopians is usually considered to be rich in iron, 
there has been a long standing impression that anaernia in Ethiopia is likely to be 
secondary to infectious diseases. Hofvander (1968) considered repeated acute or 
chronic infections of various kinds to be the main causative factors for the generally 
low haernoglobin values that he observed. Zewdie (1993) stated that nutritional 
anaernia of iron deficiency was not a problem of public health significance and even 
suggested that to control anaemia attention should be paid to programmes for the 
control of malaria and hookworm and other parasites through personal hygiene and 
environmental sanitation. 
Other investigators have taken a similar stand on the grounds that dietary iron intake 
in Ethiopia is higher than the recommended daily allowance (Gebremedhin et. al., 
1976; Ross et. al., 1972). However, the allegedly high iron intake by Ethiopians has 
not been biochemically validated, and seems to have been based mainly on the fact 
that one of the staple foods in the country, the cereal teff, has a very high iron content 
(Hofvander, 1968; Besrat et al., 1980). This view remains influential even today and 
dominates the formulation of policies and public health activities regarding the 
control of anaernia. 
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The amount of iron found in the cereal teff coupled with contamination of the seed 
with iron rich soil during threshing (Besrat et. al., 1980) is undeniably very high. On 
the other hand the assertion that teff is a staple diet for the general population seems 
to be an over generalisation, at least until qualified by dietary studies. The cereal is 
staple for the urban population but there is little or no evidence whether this applies 
also to rural communities. In urban areas, teff often commands very high prices and 
this encourages farmers to produce it for the market rather than for their own 
consumption. In the present study area, a negligible proportion of households were 
found to have used this cereal in their regular diet because it is neither grown locally 
nor available at a price affordable by the population. The generalisation that equates 
the high iron content of teff with an adequate supply of dietary iron is perhaps too 
simple. 
The adequacy of dietary iron depends upon its bioavailability: that is the amount of 
iron absorbed from the digestive tract rather than the content of iron in the diet. 
Because the efficient absorption of dietary iron depends on its chemical form, a 
higher iron content of the diet alone does not necessarily result in adequate 
absorption. Unlike haem iron, which is found in diets of animal origin, the 
bioavailability of non-haem iron in cereals such as teff is low (Hallberg, 1981). In 
addition other dietary factors are known to influence the absorption of non-haem iron 
in both directions. Absorption of non-haem iron is influenced markedly by individual 
and dietary factors; more iron is absorbed by iron-deficient and pregnant women and 
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also absorption of non-haem iron is also enhanced if eaten with meat, fish and foods 
rich in ascorbic acid (Hallberg, 1981). In spite of the ample livestock resources and 
the marked potential to produce fruits and vegetables, consumption of such food 
items was found to be extremely low in the study area. 
The poor consumption of meat and other animal products has a serious implications 
not only because it is the source of an important form of haem iron, but also because 
it is a good enhancer of non-haem iron absorption. The main reason for the low 
consumption of animal based food items is mainly due to the absolute abstention 
from all food of animal origin observed for up to 150-200 days a year by Coptic 
Christians (Knutsson. and Selinus, 1970). In addition people rarely kill their own 
animals for consumption unless for occasions such as weddings and holiday festivals, 
because owning cattle and other domestic animals reflect prestige and status in the 
community. 
The diet in the present study area and in most developing countries is by and large 
based on cereals and legumes. Cereals and legumes are not only poor sources of 
dietary iron but they also contain nutrients which inhibit the absorption of non-haem 
iron. Substance such as phytates, found commonly in cereals and legumes, are 
known to interfere with the absorption of non-haem iron (Monsen et al., 1978; 
Hallberg, 1981). 
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Iron deficiency and anaernia was highly prevalent among populations in Iran whose 
average dietary iron intake far exceeded the recommended daily allowance 
(Haghshenass et al., 1972). This was attributed to the presence of a considerable 
amount of phytates in their diet (wholemeal wheat bread). Even though the majority 
of the population from the highland regions and urban centers in Ethiopia base their 
diet on the iron rich cereal (teff), its high iron content does not ensure high iron intake 
and does not entail the absorption of the iron proportional to the amount ingested. 
The dietary pattern in the present study area was such that dietary iron intake was 
unlikely to be sufficient to reach the desired level due to both the lack of nutrients to 
enhance iron absorption and the high intake of foods which inhibit iron absorption. 
This may also be the reason for the finding of a high prevalence of iron deficiency 
anaernia in the teff growing areas of north-west highland regions of Ethiopia where 
the main diet of the population was teff (Zein and Mekonen 1987; Zein, 1991). 
Haemoglobin and haernatocrit measurements at baseline showed that anaemia was 
highly prevalent in the study population in general. Detection of a low haernoglobin 
or haernatocrit level does not by itself distinguish anaernia of iron deficiency from 
other causes. The biochemical measurement which is often regarded as the one most 
specific for iron deficiency is measurement of the serum ferritin concentration 
(INACG, 1985). In the present study, serum ferritin measurements did not show the 
picture of iron status that would have been expected on the basis of the haernoglobin 
and haernatocrit levels. Fewer women and children in the study had a ferritin level 
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below the cut off values of <12 Vtg/L set to define iron deficiency. The reasons for 
this discrepancy could be that the anaernia was due to causes other than iron 
deficiency or that serum ferritin level were raised for some other reason. Several 
studies have shown that elevation of ferritin concentration can be induced by acute 
infections including malaria (Lipschitz et al, 1974; Adelekan and Thurnham, 1990). 
Although not all subjects had a malarial illness or parasitaemia at the time that ferritin 
was measured, they may have been exposed to previous attacks or even have had 
undetectable parasitaernia. The likely explanation for the high level of ferritin found 
in the subjects in this study was malaria. In addition at the time of the baseline 
haernatological and clinical assessment there was a high degree of morbidity due to a 
variety of causes among women and children which may have distorted ferritin 
values. Thus, relatively high ferritin values falling within the normal margin did not 
necessarily indicate that the level of stored iron was normal and did not rule out iron 
deficiency as the cause for anaernia. 
In such circumstances, the role of iron deficiency as a cause of anaernia can be 
assessed by measuring the change in haernoglobin concentration following iron 
supplementation. This approach is considered a more reliable method for diagnosing 
iron deficiency anaernia in communities exposed to malarial transmission than 
biochemical measurements (Cardoso et al., 1994). 
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Although different levels of response are used as a criterion for responsiveness in 
different studies, a haernoglobin response of ý: 1.0 g/dL to a therapeutic trial of iron 
has been considered an adequate response which can serve as an indirect measure the 
presence of iron deficiency (Dallman and Yip, 1989). The substantial proportion of 
iron supplemented women and children who achieved that level of haernatological 
response in the present study indicates that iron deficiency was responsible, at least in 
part, for their anaernia. 
The results of the present study support those of previous studies (Hofvander, 1968; 
Zewdie, 1993) that show the importance of parasitic diseases to the problem of 
anaernia in Ethiopia. However, the evidence from this study has shown clearly that a 
deficiency in dietary iron intake is also important and that the value of teff containing 
foods in preventing iron deficiency may have been overstated. 
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4.3. Response to oral iron supplementation 
Major practical problems face the health authorities of most developing countries 
who wish to control anaernia. Because of its relative simplicity, iron supplementation 
is the approach of choice that is being most widely adopted. Although results of 
almost all iron supplementation trials and intervention studies show the beneficiary 
effect of iron, there is still lack of clear cut policy guidelines on this approach to the 
control of anaernia. Thus, further work is needed to improve our understanding and 
build up our experience in this area. 
Unlike iron supplementation studies in the past, which have focused largely on 
pregnant women or infants, pre-school or school children, the present trial was 
carried out among anaernic women of reproductive age and among their children. 
Anaemia was highly prevalent in women and children in the study area. Despite the 
meager health resources in Ethiopia, maternal and child health programmes are 
provided in most health facilities and these include supply of iron supplements when 
drugs are available. However, it is uncertain how much impact this exercise has on 
the prevalence of anaernia in the community. No previous study has been done to 
evaluate the outcome of iron supplementation and to document any health effects of 
such a practice. 
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This study is probably the first randomized controlled placebo trial in the country to 
report on the effect of supplementation and to quantify the response of anaemic 
women and children to oral iron. 
Nearly all women and children in this iron supplementation trial who received iron 
for twelve weeks showed an increase in their haernoglobin concentration compared 
with values at baseline or with those found in women and children receiving placebo. 
Women and children who received iron achieved an average rise in haernoglobin of 
1.43 and 1.28 g/dL compared with a rise of only 0.28 and 0.22 g/dL in the placebo 
group. The maximum rise in haemoglobin was seen among those with severe 
anaernia compared with those who had either moderate or mild anaemia at baseline; 
this effect was observed in both women and children, but it was more marked in 
women. The mean haernoglobin rise among the severely anaemic was 1.83 times 
higher in women and 1.57 times higher in children compared to the increase seen in 
those who were only mildly anaernic. The likely explanation for the inverse 
relationship between severity of the anaernia and the higher level of response was due 
to mucosal absorptive mechanism which is known to be stimulated by lower iron 
balance to increase absorption of the ingested iron (Finch and Huebers, 1982). 
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Although not all supplemented women or children achieved normal haemoglobin 
levels (10.0% for women and 18.2% for children), there was a substantial shift 
towards mild and moderate as opposed to severe anaemia. It is particularly gratifying 
that the effect was most marked in those who were severely anaernic, to whom the 
change is expected to have made a real difference to their well being. 
The overall response to oral iron shown in the present study was very encouraging 
with an implication of public health significance. However, the observed positive 
response could not be attributed to the iron supplementation alone. There was also a 
small but positive response observed in the placebo group though the reasons for this 
were unclear. It is likely that this study contributed to the general health care 
improvement such as free medical treatment. To a certain extent this improvement 
may have helped study subjects to improve their anaernia. Women and children in 
both supplementation group received antimalarial treatment during the trial when this 
was needed and this may have improved their anaernia (van-Hensbroek et A, 1995) 
and partly explain the positive haernatological response seen among those in the 
placebo group. The study was carried out in the rainy season when most people face 
a considerable food shortage because of price increases. As an alternative, people 
grow green vegetables in their back yards and tend to consume such food items more 
frequently than is the case during the dry season. The increased consumption of 
green vegetables which are good sources of ascorbic acid, may have enhanced the 
absorption of non-haem dietary iron contributing to the haernatological recovery and 
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this could be another reason for the small improvement in haernoglobin seen among 
women and children in the placebo group. 
The results of the present study are in agreement with those of previous trials which 
have almost all documented the positive effect of iron supplementation, although the 
magnitu e of the response has varied considerably between different studies. It is 
still uncertain what level of response can be regarded satisfactory and what would be 
the maximum attainable effect of iron supplementation. It is difficult to estimate the 
net health effect per unit rise in haernoglobin, but Dallman and Yip (1989) have 
suggested that any rise in haernoglobin concentration following iron repletion with a 
physiological relevance could be considered adequate and they have rather arbitrarily 
set an increase in haemoglobin of ý! 1.0 g/dL as a response of sufficient magnitude to 
warrant iron supplementation. In the present study, a large majority of both women 
and children supplemented with iron achieved a rise in haernoglobin level of ý! 1.0 
g/dL and in only a small number of women and children (21.9% and 9.2% 
respectively) was the haernatological response <0.5 g/dL. 
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Important practical questions in relation to iron supplementation that remain to be 
answered include the following. Why was the level of effect in some trials much 
more substantial than that found in others? Why do large scale intervention 
programmes often not show the beneficial effect of iron seen in supplementation 
trials? What other factors need to be considered to achieve the maximum attainable 
haernatological response in larger intervention programmes? 
To answer these questions, there is a need to address other issues which potentially 
determine the success and/or failure of intervention programmes so that due attention 
will be given to the planning and execution of supplementation programmes at the 
community level. Even though clinical and epidemiological studies regarding iron 
supplementation may all seem similar there is substantial heterogeneity between them 
which ranges from the study set up, design characteristics to the procedures for data 
collection, all of which may account in part for differences in the outcome of each 
study. It is difficult but informative to examine the characteristics of major studies 
and to see what lessons can be learnt from these that could guide the planning of 
future intervention programmes. Most iron supplementation trials reported in the 
literature were based in hospitals or on out-patient services where the environment is 
relatively conducive to manage the progress of the study. In field situations many 
external factors, some of which are beyond the control of investigators, play a major 
role even in well designed investigations. In hospital based studies, subjects come to 
seek medical assistance and are readily accessible for the supplements and evaluation 
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while in field trials study subjects are dispersed throughout the community and may 
be lost to follow up for very many reasons. This situation is even more difficult in 
intervention programmes conducted on a larger scale. In addition, iron 
supplementation studies have often been carried out in a relatively small study 
population. About 40% of the studies on iron supplementation trials published in the 
past two decades were on a sample size of less than 30 subjects and nearly 80% of 
them studied:! ý 60 subjects (Sloan, 1992). The problem with such small studies is that 
the measured effect can be biased, either failing to detect the effect or imprecisely 
estimating its outcome. In designing the present study appropriate statistical 
procedures were applied to ensure that the sample size of both women and children 
was large enough to give adequate power to detect an effect. 
Other variables in iron supplementation trials which are often considered to play a 
major role in the outcome of the study include those related to the formulation, 
dosage, frequency and duration of iron suPplementation. Although the recommended 
dosage of oral iron supplementation shown in most medical text books is 60-120 mg 
of elemental iron for women and 3 mg/kg for children given daily for up to a duration 
of six months, previous studies have rarely continued for more than three months. 
The present study lasted for three months on the basis that about two-thirds of any 
haemoglobin deficit may be corrected in one month (Dallman, et al., 1981) and that it 
may be completely overcome by two months (DeMayer, 1989). 
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Although prolonged supplementation will provide adequate iron to correct the 
deficiency, replete storage iron and maintain the iron balance (DeMaeyer, 1989) it is 
difficult to achieve in field situations and this seems to be one of the reasons why 
many trials have used supplementation schedules of shorter duration. Studies 
conducted for as long as the recommended duration are rare. 
In an earlier study undertaken in Mauritius, the effect of 8 months of supplementation 
given to school children showed an average rise in haemoglobin of 1.61 g/dL (Stott, 
1960), while such a rise has been achieved in several trials, including the present 
study, with three months or less of supplementation (Agrawal, et al., 1991; Carclosso 
et al., 1994). Driggers (1981) has even found a mean haemoglobin response of as 
much as 2.3 g/dL among anaernic I-year-old infants supplemented for three months. 
The daily administration of oral iron for three months in the present study may not 
have been optimal, but it was a realistic choice. Supplementation as a single dose per 
day minimized the inconveniency for subjects; more frequent doses might have 
adversely affected compliance and consequently the end results. 
Iron supplementation schedules, particularly dosage and duration, are currently being 
reviewed and evidence in favor of low dose and short duration of supplementation is 
emerging. Animal studies have shown that iron in low dose given infrequently have 
similar effect to that which can be achieved by high dose given daily. 
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This is because of the short term suppressive effect of routine daily oral iron dosing 
on subsequent absorption, (Wright and Southon, 1990; Viteri, et al., 1995), though 
views to the contrary also exist (Cook and Reddy, 1995). The effect of infrequent 
dosage of iron has similarly been observed in humans whose haernatological 
responses were comparable to those resulting from daily iron supply. Thus, 
Indonesian pre-school children supplemented twice weekly achieved a similar 
response to those supplemented daily (Schultink et al., 1995) and pregnant women 
who were supplemented weekly showed an effect similar to that seen in those who 
received iron daily under conditions resembling a normal antenatal care programme 
(Ridwan et al., 1996). Moreover, prolongation of supplementation over one month 
brought about only minor additional haernatological changes (Fogelholm et al., 
1994). If these new developments regarding supplementation schedules could be 
affirmed, the implications will be of paramount importance in public health 
(Stephenson, 1995) An improved supplementation schedules will not only improve 
the feasibility of interventions using iron supplementation, but also lead to 
standardization of procedures for evaluation of supplementation programmes. 
Supply of iron supplements as a strategy for controlling and preventing iron 
deficiency and anaernia is not without complications. Subjects to whom iron is 
administered, particularly if issued for an extended period of time, may experience 
undesired consequences which could potentially jeopardize the intervention itself. 
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Among the notable negative effects of iron supplementation are clinical side effects 
which are directly related to dose and duration of intake of iron (DeMaeyer, 1989). 
Side effects of iron medication has been the single factor identified most frequently 
as the reason for unsatisfactory supplementation trials because it leads to loss to 
follow up and poor compliance of subjects (Charoenlarp, et al., 1988; Kuizon, et al., 
1983; DeMaeyer, 1989). 
Failure of compliance does not necessarily imply failure of study subjects alone, but 
can also arise from factors such as the inadequacy of the service provider or 
investigators (Morrow, 1990; Galloway, 1994). To overcome this potential problem 
it is important to understand the behavioral and cultural characteristics of the 
community, to educate the study subjects and to maintain communications with them. 
The study team for the present study, recruited locally, contributed to establishing a 
mutual understanding and relationship between the study subjects and the 
investigators. A survey conducted at the end of the trial showed that most study 
women and parents of children expressed their general satisfaction with the study and 
a large majority were convinced that they have benefited from it. Such a positive 
attitude and trust of the study team coupled with the continuous effort to encourage 
subjects may have helped to maintain the relatively high rate of compliance observed 
in this study. 
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The use of free medical treatment as an incentive for women and children, to most of 
whom medical services were unaffordable, was also an important factor used to build 
the close contact and sense of sharing between the investigators and study subjects. 
Such incentives may have encouraged them to remain in the study and helped to 
minimize the problem of compliance. 
It would have been ideal if measurement of compliance could have been validated 
biochemically, but in field studies such as the present one, this is often not feasible. 
In this study, compliance was assessed on the basis of witnesses by field workers and 
on reports from subjects themselves. The problem of using this method of assessing 
compliance is that it cannot confirm that the supplements were taken in accordance to 
instructions for the entire duration of supplementation. In public health programmes, 
a similar effort to achieve compliance, particularly one using incentives, may not be 
feasible and such a high level of compliance may not be attainable. 
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4.4. Effects of oral iron supplementation on morbidity and malaria 
One of the primary objectives of this study was to test the hypothesis that oral iron 
supplementation would increase the risk of malarial illness and other morbid 
conditions in women and children. Overall oral iron administration was found to 
increase morbidity and to increase risk of malarial illness among women and children 
in the study area. 
Data obtained from the biweekly morbidity survey generally showed that women and 
children in the iron group reported more illness episodes than those in the placebo 
groups. The significant increase in episodes of illness, particularly febrile episodes, 
observed in the iron group during the supplementation period was likely to have been 
due to the iron supplementation. The mean duration of febrile episodes was also 
significantly longer in the iron compared with the placebo group. A problem with the 
evidence obtained from the morbidity survey is that the definition of illness episodes 
was based on questionnaires which included a list of symptoms and signs and the 
response to them, as perceived by study women and mothers/guardians of children. 
The questionnaire was designed to contain signs and symptoms which could best 
suggest specific diseases particularly malaria. 
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Nevertheless, the information obtained by this method may not be reliable enough to 
identify individual diseases accurately. Febrile episodes, for instance, are suggestive 
but not definitive indicators of malaria for there are many other conditions which can 
cause fever. The occurrence of fever and its duration during the two-weeks period 
was recorded as described by the respondents and validation by measuring the 
temperature was possible only for those episodes reported on the day of a home visit. 
Even if it is assumed that all febrile episodes were reported, it does not necessarily 
imply that these were all due to malaria. For example, in the Gambia it has been 
suggested that only 40% of fever episodes among children are attributable to malaria 
(Greenwood et al., 1987b; Schellenberg, et al., 1994). The frequency of visits can 
affect the estimation of the incidence of illness episodes, the longer the interval 
between visits the higher the chance of missing episodes occurring during this period. 
In a study in the Gambia (Snow et al., 1989), it was shown that increasing the 
frequency of active surveillance by home visiting increased the sensitivity of 
detection. Monthly surveillance detected only 25% of the number of episodes of 
fever detected by weekly surveillance and weekly surveillance detected 74% of the 
number of episodes detected by daily surveillance. Similar findings apply to 
detection of episodes of diarrhoea- twice weekly visits are more reliable than once 
weekly. In the present study subjects were visited every other week and it was likely 
that illnesses occurring between visits were missed or under reported. For all of these 
reasons there were limitations on the reliability of the morbidity data which would 
potentially lead to misclassification or information bias. 
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However, such bias should have been randomly distributed among the groups to be 
compared and thus unlikely to distort the effect of the intervention. 
Clinical re-evaluation of the health status of all women and children after 
supplementation revealed a higher disease burden among the groups supplemented 
with iron compared with the groups in the placebo. Women in the iron group had a 
28.0% higher prevalence of an overall morbidity compared with that experienced by 
women in the placebo group. The general health status of iron supplemented women 
also deteriorated significantly from their own status at baseline whilst women in the 
placebo group showed a slight, but insignificant, improvement in the overall disease 
prevalence compared with that observed at baseline. A similar picture was also 
observed among children supplemented with iron who were found to have a higher 
overall morbidity than children in the placebo group suggesting the adverse health 
effect of oral iron supplementation. When distributions of individually diagnosed 
disease entities were compared, no clear pattern emerged between supplementation 
groups. 
Iron supplementation did not show any statistically significant specific effect on 
common maternal conditions such as non-specific genito-urinary tract infections, 
menstrual disorder, skin and respiratory infections although each of these entities was 
diagnosed more frequently in the iron than in the placebo group. 
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The re-distribution of subjects into individual disease groups led to a depletion in the 
number of women with any one disease in each supplementation group and weakened 
the ability of the study to show statistical significance between groups. The 
morbidity situation in children at the end of supplementation was somewhat similar to 
that of women. As found in women, the difference in the overall prevalence of 
illnesses (all diagnosed diseases put together) was significantly higher among 
children in the iron supplementation than in the placebo group. 
Further analysis of individual disease entities showed that children in the iron group 
were not particularly disadvantaged in respect to specific diseases except clinical 
malaria and splenomegaly which are discussed later in this section. The prevalence 
of acute respiratory infections (ARI) and intestinal parasitic infections were generally 
low among all children but were marginally higher in those in the iron group than in 
those in the placebo group while diarrhoea was observed slightly more frequently in 
the placebo children. Several previous studies have suggested the existence of an 
impairment of cell mediated immunity and decreased bactericidal activity in 
association with iron deficiency (Joyson et al., 1972; Bhaskaram, 1975; Chandra, 
1973; Strauss, 1978) and anaernia with a haemoglobin <10 g/dL (Srikantia et al., 
1976), which implies that iron deficient and anaemic children could be more 
susceptible to respiratory tract and diarrhoea infections. Children in the present study 
were all anaernic before supplementation but the prevalences of both respiratory and 
gastrointestinal infections did not seem to reflect their vulnerability. 
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The prevalences of both ARI and diarrhoea in the present study were not very 
different from findings among children in other parts of the country (Muhe, 1994), 
further evidence against the view that anaemic children were more prone to an 
increased risk of these infections. Furthermore, correction of the anaemia and 
deficiency with iron supplementation has been shown to lead to the reversal of these 
abnormalities and reinstatement of normal phagocytosis and bactericidal capacity 
(Chandra, 1973; Strauss, 1978; Walter et al., 1986) and consequently, children in the 
iron supplementation group might have been expected to show a reduction in the rate 
of infection compared with those in the placebo had they initially been at increased 
risk. 
One possible reason for the lack of an effect of iron supplementation on the 
prevalence of these conditions may be the adverse health effects of poor 
environmental conditions in all children. Poor environmental sanitation has been 
suggested as the reason why iron supplementation of school children in two villages 
in India failed to show significant differences in the rate of clinical attacks and 
duration of respiratory conditions and diarrhoea compared with control children 
(Damodaran et al, 1979). 
In contrast, a relatively recent study in Papua New Guinea demonstrated the adverse 
effects of iron supplementation on overall infections among two-month-old infants 
(Oppenheimer et al, 1986a). Following an intramuscular iron-dextran injection, 
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infants had more respiratory infections than control infants leading to frequent 
hospital admissions and a prolongation of stay in hospital by an average of 4 more 
days or 60%. The findings from the present study seem in agreement with the 
experience of PNG infants in showing the association of iron not only with the 
overall disease burden but also with malarial illness and splenomegaly. Unlike ARI 
and diarrhoea, prevalences of malarial illness and splenomegaly were significantly 
higher among the groups supplemented with iron than among placebo groups in this 
study. The number of children with malaria and splenomegaly was larger than the 
number of children with ARI or diarrhoea and this may have contributed to the ability 
of the study to show an effect. 
In the present study, iron was given orally to relatively older children with known 
anaernia, while the study in Madang, PNG, involved new born infants given 
intramuscular iron dextran irrespective of their haemoglobin status at birth. 
Therefore it is difficult to make comparisons between the studies because of age 
factors, differences in the iron preparation itself or a combination of both. 
In an earlier study conducted on Somali nomads in Eastern Ethiopia, (Murray et al, 
1978), the increased frequency of disease episodes among those who were given iron 
was believed to have been due to activation of pre-existing infections of malaria, 
brucellosis or tuberculosis. In supplementation trials of shorter duration, as was the 
case in the study on the nomads during which supplementation was given for only 30 
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days, re-activation rather than new infections may be the rule while in the present 
study it is possible that re-activation and new infections may have occurred since the 
duration of iron supplementation was longer than the incubation period of most 
infectious diseases. 
The present study has shown women and children in the iron group were more at risk 
for malaria than in those in the placebo group. The prevalence of clinical malaria 
was increased by 32.0% in women and by 49.0% in children compared with the 
respective placebo group. Moreover, children in the iron group showed a 43.0% 
increase in the rate of splenomegaly compared with those given placebo. The 
findings of higher spleen rate among children in the iron supplementation group is in 
agreement with findings of previous studies among Gambian children (Smith et al, 
1989) and infants in Papua New Guinea (Oppenheimer et al., 1986b). 
In the Gambian study, the proportion of children with an enlarged spleen was higher 
in the iron supplemented group compared with those in the placebo (21.7% against 
15.1%), with a peak at the age of 2 years (41.7%) in contrast to the peak at the age of 
4 years onwards observed in the present study. In Papua New Guinea (Oppenheimer 
el al., 1986b) the rate ratios of splenomegaly in infants six and twelve months after 
iron treatment were similar to those found in the present study (1.51-1.56 for PNG 
infants and 1.43 for children in the present study). 
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Microscopic examination demonstrated that in the present study, more blood films 
from women and children in the iron group tested positive for malarial parasites than 
did those in the placebo group. The geometric mean parasite count followed the 
same pattern, being higher among women and children in the iron group than in the 
placebo, but with the difference between groups being significant only in children 
and not in women. In addition, parasite count of ý! 5,000 /[tl was observed 
significantly more frequently in women and children in the iron compared with the 
placebo groups, further consolidating the evidence of a deleterious effect of iron 
supplementation on malaria. This was in accordance with an observation in The 
Gambia (Smith et al., 1989) which showed an association between iron 
supplementation and fever episodes with parasitaemia, particularly in those with 
parasitaernia of ý! 50 parasites per 100 microscopic fields, a parasite density 
approximately equivalent to 5,000 per [il. A trend towards a higher parasite was also 
observed in another study done in the Gambia in a group of 5-14 year old children 
even though there was no significant difference in the overall malarial incidence 
related to the administration of combined supplements containing iron (Bates et al, 
1987). In this study, children were given iron combined with other vitamins, which 
interact with each other, so it is not straight forward to assess the net effect of iron on 
malaria. 
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The intricacy of the association between iron supplementation and increased malarial 
risk is highlighted by the fact that there are clinical and epidemiological studies 
which found no increase in risk when iron was given. Harvey (1989) found no 
adverse consequences of iron supplementation among Papua New Guinean school 
children; there were no significant difference in parasite rate, parasite density or 
spleen rates between children in the iron and placebo groups. Similarly, the 
prevalence and severity of peripheral or placental malarial infection among 
multigravid pregnant women in the Gambia did not show any difference between the 
groups given iron or placebo (Menendeez et al., 1994). There is no clear cut 
explanation for the causes of what seems irreconcilable discrepancy between these 
results. Although most of these studies were similar in design, procedural variations 
between studies and differences in the malaria situation between study areas could at 
least partially form the basis for the differences in study outcomes. 
The malaria pattern in different geographical regions and even within the same area 
varies greatly with different seasons influencing the immune status of the study 
population. The effect of iron on populations with a high level of immunity may not 
be as marked as would be expected among those with low or no immunity at all. 
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Although immunological assessment was not included in the present study, the level 
of antimalarial immunity of the study population was possibly low since the malaria 
in the area is unstable and very much seasonal. This may be one of the reasons for 
the demonstration of the adverse effect of iron on malaria not found in some other 
studies. 
The far ranging literature on iron and health and diseases of humans demonstrates the 
extent of research in this topic. In spite of such a wealth of knowledge the present 
understanding about the role of iron in the pathogenesis of certain diseases of public 
health importance, malaria in particular, appears incomplete. Epidemiological and 
clinical studies, including the present one, have provided evidence for the link 
between iron supplementation and increased risk of malarial illness, but they are still 
unable to unravel the pathways of interaction. It is still unclear whether the increased 
malarial morbidity was due to the effect of the ingested iron on host factors or due to 
its effect on the parasite behaviour or a combination of both. 
The role of iron in living cells has been investigated at length, iron is an essential 
metal for metabolism and replication of all living cells including the plasmodium and 
other pathogens. The mammalian host has established defence mechanisms by which 
the invading organism is denied the iron it needs. Under normal situations, where the 
balance of body iron is maintained, the host possesses an array of mechanisms to 
withhold iron from an invading agent (Weinberg, 1984). 
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The deployment of iron binding proteins such as unsaturated transferrin and 
lactoferrin withholds iron at the absorption site and transports it to the 
reticuloendothelial cells where it is stored in a complex with the protein ferritin. The 
host also launches an anti-inflammatory and a hypoferraemic response to an invasion 
by pathogenic organisms by sequestering iron in tissue forms and moving into 
temporary storage sites (Hersheko et al., 1988). In both situations, the concentration 
of free circulating iron salts is close to none (Hersheko, 1987) denying readily 
available iron to the invading agents. This sequence of events led to the idea that iron 
deficiency plays a protective effect against infection (Weinberg, 1984) and because 
of its similarity to the mechanism of acquired immunity, the term 'nutritional 
immunity' was coined (Kochan, 1973). The nutritional immunity theory was further 
strengthened by the increased risk of developing bacterial infections observed in 
patients with iron overload. An example of the association of iron overload and 
infection was the finding of an increased incidence of hepatic amoebiasis among 
young Zulu males whose daily iron intake was considered excessive as the result of a 
regular consumption of home made beer contaminated with iron (Diamond et al, 
1978). Similarly, the Masai nomads in Kenya whose milk diet was normally iron 
deficient, showed a dramatic increase in the prevalence of amoebiasis following 
supplementation of iron sulphate for one year, from < 9.0% at baseline up to 83.0% 
after supplementation (Murray et al, 1980). The amount of iron supply from an oral 
iron supplementation programmes, however, would normally be much less than the 
magnitude of iron overload observed among the Zulu men and the Massai nomads. 
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Iron supplementation is unlikely to lead to an overload of this magnitude or to lead to 
an excess free circulating unbound iron available to the pathogenic organism. It is 
therefore, highly unlikely that oral iron in the dose and duration of supplementation, 
as was in the present study, would meet the need of the plasmodium and seem 
improbable to be an explanation for the excess malarial morbidity. 
Many pathogenic micro-organisms obtain iron by competing with human iron 
transport systems and manage to capture iron successfully from the iron restricted 
environment of the host. The pathogen scavenges for iron by producing specific iron 
carrier molecules, known as siderophores, which interact directly with receptors on 
bacterial cell surface (Gutteridge, 1994). Siderophores are iron-chelating compounds 
capable of extracting iron from the surrounding environment in order to deliver it to 
the invading pathogen, which otherwise would be unavailable. The ability of the 
invading pathogens to overcome the host iron-withholding mechanisms and to 
acquire the iron essential for their growth and replication is an important component 
of their virulence (Weinberg, 1984; Gutteridge, 1994). Other non-bacterial pathogens, 
such as the plasmodium, are probably faced with a similar host defence response and 
an iron restricted environment. However, it is still uncertain how the plasmodium 
obtains the growth-essential iron from the host, and it may be appropriate to review 
pertinent information generated from other fields of research. 
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Because iron derived from the host plays an essential role in the successful 
replication of many pathogenic organisms, including the plasmodium, ways of 
depriving the parasites of iron has increasingly attracted biomedical researchers. 
Several natural and synthetic chelating compounds with high affinity for iron have 
already been identified which might inhibit the growth of pathogenic organisms 
including the malarial parasite. If the mode of action of these compounds could be 
established this might clarify the pathways through which the parasite obtains the iron 
it needs and demonstrate how iron supplementation can increase susceptibility to 
infectious diseases. The inhibitory effect of iron chelating agents on the growth of P. 
falciparum has been demonstrated in several in vitro studies (Raventoz et al., 1982; 
Peto and Thompson, 1986; Iheanacho et al., 1990 ) and also in vivo studies (Yinnon, 
1989). It has also been documented that iron chelation reduce P. falciparum 
parasitaernia in adults with asymptomatic malaria (Gordeuk et al., 1992a) and when 
given in combination with the standard antimalarial therapy, enhances the parasite 
clearance and hastens the recovery from deep coma in children with cerebral malaria 
(Gordeuk, et al., 1992b). In an earlier experiment to study the inhibitory effect of an 
iron chelating agent (desferrioxamide) on the growth of P. falciparum, the iron 
uptake by the parasite was postulated to be, at least partially, from transferrin 
(Pollack and Fleming, 1984). 
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In contrast, the antimalarial effect of the iron chelating agent is independent of the 
iron status of the host, implying that the parasite does not take up iron from serum 
transferrin (Peto and Thompson, 1986), an observation supported by others who 
suggested that the effect of the chelating agent was by penetrating the infected 
erythrocyte and interacting with a labile iron pool as the action neither resulted in the 
reduction of transferrin saturation nor interfered with erythropoiesis (Hersheko and 
Peto, 1988; Yinnon et al., 1989). Others have suggested that iron chelators interfere 
directly or indirectly with iron dependent functions of the parasite but not necessarily 
with iron acquisition per se (Lytton, et al., 1994). 
In spite of the studies that have been done the actual mode of action of the various 
chelating agents has not yet been clearly defined as shown by the lack of unanimity 
regarding the proposed mechanisms. The way in which oral iron supplementation 
can lead to an increased malarial risk among the human populations remains 
unanswered. 
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The study and its implications 
5.1.1. The study area and population 
Rural populations in Ethiopia and other developing countries are faced with complex 
health problems. A poor economic situation, a rapidly growing population, natural 
and man made disasters, excessive morbidity and mortality compounded with acute 
shortage of health resources are common features of these countries. The present 
study area was a typical example of a rural underdeveloped area where these human 
calamities coexist. The study area located in the far north-western Ethiopia, was, 
until very recently, the site of a protracted civil conflict which has left several 
thousands people dead or displaced. Health facilities which were scarce in the first 
place, were either destroyed or severely depleted to meet the needs of the population 
who had already been victims of recurrent famine and drought. 
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Under such circumstances, vector borne diseases and nutritional deficiencies are 
often highly prevalent. The area was, thus, appropriate for this study, as the study 
objectives required an area where malaria was endemic and a population for whom 
iron supplementation would be justified. 
The major demographic characteristics of the study area were typical of developing 
countries with a large majority of the population aged less than 15 years and with a 
small proportion of older subjects (>55 years). The male population aged 10-30 
years was smaller than that of females in the same age group, probably because of the 
long standing civil war which recruited young males forcefully or otherwise. There 
was no apparent reason for the smaller number of elderly subjects (> 50 years) except 
the short life expectancy which one would expect in communities of this type. In 
general, selection of the study area and its population was appropriate to meet the 
study objectives. 
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5.1.2. The overall strengths and limitations of the study 
To assess the haernatological responses to oral iron supplementation and to 
investigate whether or not the supplement was associated with an increased risk of 
malaria, a randomized placebo-controlled design was most appropriate as it allowed 
for the control of the effect of potential confounding factors. This design ensured the 
similarity of the two treatment groups being compared; the subjects allocated to iron 
and placebo groups were similar in all characteristics at baseline. 
Anaernia and malaria are both known to affect people of all ages. Studying the effect 
of iron supplementation on all population groups would, therefore, have been ideal. 
However, the practical implications of studying the whole population, particularly in 
terms of resources, are substantial and this was not possible. Limiting the study to 
anaernic women and children was necessary not only because it was logistically 
manageable but also because the prevalence of both malaria and anaemia is higher in 
women and children than in other age groups in the total population. 
In spite of the apparent strength in the design and the effort made to minimise 
measurement errors, executing this study was not without limitations. The main 
problems were definition of the outcome measures, particularly malaria and anaernia. 
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Although the criteria used to diagnose clinical malaria may depend on the purpose of 
the definition, epiderniologic studies usually employ a combination of malariornetric 
indices generated from clinical, parasitological, and serological data. The 
malariometric indices used in the present study were generated from both objective 
and partially subjective data which included clinical assessment, parasitaernia and 
morbidity surveys. 
Because of methodological problems the definition of malariometric indices of this 
study may not have been sensitive and/or specific enough to discriminate the disease 
very well. The uncertainty over the sensitivity and specificity of each of these 
measures could have affected the estimation of the magnitude of the effect and may 
have introduced a misclassification bias which could potentially reduce the validity of 
the end results. However, the misclassification bias that may have occurred in this 
study will be non-differential since, by design, it should be similar in the 
supplementation and control groups under comparison. The non-differential effect 
was therefore unlikely to have affected the relative effect between the comparison 
groups which implies that the observed association between iron supplementation and 
malaria was valid although it is possible that it was under-estimated. 
The other limitation of this study was in relation to the assessment of iron status and 
anaernia among women and children. Two major problems surfaced at the start of 
the study. The first problem was related to the unpopular, often hostile, attitude of 
213 
5. conclusion and recommendations 
women and parents of children towards drawing venous blood on which estimation of 
most parameters were first planned. This problem resulted in the modification of 
procedures to accommodate collection of blood using the capillary method which was 
more familiar and more acceptable. As the result, serum iron was not measured and 
ferritin levels could be determined only in a small number of women and a fewer 
number of children. 
The second problem was the irregularity and unavailability of electric power which 
made it difficult to use some of the laboratory equipment and which resulted in the 
need to measure haemoglobin by the Sahli method. The Sahli method, which is 
simple to operate and which does not require electric power, is still used widely in 
Ethiopia and in other developing countries. However, the Sahli method is now being 
used less frequently to estimate haemoglobin levels in community surveys because of 
the measurement error related to the manual procedures involved in the technique. In 
spite of this limitations, however, the Sahli technique is still a valid method in 
circumstances such as in the present study, and it has been shown that it can perform 
well, particularly in monitoring haernoglobin changes and in screening for anaernia 
(Lerberghe, 1983). 
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5.1.3. Implications of results of the study 
The results of the present study have implications for two issues which are very much 
related but with distinctive characteristics of importance for public health. Firstly, 
evidence from this study strongly suggested that dietary iron intake in the community 
was inadequate to meet the increased iron demands of women and children leading to 
a high prevalence of anaernia. This finding strongly contests the long-standing view 
that dietary iron insufficiency is not the cause of anaernia in Ethiopia. The realisation 
that iron deficiency is one of the main causes of anaemia will have a significant 
impact on existing health policies for the control and prevention of anaemia. The 
observed beneficial effect will bolster the existing use of iron supplementation in 
maternal and child health activities and will contribute to revitalise this exercise 
which at present is fragmented. 
Secondly, findings of this study indicated that women and children experienced a 
significant malarial risk in association with oral iron supplementation. This 
observation potentially jeopardises the public health effort of controlling anaemia 
using this strategy. This finding is in agreement with previous research results which 
showed potential drawbacks of iron supplementation in relation to infections, 
including malaria. The debate on the role of iron in the pathogenesis of some 
diseases seems likely to continue. 
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5.2. Conclusion and recommendations 
5.2.1 Conclusions 
dietary iron deficiency and anaemia 
In the present study area, anaernia among women and children was highly 
prevalent. The food composition and eating habits of the population strongly 
suggested inadequacy of dietary iron intake. In addition to the low content of 
iron in the diet, the chemical form of dietary iron was largely non-haem, 
which is less readily bioavailable. The insufficiency of dietary iron was 
exacerbated both by inadequate intake of food items which enhance iron 
absorption and high intake of nutrients which inhibit the absorption of the 
ingested iron. The overall evidence clearly showed that iron deficiency is an 
important contributor to the anaemia in the study population. 
response to oral iron supplementation 
Anaemic women and children in the study showed an excellent response to 
twelve weeks of oral iron supplementation. The effect of oral iron 
supplementation in improving the anaemia was substantially higher among 
those with severe anaernia than those with either moderate or mild anaernia. 
216 
5. conclusion and recommendations 
In the wake of anaernia resulting from either nutritional deficiency or 
infection, oral iron supplementation remains an effective strategy to the 
control of anaemia in the study area. 
oral iron supplementation and risk of malaria 
Oral iron supplementation to women and children during the malaria season 
was associated with a considerably increased risk of uncomplicated malaria. 
Similarly, study subjects suffered increased morbidity and poor general health 
status in association with oral iron supplementation. 
5.2.2. Recommendations 
* In view of the enormity of the problem of anaernia among women and 
children in the present study area, there is an urgent need to give this topic 
a higher profile and to undertake measures to prevent it. 
0 The policy for the control and prevention of anaernia in Ethiopia needs to 
be reviewed so that appropriate strategic approaches can be adopted. The 
contribution of iron deficiency in causing anaernia, which appears to have 
been underestimated should be given more consideration in the policy 
making process. 
217 
5. conclusion and recommendations 
0 In the study area there was a huge agricultural potential which could be 
focused towards improving the nutritional and eating habits of the 
community. Although changing deeply rooted cultural and religious 
practices may be difficult, there were factors which could be exploited for 
improvement of dietary habits. The high level of knowledge and 
awareness of good sources of haern iron was a promising target for 
nutritional education. 
In situations where the problem of anaernia exists and strategies for its 
control such as food fortification with iron are unrealisticl oral iron 
supplementation is a relatively feasible and effective choice. However, 
the necessary precautions should be taken when implementing iron 
supplementation programmes in malaria endemic areas due to the fact that 
it is associated with increased malarial risk. 
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0 The contradictory role of iron supplementation on the health and 
disease of populations demands an extra effort from health planners 
and programme managers to skilfully weigh the health advantages 
against the drawbacks of iron supplementation. In the present study 
area, the problem alleviated by iron supplementation clearly outweighs 
the problem of malaria attributed to iron. Iron supplementation to 
anaemic women and children should thus be promoted in parallel with 
an increased malaria control effort in the area. 
0 The research effort need to resolve the controversy surrounding the 
role of iron on malaria and other infections should continue. The 
investigation of the iron-infection interaction requires a 
comprehensive and multidisciplinary approach involving scientists in 
various disciplines of the health sciences. Studying the effect of iron 
supplementation on the severity of malaria in populations in areas of 
varying endemicity will be particularly important. 
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APPENDICES 
Appendix 1. General census and household questionnaire 
IRON SUPPLEMENTATION & MALARIA STUDY 
AMONG WOMEN AND CHILDREN IN METEMA (SHEHDI), NORTH GONDAR 
. 
General Census and Household Questionnairgj Form GCH0194) 
100 
- IDENTIFYING INFORMATION 
101. village: 1-1-1 102. HH No: 
HEAD OF THE HOUSEHOLD 
103. Name: 
104. Age (yrs) 
105. Sex: [1 =Male 2=Female] 
106. Education: [1 =None 2=Read/Write 3=Above 2] 
107. Occupation: 
[1 =Farming 2=Trade 3=Labourer 4=Govt. /NGO 
5=Other 
specffy 
237 
General Census and Household Questionnaire (contd. ) page 2 
instructions for completing the following table: 
1 List all household members, in age order, living in the house, including those 
who temporarily are absent. 
2. Ask their age as accurate as possible. Help them remember birth dates by 
cross questioning and associating events and public holidays. 
I Write down name of wife or husband of the head next and continue with the 
eldest child until all children are registered. 
MEMBERS OF THE HOUSEHOLD: Use the following codes to complete the table. 
AGE: in years or months. Indicate (Y) for years, and (M) for months next to age. 
SEX: 1 =Male 2=Female 
RH: Relation to the head of the HH. 1 =wife/husband 2=son/daughter 
3=grandchild 4=other 
ED: Educational status aged >5yr. 1 =none 2=read & write 3 =above 3 
No NAME OF MEMBER 
ID 
NUMBER 
A 
G 
E 
S 
E 
X 
R 
H 
E 
D REMARK 
2 
3 
4 
5 
6 
7 
8 
9 
10 
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General Census and Household Questionnaire (contd. ) page 
200. VITAL INFORMATION REGISTRATION 
201. Any birth in past 12 months? [1 =Yes, 2=No] 
(if Yes to 201, complete 202 & 203 below) 
202. Infant's age in months 
203. Infant's Sex: P =Male, 2=Female] 
204. Any death in past 12 months? [1 =Yes, 2=No] 
(if yes to 204, complete 205,206 & 207 below) 
205. Age at time of death: yrs 1_1_1 mths 
206. Sex of the deceased: [1 =Male, 2=Female] 
207. Actual/probable cause of death: 
DIETARY INFORMATION 
300. crops : Are the following crops grown locally? [1 =Yes 2=No] 
301. Barley: 1_1 302. Wheat: 1_1 303. Corn: 304. Teff: 
1-1 305. Lentil: 1_1 306. Millet: 1-1 
307. Oilseeds: 1_1 308. Sorghum: 1_1 309. beans, peas: 1-1 
310. Others (specify): 
400. vegetables & fruits: Are the following vegetables grown locally? [1 =Yes 2=Nol 
401. Leafy & green vegetables (cabbage, onion.. ): 
402. Rooty vegetables (carrot, radish, potato.. ): 
403. Fruits (orange, lemon, banana... ): 
404. Others (specify): 
500. dairy products: Are the following items locally available? 
501. Milk: 1_1 502. Bufter: 1_1 
Chicken: l_l 505. Eggs: 1-1 506. Meat: 
507. Others (specify); 
503. Cheese: 
[1 =Yes 2=No] 
1-1 504. 
239 
General Census and Household Questionnaire (contd. )page 4 
600. special dietary provisions: 
Are there special dietary provisions for the following groups? [1 =Yes 
2=No; If yes, specify in the space provided] 
601. Newborn infants: 
602. Children: 
603. Pregnant women: 
604. Other women: 
700. special dietary prohibitions: 
Are there special dietary prohibitions for the following? 
[1 =Yes 2=No; if yes, specify in the space provided] 
701. Newborn infants: 
702. Children: 
703. Pregnant women: 
704. Other women: 
800. contents of meals on ordinary days 
What were the main composition of your meals yesterday? 
801. Fasting: 1-2.3.4. 
802. Non-fasting: 1.2.3. 
What did/will you eat yesterday for: 
803. Breakfast 
804. Lunch 
805. Dinner 
4. 
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General Census and Household Questionnaire (contd. ) 
How frequent do you eat the following? 
806. Meat/chicken/eggs in: 1 /wk 
807. Milk/cheese/curd in: 1/wk 
808. Butter/oil/telba in: 1 /wk 
809. Vegetables in: 1/wk 
810. Beans/peas in: 1/wk 1_1 
811. Lemon/orange in: 1 /wk 1_1 
900. socio-economy, water & sanitation 
page 
2/wk : ý! 3/wk 
2/wk ý3/wk 
2/wk ý3/wk 
2/wk ý3/wk 
2/wk A/wk 
2/wk A/wk 
901. Housing ownership: [1 =Owned 2=Rented] 
902. Number of rooms: 
903. Roofing: [1 =Thatched 2=Corrugated iron] 
904. Source of drinking water: 
[1 =Spring 2=River 3=Pond/Lake 4=Well 5=Other] 
905. Do you have latrine? [1 =Yes 2=Nol 
906. Do you have land of your own? [1 -Yes 2=No] 
How many of the following do you have? 
909. Oxen for ploughing: 1_1_1 910. Cattle (cows): 
911. Sheep/Goat: 1_1_1912. Horse/Mule/Donkey: 1_1_1 
913. Other means of income: (specify) 
NAME OF INTERVIEWER: 
DATE OF INTERVIEW: __/ /I 
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Appendix 11 Clinical Assessment questionnaire 
IRON SUPPLEMENTATION & MALARIA STUDY 
Clinical Assessment Record FORM-clinical-92ID-1 
DATE: (djMjy): j_j_jj_j_jj_j_j SESSION NUMBER: 1_1_1 
100. IDENTIFICATION 
101. Village Id: 1_1_1 
103. Name: 
102. HH 
104. Category (W=women; C=children) 1_1 
105. Code No.: 105. Age: 1_1_1 yr 1_1_1 mo 105. Sex 
200. Anthropometry: [weight in kgs & length in cms] 
201. Weight: 1_1_1.1_1 202. Height: : 
203. Child mid-arm circumference(cý: 
204 Woman's hip cf: 
Woman's waist cf: 
Any present complaint: 
300. On Examination: 
301. Temperature in degree celsius: 
205. 
Mark Y for the presence and N for the absence of the following signs and symptoms. 
302. pale conjunctiva: 
303. sunken eye balls: 
304. ear discharge: 
305. flaring of alae nasa: 
306. wheezing: 
307. chest indrawing: 
308. abnormal heart sound and rhythm: 
309. abdominal distention (except pregnancy): 
310. enlarged liver (hepatomegaly): 
311. enlarged spleen (splenomegaly): 
312. pitting oedema of legs : 1-1 
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313. skin rash (if any): 
314. any abnormal signs of CNS: 
315. any other clinically significant signs: 
400. For pregnant women only: 
401. height of fundus: 
402. foetal position: 
403. any vaginal discharge: 
404. any vaginal bleeding: 
405. any other pregnancy related abnormal sign: 
500. DOCTOR'S DIAGNOSTIC REMARK: (Y/N) 
501. Anaemia: 
502. if yes, 1 =Mild 2=Moderate 3=Severe 
503. Malaria: 
504. if yes, is it severe (coma, jaundice.. etc. ): 
505. Splenomegaly: 
506. Acute Respiratory Infection (ARI): 
507. if yes, is it severe (rpm 50+, chest indrawing): 
508. Diarrhoea: 
509. if yes, is dehydration present: 
510. is dehydration 1 =mild 2=moderate 3=severe 
509. Pregnancy related illness: 
510. if yes, speci 
510. Intestinal helminthic infections: 
511. if yes, specify: 
512. Other disease(s): 
513. if yes, specify: 
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514. any clinical condition that jeopardise supplementation (Y/N) 1-1 
515. if yes specify, 
516. Any laboratory investigation to be made: 
517. if yes, specify 
518. Any treatment prescribed: 
519. if yes, specify 
DOCTOR'S NAME & SIGNATURE: 
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Appendix 111111. Biweekly morbidity survey Questionnaire. 
IRON SUPPLEMENTATION & MALARIA STUDY 
Biweekly Morbidity Survey Questionnaire, FORM BWKLY/94 (CHILD) 
1. IDENTIFICATION INFORMATION 
1.1 Village: 1_1_1_1 1.2 House. no.: 
1.3. Name: 1.4 Code. no. 
2. MEDICAL HISTORY 
2.1 Any visit to health facility in last 2 weeks [1=yes 2=no] 
2.2 If yes, reason for visit 
2.3 Any medication given 
2.4 If yes, specify medication, 
3. Symptoms & signs experienced by child in the past 2 weeks. 
[1=yes 2=no], If yes, indicate duration in days. 
3.1 Fever (being hot than usual) 
3.2 Child don't play as usual 
3.3 Seizure &/or rigors 
3.4 Body pain Ooint, back) 
3.5 Running nose & sneezing 
3.6 Cough 
3.7 Wheezing while breathing 
3.8 Fast & difficult breathing 
3.9 Pain of the ear (hands on ears) 
3.10 Discharge from ears 
3.11 Loss of feeding interest 
3.12 Nausea &/or vomiting 
[1=yes 2=no] 
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3.13 Abdominal pain 
3.14 Diarrhoea, 3 or more per day 
3.15 Is diarrhoea bloody 
3.16 Swelling of lower legs 
3.17 Intestinal worms passed 
3.18 Any other complaint (specify) 
4. INTERVIWER'S ACTION: 
4.1. Temperature (if recorded) 
4.2. Supplementation inspected 
4.3. Any advice or remark 
[1=yes 2=no] 1-1 
NAME: Date: 
-/-/ 
Visit No. 
246 
Appendix IV. Biweekly Morbidity Survey Questionnaire for Women 
IRON SUPPLEMENTATION & MALARIA (ISMAL) STUDY 
Biweekly Morbidity Survey Questionnaire- WONLAN 
1. IDENTIFICATION INFORMATION 
1.1 Village Id. 1_1_1 1.2 House. no. 1_1_1_1 
1.3 Name 1.4 Code number 
2. MEDICAL HISTORY (in the past 2 weeks) 
2.1. Any visit to health facility? [1=Yes 2=No] 
1.2. If yes, reason for visit 
1.3. Any medication given [1=yes 2=no] 
1.4. If yes, specify medication 
1.5. Your last menstruation period in weeks 
1.6. If lactating [I =Continued 2=Discontinued] 
1.7. If discontinued, when? /// 
3. ILLNESSES EXPERIENCED BY THE WOMAN IN THE PAST 2 WEEKS 
[1=yes 2=no], If yes, indicate duration in days. 
3.1. Fever 
3.2. Headache 
3.3. Chills &/or rigors 
3.4. Joint &/or back pain 
3.5. Blurring of vision 
3.6. Generalised body weakness 
3.7. Breathlessness on exertion 
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3.8. Cough 1-1 1-1-1 
I=No 2=Dry 3=Productive 4=Bloody sputum 
3.9. Epigastric pain (burning) 
3.10 Loss of appetite 
3.11 Nausea &/or vomiting 
3.12 Lower abdominal pain 
3.13 Urgency & painful urination 
3.14 Vaginal discharge 
3.15 Vaginal bleeding 
3.16 Swelling of lower legs 
3.17 Any other complaint 
3.18. (specify) 
4. INTERVIWER'S ACTION: 
4.1. Temperature 
4.2. Supplementation inspection 
[I=Continued 2=Discontinued] 
4.3. If discontinued, when? 
4.4. Any advice or remark 
NAME: DATE: /-/-/ VISIT NO. 1_1_j 
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